These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [Fee Required]
|
|
¨
|
Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 [No Fee Required]
|
|
Delaware
|
|
63-1261433
|
|
(State of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
100 Brookwood Place,
Birmingham, AL
|
|
35209
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Title of Each Class
|
|
Name of Each Exchange On Which Registered
|
|
Common Stock, par value $0.01 per share
|
|
New York Stock Exchange
|
|
Large accelerated filer
|
|
ý
|
|
Accelerated filer
|
|
¨
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
The definitive proxy statement for the
2015
Annual Meeting of the Stockholders of ProAssurance Corporation (File No. 001-16533) is incorporated by reference into Part III of this report.
|
|
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
|
|
our ability to maintain our dividend payments;
|
|
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations;
|
|
|
the enactment or repeal of tort reforms;
|
|
|
formation or dissolution of state-sponsored insurance entities providing coverages now offered by ProAssurance which could remove or add sizable numbers of insureds from or to the private insurance market;
|
|
|
changes in the interest rate environment;
|
|
|
changes in U.S. laws or government regulations regarding financial markets or market activity that may affect the U.S. economy and our business;
|
|
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
|
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
|
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the Financial Accounting Standards Board, the Securities and Exchange Commission (SEC), the Public Company Accounting Oversight Board, or the New York Stock Exchange (NYSE) and that may affect our business;
|
|
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or particular insurance lines underwritten by our subsidiaries;
|
|
|
the effect on our insureds, particularly the insurance needs of our insureds, and our loss costs, of changes in the healthcare delivery system, including changes attributable to the Patient Protection and Affordable Care Act (the Affordable Care Act);
|
|
|
consolidation of our insureds into or under larger entities which may not have a risk profile that meets our underwriting criteria or which may not use external providers for insuring or otherwise managing substantial portions of their liability risk;
|
|
|
uncertainties inherent in the estimate of our loss and loss adjustment expense reserve and reinsurance recoverable;
|
|
|
changes in the availability, cost, quality, or collectability of insurance/reinsurance;
|
|
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
|
|
allegations of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
|
|
loss or consolidation of independent agents, agencies, brokers, or brokerage firms;
|
|
|
changes in our organization, compensation and benefit plans;
|
|
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
|
|
our ability to retain and recruit senior management;
|
|
|
the availability, integrity and security of our technology infrastructure;
|
|
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
|
|
the impact of acts of terrorism and acts of war;
|
|
|
the effects of terrorism related insurance legislation and laws;
|
|
|
assessments from guaranty funds;
|
|
|
our ability to achieve continued growth through expansion into other states or through acquisitions or business combinations;
|
|
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
|
|
provisions in our charter documents, Delaware law and state insurance laws may impede attempts to replace or remove management or may impede a takeover;
|
|
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
|
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
|
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees and key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
|
Additional risks that could arise from our membership in the Lloyd's of London market (Lloyd's) and our participation in Lloyd's Syndicate 1729 (Syndicate 1729) include, but are not limited to, the following:
|
|
|
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%, but can be increased by Lloyd's;
|
|
|
Syndicate operating results can be affected by decisions made by the Council of Lloyd's over which the management of Syndicate 1729 has little ability to control, such as a decision to not approve the business plan of the Syndicate, or a decision to increase the capital required to continue operations, and by our obligation to pay levies to Lloyd's;
|
|
|
Lloyd's insurance and reinsurance relationships and distribution channels could be disrupted or Lloyd's trading licenses could be revoked making it more difficult for Syndicate 1729 to distribute and market its products; and
|
|
|
rating agencies could downgrade their ratings of Lloyd's as a whole.
|
|
•
|
American Physicians Service Group, Inc. and subsidiaries, (APS), acquired November 30, 2010,
|
|
•
|
Independent Nevada Doctors Insurance Exchange, (IND), acquired November 30, 2012,
|
|
•
|
Medmarc Mutual Insurance Company and subsidiaries, (Medmarc), acquired January 1, 2013, and
|
|
•
|
Eastern Insurance Holdings, Inc., (Eastern), acquired January 1, 2014.
|
|
•
|
Serve a broad spectrum of the healthcare market, providing specialized expertise to meet evolving demands
. In addition to providing traditional products to healthcare providers in a number of professions, we are also leveraging our reach, expertise and financial strength to provide innovative and customized products to meet the risk management needs of larger organizations or groups.
|
|
•
|
Effectively manage capital.
We carefully monitor use of our capital, and consider various options for capital deployment, such as business expansion by our existing subsidiaries, opportunities that arise for mergers or acquisitions, share repurchases and payment of dividends.
|
|
•
|
Pursue profitable underwriting opportunities.
We emphasize profitability, not market share. Key elements of our approach are prudent risk selection using established underwriting guidelines, appropriate pricing and adjusting our business mix as appropriate to effectively utilize capital and achieve market synergies.
|
|
•
|
Emphasize risk management.
We seek to reduce risk at the corporate level by actively managing our enterprise risk and by maintaining strong internal controls. We also emphasize the importance of risk management to our insureds and offer training in the use of risk reduction tools and techniques.
|
|
•
|
Manage claims effectively.
Our experienced claims teams have industry and insurance expertise that, with our extensive local knowledge, allows us to resolve claims in an effective manner, considering the circumstances of each claim. When practical, we utilize formalized claims management processes and protocols as a means of reducing claim costs.
|
|
•
|
Provide superior customer service.
Our mission statement, We Exist to Protect Others, goes hand-in-hand with our corporate motto, "Treated Fairly." Our employees demonstrate our core values of integrity, respect, involvement of our insureds, collaboration, communication and enthusiasm every day and are focused on meeting the needs of our customers.
|
|
•
|
Maintain a conservative investment strategy.
We believe that we follow a conservative investment strategy designed to emphasize the preservation of our capital and provide adequate liquidity for the prompt payment of claims. Our investment portfolio consists primarily of investment-grade, fixed-maturity securities of short-to medium-term duration.
|
|
•
|
Maintain financial stability
. We are committed to maintaining claims paying ratings of "A" or better.
|
|
•
|
Specialty Property and Casualty Segment
- This segment includes our professional liability business and our medical technology and life sciences business.
|
|
•
|
Workers' Compensation Segment
- This segment includes our workers' compensation business which we provide for employers, groups and associations.
|
|
•
|
Lloyd's Syndicate Segment
- This segment includes operating results from our participation in Lloyd's Syndicate 1729.
|
|
•
|
Corporate Segment -
This segment includes our investing operations managed at the corporate level, non-premium revenues generated outside of our insurance entities, and corporate expenses, including interest and U. S. income taxes.
|
|
|
Year Ended December 31
|
||||||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
2012
|
||||||||||||
|
Professional liability:
|
|
|
|
|
|
|
|
|
|||||||||
|
Healthcare related (1) (2)
|
$
|
449,115
|
|
58
|
%
|
|
$
|
483,494
|
|
85
|
%
|
|
$
|
488,261
|
|
91
|
%
|
|
Legal professionals
|
27,776
|
|
4
|
%
|
|
27,060
|
|
5
|
%
|
|
17,146
|
|
3
|
%
|
|||
|
Medical technology and life sciences products liability
|
35,265
|
|
5
|
%
|
|
34,190
|
|
6
|
%
|
|
—
|
|
—
|
%
|
|||
|
Workers' compensation
|
225,363
|
|
29
|
%
|
|
—
|
|
—
|
%
|
|
—
|
|
—
|
%
|
|||
|
Syndicate 1729: (3)
|
|
|
|
|
|
|
|
|
|||||||||
|
Casualty
|
21,703
|
|
3
|
%
|
|
—
|
|
—
|
%
|
|
—
|
|
—
|
%
|
|||
|
Property
|
6,110
|
|
1
|
%
|
|
—
|
|
—
|
%
|
|
—
|
|
—
|
%
|
|||
|
Catastrophe
|
5,918
|
|
1
|
%
|
|
—
|
|
—
|
%
|
|
—
|
|
—
|
%
|
|||
|
All other, primarily tail
|
20,452
|
|
3
|
%
|
|
22,803
|
|
4
|
%
|
|
31,024
|
|
6
|
%
|
|||
|
Inter-segment revenues (2)
|
(12,093
|
)
|
(2
|
%)
|
|
—
|
|
—
|
%
|
|
—
|
|
—
|
%
|
|||
|
Total
|
$
|
779,609
|
|
100
|
%
|
|
$
|
567,547
|
|
100
|
%
|
|
$
|
536,431
|
|
100
|
%
|
|
(2)
|
In 2014, Lloyd's Syndicate 1729 casualty premiums included
$12.1 million
of healthcare related premiums assumed from our Specialty P&C segment. The assumption was eliminated on a consolidated basis.
|
|
(3)
|
Attributable to our 58% share of premiums written by Syndicate 1729.
|
|
•
|
Traditional workers' compensation insurance coverages provided to employers, generally those with 1,000 employees or less. Types of policies offered include guaranteed cost policies, policyholder dividend policies, retrospectively-rated policies, and deductible policies.
|
|
•
|
Alternative market workers’ compensation solutions provided to individual companies, groups and associations whereby the policy written is 100% reinsured though a reinsurance entity owned by or related to the policyholder. Most often this reinsurance entity is a segregated portfolio cell (SPC) operated through Eastern Re Ltd., SPC (Eastern Re), our subsidiary domiciled in the Cayman Islands. Each SPC is owned, fully or in part, by the policyholder or affiliates of the policyholder, hereafter referred to as cell participants. The SPC is operated solely for the benefit of cell participants of that particular cell, and the pool of assets of one segregated portfolio cell are statutorily protected from the creditors of any other SPC. The underwriting results and investment income of the segregated portfolio cells are shared with the cell participants in accordance with the terms of the cell agreements. We are a partial owner in selected SPCs and receive a share of the earnings of these SPCs. We generally hold a 50% participation, but our interest ranges from 25% to 82.5%. Our share of SPC profits for the year ended
December 31, 2014
was approximately
27%
.
|
|
•
|
for reported claims, the nature of the claim and the jurisdiction in which the claim occurred;
|
|
•
|
trends in paid and incurred loss development;
|
|
•
|
trends in claim frequency and severity;
|
|
•
|
emerging economic and social trends;
|
|
•
|
trend of healthcare costs for claims involving bodily injury;
|
|
•
|
inflation and levels of employment; and
|
|
•
|
changes in the regulatory, legal and political environment.
|
|
|
|
Rating Agency (1)
|
||||
|
|
|
A.M. Best
(www.ambest.com) |
|
Fitch
(www.fitchratings.com) |
|
Moody’s
(www.moodys.com) |
|
ProAssurance Indemnity Company, Inc.
|
|
A+ (Superior)
|
|
A (Strong)
|
|
A2
|
|
ProAssurance Casualty Company
|
|
A+ (Superior)
|
|
A (Strong)
|
|
A2
|
|
ProAssurance Specialty Insurance Company, Inc.
|
|
A+ (Superior)
|
|
A (Strong)
|
|
NR
|
|
Podiatry Insurance Company of America
|
|
A (Excellent)
|
|
A (Strong)
|
|
A2
|
|
PACO Assurance Company, Inc.
|
|
A- (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Noetic Specialty Insurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Medmarc Casualty Insurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Lloyd's Syndicate 1729 (2)
|
|
A (Excellent)
|
|
AA- (Strong)
|
|
NR
|
|
Eastern Alliance Insurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Allied Eastern Indemnity Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Eastern Advantage Assurance Company
|
|
A (Excellent)
|
|
A (Strong)
|
|
NR
|
|
Eastern Re Ltd., SPC
|
|
A (Excellent)
|
|
NR
|
|
NR
|
|
(1)
NR indicates that the subsidiary has not been rated by the listed rating agency.
|
|
|
||||
|
(2)
Rating provided is the rating applicable to all Lloyd's syndicates.
|
|
|
||||
|
•
|
licensing requirements;
|
|
•
|
trade practices;
|
|
•
|
capital and surplus requirements;
|
|
•
|
investment practices; and
|
|
•
|
rates charged to insurance customers.
|
|
•
|
its reliance on insurance and reinsurance brokers and distribution channels to distribute and market its products;
|
|
•
|
its obligation to pay levies to Lloyds;
|
|
•
|
its obligations to maintain funds to support its underwriting activities in that its risk-based capital requirements are assessed periodically by Lloyd's and subject to variation;
|
|
•
|
its reliance on ongoing approvals from Lloyd's and various regulators to conduct its business, including a requirement that its Annual Business Plan be approved by Lloyd's before the start of underwriting for each account year;
|
|
•
|
its financial strength rating is derived from the rating assigned to Lloyd's, although it has limited ability to directly affect the overall Lloyd's rating; and
|
|
•
|
its reliance on Lloyd's trading licenses in order to underwrite business outside the U.K.
|
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS.
|
|
ITEM 2.
|
PROPERTIES.
|
|
|
|
Square Footage of Properties
|
|||||||
|
Property Location
|
|
Occupied by
ProAssurance |
|
Leased or Available
for Lease |
|
Total
|
|||
|
Birmingham, AL*
|
|
104,000
|
|
|
61,000
|
|
|
165,000
|
|
|
Franklin, TN
|
|
52,000
|
|
|
51,000
|
|
|
103,000
|
|
|
Okemos, MI
|
|
53,000
|
|
|
—
|
|
|
53,000
|
|
|
Madison, WI
|
|
38,000
|
|
|
—
|
|
|
38,000
|
|
|
Las Vegas, NV
|
|
4,640
|
|
|
—
|
|
|
4,640
|
|
|
ITEM 3.
|
LEGAL PROCEEDINGS.
|
|
W. Stancil Starnes
|
|
Mr. Starnes was appointed as Chief Executive Officer in 2007 and has served as the Chairman of the Board since 2008. In 2012 he was appointed President of ProAssurance. Mr. Starnes previously served as President, Corporate Planning and Administration of Brasfield & Gorrie, Inc., a large national commercial contractor. Prior to 2006, Mr. Starnes served as the Senior and Managing Partner of the law firm of Starnes & Atchison, LLP, where he was extensively involved with ProAssurance and its predecessors in the defense of healthcare professional liability claims for over 25 years. Mr. Starnes currently serves as a director of Infinity Property and Casualty Corporation, a public insurance holding company, where he serves on the audit, compensation and executive committees. He is also on the Board of Directors of The National Bank of Commerce, located in Birmingham, Alabama, where he serves as Chairman of the Nominating and Corporate Governance Committee and is a member of the compensation committee. (Age 66)
|
|
|
|
|
|
Howard H. Friedman
|
|
Mr. Friedman was appointed as President of our Healthcare Professional Liability Group in 2014, and is also our Chief Underwriting Officer and Chief Actuary. Mr. Friedman has previously served as a Co-President of our Professional Liability Group, Chief Financial Officer, Corporate Secretary, and as the Senior Vice President of Corporate Development. Mr. Friedman joined our predecessor in 1996. Mr. Friedman is an Associate of the Casualty Actuarial Society and a member of the American Academy of Actuaries. (Age 56)
|
|
|
|
|
|
Jeffrey P. Lisenby
|
|
Mr. Lisenby was appointed as an Executive Vice President in 2014 and is also our General Counsel, Corporate Secretary and head of the corporate Legal Department. Mr. Lisenby has previously served as Senior Vice President. Prior to joining ProAssurance, Mr. Lisenby practiced law privately in Birmingham, Alabama. Mr. Lisenby is a member of the Alabama State Bar and the United States Supreme Court Bar and is a Chartered Property Casualty Underwriter. (Age 46)
|
|
|
|
|
|
Edward L. Rand, Jr.
|
|
Mr. Rand was appointed as an Executive Vice President in 2014 and is also our Chief Financial Officer. Mr. Rand previously served as our Senior Vice President of Finance upon joining ProAssurance in 2004. Prior to joining ProAssurance, Mr. Rand was the Chief Accounting Officer and Head of Corporate Finance for PartnerRe Ltd. Prior to that time Mr. Rand served as the Chief Financial Officer of Atlantic American Corporation. (Age 48)
|
|
|
|
|
|
Frank B. O’Neil
|
|
Mr. O’Neil was appointed as our Senior Vice President and Chief Communications Officer in 2001. Mr. O’Neil has previously served as our Senior Vice President of Corporate Communications, having joined our predecessor in 1987. (Age 61)
|
|
|
|
|
|
Michael L. Boguski
|
|
Mr. Boguski is President of our Eastern subsidiary. Prior to the acquisition of Eastern, Mr. Boguski served as President and Chief Executive Officer of Eastern, and first joined Eastern in 1997. (Age 52)
|
|
|
|
|
|
Mary Todd Peterson
|
|
Ms. Peterson is President of our Medmarc subsidiary. Prior to the acquisition of Medmarc, Ms. Peterson served as Medmarc's President and CEO. She previously served as Medmarc's Senior Vice President and Chief Operating Officer as well as its Senior Vice President, Chief Financial Officer and Treasurer. Ms. Peterson serves on the Board of Governors for the Property Casualty Insurance Association of America where she chairs the Investment Committee and serves on the Executive and Finance Committees. Ms. Peterson also serves on the Board of Directors of The Community Financial Corporation where she chairs the Audit Committee. (Age 60)
|
|
|
|
|
|
Ross E. Taubman
|
|
Dr. Taubman is President and Chief Medical Officer of our PICA subsidiary. Prior to joining PICA, Dr. Taubman practiced podiatry for 26 years. During that time, Dr. Taubman served as Treasurer, Vice-President and President of the Maryland Podiatric Medical Association. Dr. Taubman is a diplomate in the American Board of Podiatric Surgery. (Age 57)
|
|
|
|
|
|
Kelly B. Brewer
|
|
Ms. Brewer was appointed as our Chief Accounting Officer in 2014 and has served as our Vice President of Finance since joining ProAssurance in 2008. Prior to joining ProAssurance, Ms. Brewer was a Senior Manager for PricewaterhouseCoopers for four years. Prior to that time Ms. Brewer served financial services clients in audit and forensic accounting engagements for five years. Ms. Brewer is a Certified Public Accountant. (Age 39)
|
|
|
|
2014
|
|
2013
|
||||||||||||||||
|
Quarter
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||||||
|
First
|
|
$
|
48.11
|
|
|
|
$
|
42.90
|
|
|
|
$
|
47.92
|
|
|
|
$
|
43.06
|
|
|
|
Second
|
|
45.79
|
|
|
|
43.71
|
|
|
|
52.73
|
|
|
|
47.11
|
|
|
||||
|
Third
|
|
46.58
|
|
|
|
43.63
|
|
|
|
55.28
|
|
|
|
45.06
|
|
|
||||
|
Fourth
|
|
48.08
|
|
|
|
43.78
|
|
|
|
49.38
|
|
|
|
42.70
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Dividends Declared
|
|
|
Dividends Paid
|
|
||||||||||||||
|
Quarter
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||
|
First
|
|
$
|
0.30
|
|
|
|
$
|
0.25
|
|
|
|
$
|
0.30
|
|
|
|
$
|
—
|
|
|
|
Second
|
|
0.30
|
|
|
|
0.25
|
|
|
|
0.30
|
|
|
|
0.25
|
|
|
||||
|
Third
|
|
0.30
|
|
|
|
0.25
|
|
|
|
0.30
|
|
|
|
0.25
|
|
|
||||
|
Fourth*
|
|
2.96
|
|
|
|
0.30
|
|
|
|
0.30
|
|
|
|
0.25
|
|
|
||||
|
Plan Category
|
|
Number of securities to be
issued upon exercise of outstanding options, warrants and rights |
|
Weighted-average
exercise price of outstanding options, warrants and rights |
|
Number of securities
remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
|
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
796,934
|
|
$24.64
|
*
|
2,680,075
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
—
|
|
—
|
|
Period
|
|
Total Number of
Shares Purchased |
|
Average
Price Paid per Share |
|
Total Number
of Shares Purchased as Part of Publicly Announced Plans or Programs |
|
Approximate Dollar
Value of Shares that May Yet Be Purchased Under the Plans or Programs * (in thousands) |
|
October 1 - 31, 2014
|
|
496,623
|
|
$44.77
|
|
496,623
|
|
$111,869
|
|
November 1 - 30, 2014
|
|
363,388
|
|
$45.48
|
|
363,388
|
|
$97,880
|
|
December 1 - 31, 2014
|
|
348,474
|
|
$46.86
|
|
348,474
|
|
$181,542
|
|
Total
|
|
1,208,485
|
|
$45.59
|
|
1,208,485
|
|
|
|
|
|
Year Ended December 31
|
||||||||||||||||||
|
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
|
|
(In thousands except per share data)
|
||||||||||||||||||
|
Selected Financial Data
(1)
|
|
|
||||||||||||||||||
|
Gross premiums written
|
|
$
|
779,609
|
|
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
565,895
|
|
|
$
|
533,205
|
|
|
Net premiums earned
|
|
699,731
|
|
|
527,919
|
|
|
550,664
|
|
|
565,415
|
|
|
519,107
|
|
|||||
|
Net investment income
|
|
125,557
|
|
|
129,265
|
|
|
136,094
|
|
|
140,956
|
|
|
146,380
|
|
|||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
3,986
|
|
|
7,539
|
|
|
(6,873
|
)
|
|
(9,147
|
)
|
|
1,245
|
|
|||||
|
Net realized investment gains (losses)
|
|
14,654
|
|
|
67,904
|
|
|
28,863
|
|
|
5,994
|
|
|
17,342
|
|
|||||
|
Other revenues
|
|
8,398
|
|
|
7,551
|
|
|
7,106
|
|
|
13,566
|
|
|
7,991
|
|
|||||
|
Total revenues
|
|
852,326
|
|
|
740,178
|
|
|
715,854
|
|
|
716,784
|
|
|
692,065
|
|
|||||
|
Net losses and loss adjustment expenses
|
|
363,084
|
|
|
224,761
|
|
|
179,913
|
|
|
162,287
|
|
|
221,115
|
|
|||||
|
Net income (2)
|
|
$
|
196,565
|
|
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
$
|
287,096
|
|
|
$
|
231,598
|
|
|
Net income per share (3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
$
|
3.32
|
|
|
$
|
4.82
|
|
|
$
|
4.49
|
|
|
$
|
4.70
|
|
|
$
|
3.64
|
|
|
Diluted
|
|
$
|
3.30
|
|
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
$
|
4.65
|
|
|
$
|
3.60
|
|
|
Weighted average shares outstanding (3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
|
59,285
|
|
|
61,761
|
|
|
61,342
|
|
|
61,140
|
|
|
63,576
|
|
|||||
|
Diluted
|
|
59,525
|
|
|
62,020
|
|
|
61,833
|
|
|
61,684
|
|
|
64,351
|
|
|||||
|
Balance Sheet Data, as of December 31
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total investments
|
|
$
|
4,009,707
|
|
|
$
|
3,941,045
|
|
|
$
|
3,926,902
|
|
|
$
|
4,090,541
|
|
|
$
|
3,990,431
|
|
|
Total assets
|
|
5,169,160
|
|
|
5,150,099
|
|
|
4,876,578
|
|
|
4,998,878
|
|
|
4,875,056
|
|
|||||
|
Reserve for losses and loss adjustment expenses
|
|
2,058,266
|
|
|
2,072,822
|
|
|
2,054,994
|
|
|
2,247,772
|
|
|
2,414,100
|
|
|||||
|
Long-term debt
|
|
250,000
|
|
|
250,000
|
|
|
125,000
|
|
|
49,687
|
|
|
51,104
|
|
|||||
|
Total liabilities
|
|
3,011,216
|
|
|
2,755,685
|
|
|
2,605,998
|
|
|
2,834,425
|
|
|
3,019,193
|
|
|||||
|
Total capital
|
|
$
|
2,157,944
|
|
|
$
|
2,394,414
|
|
|
$
|
2,270,580
|
|
|
$
|
2,164,453
|
|
|
$
|
1,855,863
|
|
|
Total capital per share of common stock outstanding (3)
|
|
$
|
38.17
|
|
|
$
|
39.13
|
|
|
$
|
36.85
|
|
|
$
|
35.42
|
|
|
$
|
30.17
|
|
|
Common stock outstanding, period end (3)
|
|
56,534
|
|
|
61,197
|
|
|
61,624
|
|
|
61,107
|
|
|
61,506
|
|
|||||
|
(1)
|
Includes acquired entities since date of acquisition only.
|
|
(2)
|
Includes a loss on extinguishment of debt of
$2.2 million
for the year ended December 31, 2012.
|
|
(3)
|
For all periods presented, share and per share amounts reflect the effect of the two-for-one stock split effected in the form of a stock dividend that was effective December 27, 2012.
|
|
•
|
The
net loss ratio
is calculated as net losses incurred divided by net premiums earned and is a component of underwriting profitability.
|
|
•
|
The
underwriting expense ratio
is calculated as underwriting, policy acquisition and operating expenses incurred divided by net premiums earned and is a component of underwriting profitability.
|
|
•
|
The
combined ratio
is the sum of the underwriting expense ratio and the net loss ratio and measures underwriting profitability.
|
|
•
|
The
investment income ratio
is calculated as net investment income divided by net premiums earned and measures the contribution investment earnings provides to our overall profitability.
|
|
•
|
The
operating ratio
is the combined ratio, less the investment income ratio. This ratio provides the combined effect of investment income and underwriting profitability.
|
|
•
|
The
tax ratio
is calculated as total income tax expense divided by income (loss) before income taxes and measures our effective tax rate.
|
|
•
|
Return on equity (ROE)
is calculated as net income for the period divided by the average of beginning and ending shareholders’ equity. This ratio measures our overall after-tax profitability and shows how efficiently invested capital is being used.
|
|
•
|
Growth in book value.
Book value per share is calculated as total shareholders’ equity at the balance sheet date divided by the total number of common shares outstanding. This ratio measures the net worth of the company to shareholders on a per-share basis. The declaration of dividends decreases book value per share. Growth in book value per share adjusted for dividends declared is an indicator of overall profitability.
|
|
•
|
Bornhuetter-Ferguson (Paid and Reported) Method
|
|
•
|
Paid Development Method
|
|
•
|
Reported Development Method
|
|
•
|
Average Paid Value Method
|
|
•
|
Average Reported Value Method
|
|
•
|
Backward Recursive Development Method
|
|
•
|
The Adjusted Reported and the Adjusted Paid Methods
|
|
(In thousands)
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance at December 31, 2014
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
2014
|
$395,067
|
|
N/A
|
|
19.8%
|
|
N/A
|
|
N/A
|
|
N/A
|
|
N/A
|
|
2013
|
435,516
|
|
$14
|
|
53.4%
|
|
N/A
|
|
18.7%
|
|
N/A
|
|
N/A
|
|
2012
|
465,722
|
|
(7,528)
|
|
73.2%
|
|
$5,905
|
|
46.6%
|
|
N/A
|
|
13.5%
|
|
2011
|
450,124
|
|
(37,246)
|
|
84.5%
|
|
(11,022)
|
|
69.5%
|
|
$(4,889)
|
|
45.0%
|
|
2010
|
434,458
|
|
(34,399)
|
|
91.8%
|
|
(26,032)
|
|
82.4%
|
|
(13,612)
|
|
68.8%
|
|
2009
|
395,560
|
|
(24,995)
|
|
94.9%
|
|
(44,086)
|
|
89.0%
|
|
(24,378)
|
|
80.6%
|
|
2008
|
370,919
|
|
(14,598)
|
|
97.5%
|
|
(38,233)
|
|
94.6%
|
|
(55,659)
|
|
90.3%
|
|
2007
|
355,276
|
|
(11,476)
|
|
98.7%
|
|
(34,199)
|
|
97.2%
|
|
(51,047)
|
|
93.9%
|
|
2006
|
337,357
|
|
(4,673)
|
|
99.2%
|
|
(19,680)
|
|
98.5%
|
|
(38,708)
|
|
97.1%
|
|
2005
|
360,029
|
|
(5,092)
|
|
99.4%
|
|
(14,232)
|
|
99.0%
|
|
(24,961)
|
|
98.4%
|
|
Prior to 2005
|
$5,891,013
|
|
(28,862)
|
|
|
|
(27,420)
|
|
|
|
(58,785)
|
|
|
|
($ in millions)
|
2014
|
|
2013
|
|
2012
|
|
Prior accident years
|
2011-2013
|
|
2010-2012
|
|
2009-2011
|
|
Net favorable development recognized for the specified years
|
$44.8
|
|
$31.1
|
|
$42.9
|
|
Development as a % of established ultimates, prior calendar year end
|
3.2%
|
|
2.1%
|
|
2.9%
|
|
(In thousands)
|
|
|
2014
|
|
2013
|
||||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance at December 31, 2014
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
2014
|
$13,920
|
|
N/A
|
|
48.6%
|
|
N/A
|
|
N/A
|
|
2013
|
12,032
|
|
$(2)
|
|
74.1%
|
|
N/A
|
|
36.1%
|
|
2012
|
13,456
|
|
1,891
|
|
84.8%
|
|
$(1,521)
|
|
66.7%
|
|
2011
|
18,695
|
|
(3,635)
|
|
75.8%
|
|
(1,330)
|
|
63.6%
|
|
2010
|
27,169
|
|
(4,997)
|
|
94.9%
|
|
(371)
|
|
65.1%
|
|
2009
|
25,740
|
|
(4,693)
|
|
95.4%
|
|
(3,264)
|
|
92.4%
|
|
2008
|
46,645
|
|
2,997
|
|
99.7%
|
|
(3,645)
|
|
98.3%
|
|
Prior to 2008
|
498,970
|
|
(3,492)
|
|
|
|
(3,619)
|
|
|
|
(In thousands)
|
|
|
2014
|
||
|
Accident Years
|
Estimated Ultimate Losses, Net of Reinsurance at December 31, 2014
|
|
Reserve Development (favorable) unfavorable
|
|
% of Known Claims Closed
|
|
2014
|
$126,854
|
|
N/A
|
|
41.4%
|
|
2013
|
117,314
|
|
$1,519
|
|
82.9%
|
|
2012
|
101,986
|
|
(463)
|
|
93.6%
|
|
2011
|
95,398
|
|
854
|
|
97.4%
|
|
2010
|
76,011
|
|
(288)
|
|
98.8%
|
|
2009
|
66,061
|
|
(412)
|
|
99.1%
|
|
Prior to 2009
|
351,705
|
|
(955)
|
|
|
|
|
Low End Point
|
|
Carried Net Reserve
|
|
High End Point
|
|
80% Confidence Level
|
$1.402 billion
|
|
$1.820 billion
|
|
$2.294 billion
|
|
60% Confidence Level
|
$1.516 billion
|
|
$1.820 billion
|
|
$2.102 billion
|
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
December 31, 2014
|
||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
Investments |
|
Investments recorded at:
|
|
|
|
|
|
|
|
|
Fair value
|
10%
|
|
80%
|
|
4%
|
|
94%
|
|
Other valuations
|
|
|
|
|
|
|
6%
|
|
Total Investments
|
|
|
|
|
|
|
100%
|
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement
Method |
||
|
Other investments:
|
|
|
|
||
|
Investments in LPs, at cost
|
$
|
53.3
|
|
|
Cost
|
|
Other, principally Federal Home Loan Bank capital stock
|
3.8
|
|
|
Cost
|
|
|
Total other investments
|
57.1
|
|
|
|
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
||
|
Investments in tax credit partnerships
|
133.1
|
|
|
Equity
|
|
|
Equity method LPs/LLCs
|
10.1
|
|
|
Equity
|
|
|
Total investment in unconsolidated
|
143.2
|
|
|
|
|
|
Business owned life insurance
|
56.4
|
|
|
Cash surrender value
|
|
|
Total investments - Other valuation methodologies
|
$
|
256.7
|
|
|
|
|
•
|
third party research and credit rating reports;
|
|
•
|
the current credit standing of the issuer, including credit rating downgrades;
|
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
|
•
|
our internal assessments and those of our external portfolio managers regarding specific circumstances surrounding a security, which can cause us to believe the security is more or less likely to recover its value than other securities with a similar structure;
|
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
|
•
|
any changes to the rating of the security by a rating agency;
|
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date; and
|
|
•
|
our intent to sell and whether it is more likely than not we will be required to sell the security before the recovery of its amortized cost basis.
|
|
|
Operating Cash Flow
|
||||||||||
|
|
Year Ended December 31,
|
||||||||||
|
(In millions)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Cash provided by operating activities
|
$
|
96
|
|
|
$
|
39
|
|
|
$
|
91
|
|
|
|
|
|
|
|
|
||||||
|
Reconciliation of Operating Cash Flows
|
2014 vs 2013
|
|
2013 vs 2012
|
|
2012 vs 2011
|
||||||
|
Cash provided by operating activities, prior year
|
$
|
39
|
|
|
$
|
91
|
|
|
$
|
159
|
|
|
Increase (decrease) in operating cash flows attributable to:
|
|
|
|
|
|
||||||
|
Premium receipts
|
(30
|
)
|
|
(33
|
)
|
|
(12
|
)
|
|||
|
Payments to reinsurers
|
(14
|
)
|
|
3
|
|
|
(8
|
)
|
|||
|
Losses paid, net of reinsurance recoveries
|
(3
|
)
|
|
(3
|
)
|
|
(35
|
)
|
|||
|
Deposit contracts
|
—
|
|
|
(4
|
)
|
|
3
|
|
|||
|
Cash received from investments
|
(10
|
)
|
|
(9
|
)
|
|
(8
|
)
|
|||
|
Cash paid for other expenses and operating liabilities
|
(5
|
)
|
|
6
|
|
|
13
|
|
|||
|
Cash paid for interest on long-term debt
|
(13
|
)
|
|
2
|
|
|
1
|
|
|||
|
Federal and state income tax payments
|
95
|
|
|
(3
|
)
|
|
(18
|
)
|
|||
|
Operations acquired or begun during the period
|
34
|
|
|
(11
|
)
|
|
—
|
|
|||
|
Other amounts not individually significant, net
|
3
|
|
|
—
|
|
|
(4
|
)
|
|||
|
Cash provided by operating activities, current year
|
$
|
96
|
|
|
$
|
39
|
|
|
$
|
91
|
|
|
(In millions)
|
2014 vs 2013
|
|
2013 vs 2012
|
|
2012 vs 2011
|
||||||
|
Effect of Syndicate 1729 reporting lag (1)
|
$
|
(8.0
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Other (2)
|
3.5
|
|
|
6.4
|
|
|
13.0
|
|
|||
|
|
$
|
(4.5
|
)
|
|
$
|
6.4
|
|
|
$
|
13.0
|
|
|
(1)
|
We report Syndicate 1729 activity on a one quarter lag, and, for consistency, have reported the reinsurance payment made to Syndicate 1729 during the fourth quarter of 2014 as an operating liability payment.
|
|
(2)
|
The increase for 2012 primarily reflects the effect of acquisition payments made during 2011 related to the integration costs of an entity acquired in 2010.
|
|
(In millions)
|
2014 vs 2013
|
|
2013 vs 2012
|
|
2012 vs 2011
|
||||||
|
Refunds and payments related to Internal Revenue Service (IRS) examination settled in 2014 (1)
|
$
|
51.1
|
|
|
$
|
(20.6
|
)
|
|
$
|
—
|
|
|
Final tax payments made in the current year for the prior fiscal year
|
29.6
|
|
|
8.3
|
|
|
(7.4
|
)
|
|||
|
Estimated tax payments for the current fiscal year
|
17.0
|
|
|
3.4
|
|
|
4.8
|
|
|||
|
Change in excess tax benefits associated with share-based compensation (2)
|
0.4
|
|
|
4.9
|
|
|
(5.3
|
)
|
|||
|
Refunds and payments related to prior years (3)
|
(3.3
|
)
|
|
|
|
(11.4
|
)
|
||||
|
State and other tax payments
|
0.5
|
|
|
1.0
|
|
|
1.8
|
|
|||
|
|
$
|
95.3
|
|
|
$
|
(3.0
|
)
|
|
$
|
(17.5
|
)
|
|
(1)
|
The effect of funds returned in 2014 and a protective tax payment made in 2013 related to an IRS examination of our 2009 and 2010 tax returns. See discussion that follows under the heading "Taxes."
|
|
(2)
|
GAAP requires that excess tax benefits recognized when shares are issued under stock compensation plans be reflected as a reduction to operating cash flows and as an increase to financing cash flows in the period the shares are issued.
|
|
(3)
|
Both 2014 and 2013 were affected by a refund received in 2013 of
$3.3 million
related to pre-acquisition tax periods of acquired entities. Comparatively, our 2012 cash flows were lower than in 2011 due to refunds received in 2011 of
$17.3 million
related to pre-acquisition tax periods of acquired entities and capital loss carry backs, and a payment made in 2011 of
$5.9 million
which related to previously recorded tax liabilities for the 2008 and 2007 tax years.
|
|
(In millions)
|
2014 vs 2013
|
|
2013 vs 2012
|
|
2012 vs 2011
|
||||||
|
Cash flows contributed in the year operations commenced or were acquired, including the effect of transaction-related costs paid in the fiscal year in which the transaction is closed:
|
|
|
|
|
|
||||||
|
Eastern acquisition
|
$
|
31.2
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Lloyd's Syndicate operations
|
(0.9
|
)
|
|
—
|
|
|
—
|
|
|||
|
Medmarc and IND acquisitions (1)
|
—
|
|
|
(7.7
|
)
|
|
—
|
|
|||
|
Transaction costs (2)
|
3.2
|
|
|
(3.2
|
)
|
|
—
|
|
|||
|
|
$
|
33.5
|
|
|
$
|
(10.9
|
)
|
|
$
|
—
|
|
|
(1)
|
Primarily attributable to transaction costs, loss payments related to accident years prior to the acquisition, and normal expense payments for which the timing of the payment differs from the recognition of the expense.
|
|
(2)
|
In 2013 we paid approximately $3.2 million related to the formation of Syndicate 1729, which, comparatively, increased 2014 cash flows.
|
|
•
|
The line entitled “Reserve for losses, undiscounted and net of reinsurance recoverables” reflects our reserve for losses and loss adjustment expense, less the receivables from reinsurers, each as reported in our consolidated financial statements at the end of each year (the Balance Sheet Reserves).
|
|
•
|
The section entitled “Cumulative net paid, as of” reflects the cumulative amounts paid as of the end of each succeeding year with respect to the previously recorded Balance Sheet Reserves.
|
|
•
|
The section entitled “Re-estimated net liability as of” reflects the re-estimated amount of the liability previously recorded as Balance Sheet Reserves that includes the cumulative amounts paid and an estimate of the remaining net liability based upon claims experience as of the end of each succeeding year (the Net Re-estimated Liability).
|
|
•
|
The line entitled “Net cumulative redundancy (deficiency)” reflects the difference between the previously recorded Balance Sheet Reserve for each applicable year and the Net Re-estimated Liability relating thereto as of the end of the most recent fiscal year.
|
|
Analysis of Reserve Development
|
|||||||||||||||||||||||||||||||||||||||||||
|
(in thousands)
|
|||||||||||||||||||||||||||||||||||||||||||
|
December 31,
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
||||||||||||||||||||||
|
Reserve for losses, undiscounted and net of reinsurance recoverables
|
$
|
1,544,981
|
|
|
$
|
1,896,743
|
|
|
$
|
2,236,385
|
|
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
$
|
1,820,300
|
|
|
Cumulative net paid, as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
One Year Later
|
199,617
|
|
|
242,608
|
|
|
331,295
|
|
|
312,348
|
|
|
278,655
|
|
|
291,654
|
|
|
264,597
|
|
|
300,703
|
|
|
311,835
|
|
|
343,197
|
|
|
|
||||||||||||
|
Two Years Later
|
384,050
|
|
|
503,271
|
|
|
600,500
|
|
|
550,042
|
|
|
468,277
|
|
|
476,682
|
|
|
491,657
|
|
|
526,903
|
|
|
563,805
|
|
|
|
|
|
|||||||||||||
|
Three Years Later
|
578,455
|
|
|
697,349
|
|
|
787,347
|
|
|
694,113
|
|
|
584,410
|
|
|
614,369
|
|
|
639,220
|
|
|
682,576
|
|
|
|
|
|
|
|
||||||||||||||
|
Four Years Later
|
728,582
|
|
|
825,139
|
|
|
897,814
|
|
|
777,114
|
|
|
666,105
|
|
|
706,091
|
|
|
737,253
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Five Years Later
|
805,270
|
|
|
901,644
|
|
|
955,728
|
|
|
833,471
|
|
|
724,377
|
|
|
761,659
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Six Years Later
|
861,512
|
|
|
937,984
|
|
|
995,921
|
|
|
874,479
|
|
|
758,863
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Seven Years Later
|
888,065
|
|
|
959,870
|
|
|
1,022,273
|
|
|
898,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Eight Years Later
|
901,867
|
|
|
980,665
|
|
|
1,038,821
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Nine Years Later
|
919,840
|
|
|
996,393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Ten Years Later
|
930,128
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Re-estimated net liability as of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
End of Year
|
1,544,981
|
|
|
1,896,743
|
|
|
2,236,385
|
|
|
2,232,596
|
|
|
2,111,112
|
|
|
2,159,571
|
|
|
2,136,664
|
|
|
2,000,114
|
|
|
1,860,076
|
|
|
1,825,304
|
|
|
|
||||||||||||
|
One Year Later
|
1,522,000
|
|
|
1,860,451
|
|
|
2,131,400
|
|
|
2,047,344
|
|
|
1,903,812
|
|
|
1,925,581
|
|
|
1,810,799
|
|
|
1,728,076
|
|
|
1,644,203
|
|
|
1,644,516
|
|
|
|
||||||||||||
|
Two Years Later
|
1,479,773
|
|
|
1,764,076
|
|
|
1,955,903
|
|
|
1,829,140
|
|
|
1,665,832
|
|
|
1,615,603
|
|
|
1,543,650
|
|
|
1,498,158
|
|
|
1,472,259
|
|
|
|
|
|
|||||||||||||
|
Three Years Later
|
1,418,802
|
|
|
1,615,125
|
|
|
1,747,459
|
|
|
1,596,508
|
|
|
1,383,189
|
|
|
1,362,538
|
|
|
1,324,906
|
|
|
1,342,996
|
|
|
|
|
|
|
|
||||||||||||||
|
Four Years Later
|
1,340,061
|
|
|
1,450,275
|
|
|
1,548,605
|
|
|
1,357,126
|
|
|
1,154,552
|
|
|
1,172,091
|
|
|
1,205,737
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Five Years Later
|
1,234,223
|
|
|
1,330,039
|
|
|
1,366,793
|
|
|
1,185,051
|
|
|
1,019,407
|
|
|
1,086,027
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Six Years Later
|
1,158,590
|
|
|
1,225,114
|
|
|
1,249,234
|
|
|
1,084,422
|
|
|
961,808
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
Seven Years Later
|
1,092,186
|
|
|
1,148,102
|
|
|
1,180,804
|
|
|
1,041,623
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Eight Years Later
|
1,040,035
|
|
|
1,104,687
|
|
|
1,147,096
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
Nine Years Later
|
1,012,643
|
|
|
1,084,527
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Ten Years Later
|
996,312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
Net cumulative redundancy (deficiency)
|
$
|
548,669
|
|
|
$
|
812,216
|
|
|
$
|
1,089,289
|
|
|
$
|
1,190,973
|
|
|
$
|
1,149,304
|
|
|
$
|
1,073,544
|
|
|
$
|
930,927
|
|
|
$
|
657,118
|
|
|
$
|
387,817
|
|
|
$
|
180,788
|
|
|
|
||
|
Original gross liability - end of year
|
$
|
1,818,635
|
|
|
$
|
2,224,436
|
|
|
$
|
2,607,148
|
|
|
$
|
2,559,707
|
|
|
$
|
2,379,468
|
|
|
$
|
2,422,230
|
|
|
$
|
2,414,100
|
|
|
$
|
2,247,772
|
|
|
$
|
2,051,428
|
|
|
$
|
2,072,822
|
|
|
|
||
|
Less: reinsurance recoverables
|
(273,654
|
)
|
|
(327,693
|
)
|
|
(370,763
|
)
|
|
(327,111
|
)
|
|
(268,356
|
)
|
|
(262,659
|
)
|
|
(277,436
|
)
|
|
(247,658
|
)
|
|
(191,352
|
)
|
|
(247,518
|
)
|
|
|
||||||||||||
|
Original net liability - end of year
|
$
|
1,544,981
|
|
|
$
|
1,896,743
|
|
|
$
|
2,236,385
|
|
|
$
|
2,232,596
|
|
|
$
|
2,111,112
|
|
|
$
|
2,159,571
|
|
|
$
|
2,136,664
|
|
|
$
|
2,000,114
|
|
|
$
|
1,860,076
|
|
|
$
|
1,825,304
|
|
|
|
||
|
Gross re-estimated liability - latest
|
$
|
1,267,771
|
|
|
$
|
1,400,859
|
|
|
$
|
1,505,436
|
|
|
$
|
1,283,526
|
|
|
$
|
1,112,413
|
|
|
$
|
1,214,995
|
|
|
$
|
1,342,924
|
|
|
$
|
1,482,497
|
|
|
$
|
1,614,541
|
|
|
$
|
1,859,076
|
|
|
|
||
|
Re-estimated reinsurance recoverables
|
(271,459
|
)
|
|
(316,332
|
)
|
|
(358,340
|
)
|
|
(241,903
|
)
|
|
(150,605
|
)
|
|
(128,968
|
)
|
|
(137,187
|
)
|
|
(139,501
|
)
|
|
(142,282
|
)
|
|
(214,560
|
)
|
|
|
||||||||||||
|
Net re-estimated liability - latest
|
$
|
996,312
|
|
|
$
|
1,084,527
|
|
|
$
|
1,147,096
|
|
|
$
|
1,041,623
|
|
|
$
|
961,808
|
|
|
$
|
1,086,027
|
|
|
$
|
1,205,737
|
|
|
$
|
1,342,996
|
|
|
$
|
1,472,259
|
|
|
$
|
1,644,516
|
|
|
|
||
|
Gross cumulative redundancy (deficiency)
|
$
|
550,864
|
|
|
$
|
823,577
|
|
|
$
|
1,101,712
|
|
|
$
|
1,276,181
|
|
|
$
|
1,267,055
|
|
|
$
|
1,207,235
|
|
|
$
|
1,071,176
|
|
|
$
|
765,275
|
|
|
$
|
436,887
|
|
|
$
|
213,746
|
|
|
|
||
|
•
|
Reserves for 2005 and thereafter include gross and net reserves acquired in 2005 business combinations of $183.2 million and $139.7 million, respectively.
|
|
•
|
Reserves for 2006 and thereafter include gross and net reserves acquired in 2006 business combinations of $228.4 million and $171.2 million, respectively.
|
|
•
|
Reserves for 2009 and thereafter include gross and net reserves acquired in 2009 business combinations of $169.4 million and $163.9 million, respectively.
|
|
•
|
Reserves for 2010 and thereafter include gross and net reserves acquired in 2010 business combinations of $88.1 million and $82.2 million, respectively.
|
|
•
|
Reserves for 2012 and thereafter include gross and net reserves acquired in 2012 business combinations of
$21.8 million
and
$19.2 million
, respectively, which considers reductions of
$3.6 million
and
$3.3 million
, respectively, recorded in 2013 due to the re-estimation of the fair value of the acquired reserves.
|
|
•
|
Reserves for 2013 include gross and net reserves acquired in 2013 business combinations of
$201.1 million
and
$126.0 million
, respectively.
|
|
•
|
Reserves for 2014 include gross and net reserves acquired in 2014 business combinations of
$153.2 million
and
$139.5 million
, respectively.
|
|
•
|
The HCPL legal environment deteriorated in the late 1990’s and severity began to increase at a greater pace than anticipated in our rates and reserve estimates. We addressed the adverse severity trends through increased rates, stricter underwriting and modifications to claims handling procedures, and reflected this adverse severity trend when we established our initial reserves for subsequent years.
|
|
•
|
These adverse severity trends later moderated with that moderation becoming more pronounced beginning in 2009. We have been cautious in giving full recognition to indications that the pace of severity increase had slowed, but have given measured recognition of the improved trend in our reserve estimates, as discussed more fully under “Critical Accounting Estimates—Reserve for Losses and Loss Adjustment Expenses (reserve for losses or reserve).” The favorable development was most pronounced for years 2004 to 2008, as the initial reserves for these accident years were established prior to substantial indication that severity trends were moderating. We have given stronger recognition to the lower severity trend as time has elapsed and a greater percentage of claims have closed.
|
|
•
|
A general decline in claim frequency has also been a contributor to favorable loss development. A significant portion of our policies through 2003 were issued on an occurrence basis, and a smaller portion of our ongoing business results from the issuance of extended reporting endorsements which have occurrence-like exposure. As claim frequency declined, the number of reported claims related to these coverages was less than originally expected.
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Balance, beginning of year
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
247,518
|
|
|
191,645
|
|
|
247,658
|
|
|||
|
Net balance, beginning of year
|
1,825,304
|
|
|
1,863,349
|
|
|
2,000,114
|
|
|||
|
Reserves acquired from acquisitions (1)
|
139,549
|
|
|
126,007
|
|
|
22,464
|
|
|||
|
Incurred related to:
|
|
|
|
|
|
||||||
|
Current year
|
545,168
|
|
|
447,510
|
|
|
451,951
|
|
|||
|
Favorable development of reserves established in prior years, net (2)
|
(182,084
|
)
|
|
(222,749
|
)
|
|
(272,038
|
)
|
|||
|
Total incurred
|
363,084
|
|
|
224,761
|
|
|
179,913
|
|
|||
|
Paid related to:
|
|
|
|
|
|
||||||
|
Current year
|
(93,737
|
)
|
|
(43,616
|
)
|
|
(38,439
|
)
|
|||
|
Prior years (3)
|
(413,900
|
)
|
|
(345,197
|
)
|
|
(300,703
|
)
|
|||
|
Total paid
|
(507,637
|
)
|
|
(388,813
|
)
|
|
(339,142
|
)
|
|||
|
Net balance, end of year
|
1,820,300
|
|
|
1,825,304
|
|
|
1,863,349
|
|
|||
|
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
237,966
|
|
|
247,518
|
|
|
191,645
|
|
|||
|
Balance, end of year
|
$
|
2,058,266
|
|
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
|
Professional
Liability
|
|
Medical Technology & Life Sciences Products
|
|
Workers'
Compensation - Traditional
|
|
|
Per Occurrence Coverage
|
|
Aggregate Coverage
|
|
Reinsurer
|
Domiciliary
Country |
A.M. Best
Company Rating |
Net Amounts Due
From Reinsurer |
|||
|
(In thousands)
|
|
|
|
|
||
|
Hannover Rück SE
|
Germany
|
|
A+
|
$
|
23,081
|
|
|
Everest Reinsurance Company
|
United States
|
|
A+
|
$
|
21,582
|
|
|
Aspen Insurance UK, Ltd.
|
United Kingdom
|
|
A
|
$
|
22,236
|
|
|
|
|
|
Included in Carrying Value:
|
|
|
|
|
|
|
|||||||||
|
($ in thousands)
|
Carrying
Value
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Average
Rating
|
|
(1)
|
|
% Total
Investments |
|||||||
|
Fixed Maturities, Available for Sale
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Government
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
U.S. Treasury
|
$
|
166,512
|
|
|
$
|
3,785
|
|
|
$
|
987
|
|
|
AA+
|
|
(2)
|
|
4
|
%
|
|
U.S. Government-sponsored enterprise
|
39,563
|
|
|
1,641
|
|
|
100
|
|
|
AA+
|
|
(2)
|
|
1
|
%
|
|||
|
Total government
|
206,075
|
|
|
5,426
|
|
|
1,087
|
|
|
AA+
|
|
(2)
|
|
5
|
%
|
|||
|
State and Municipal Bonds
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Pre-refunded
|
178,419
|
|
|
7,475
|
|
|
24
|
|
|
AA
|
|
|
|
4
|
%
|
|||
|
General obligation
|
245,465
|
|
|
11,748
|
|
|
35
|
|
|
AA
|
|
|
|
6
|
%
|
|||
|
Special revenue
|
638,731
|
|
|
28,172
|
|
|
276
|
|
|
AA
|
|
|
|
17
|
%
|
|||
|
Total state and municipal bonds
|
1,062,615
|
|
|
47,395
|
|
|
335
|
|
|
AA
|
|
|
|
27
|
%
|
|||
|
Corporate Debt
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Financial
|
426,983
|
|
|
12,789
|
|
|
589
|
|
|
A
|
|
|
|
11
|
%
|
|||
|
Consumer oriented
|
302,049
|
|
|
9,621
|
|
|
2,873
|
|
|
A-
|
|
|
|
8
|
%
|
|||
|
Utilities/Energy
|
274,844
|
|
|
9,817
|
|
|
10,292
|
|
|
BBB+
|
|
|
|
7
|
%
|
|||
|
Industrial
|
394,782
|
|
|
11,711
|
|
|
3,340
|
|
|
BBB+
|
|
|
|
10
|
%
|
|||
|
Other
|
18,443
|
|
|
296
|
|
|
9
|
|
|
AA-
|
|
|
|
<1%
|
|
|||
|
Total corporate debt
|
1,417,101
|
|
|
44,234
|
|
|
17,103
|
|
|
A-
|
|
|
|
35
|
%
|
|||
|
Securities backed by:
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Agency mortgages
|
269,430
|
|
|
10,186
|
|
|
436
|
|
|
AA+
|
|
(2)
|
|
7
|
%
|
|||
|
Non-agency mortgages
|
6,626
|
|
|
12
|
|
|
12
|
|
|
AA+
|
|
|
|
<1%
|
|
|||
|
Agency commercial mortgages
|
15,493
|
|
|
208
|
|
|
59
|
|
|
AA+
|
|
(2)
|
|
<1%
|
|
|||
|
Other commercial mortgages
|
51,063
|
|
|
1,137
|
|
|
99
|
|
|
AAA
|
|
|
|
1
|
%
|
|||
|
Automobile loans
|
50,185
|
|
|
48
|
|
|
60
|
|
|
AAA
|
|
|
|
1
|
%
|
|||
|
Other asset loans
|
66,439
|
|
|
240
|
|
|
145
|
|
|
AA+
|
|
|
|
2
|
%
|
|||
|
Total asset-backed securities
|
459,236
|
|
|
11,831
|
|
|
811
|
|
|
AAA
|
|
|
|
11
|
%
|
|||
|
Total fixed maturities
|
3,145,027
|
|
|
108,886
|
|
|
19,336
|
|
|
A+
|
|
|
|
78
|
%
|
|||
|
Equity Securities, Trading
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Financial
|
79,341
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
|
Utilities/Energy
|
25,629
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
Industrial
|
55,460
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
Consumer oriented
|
65,670
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
|
Bond Funds
|
55,196
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
All Other
|
33,186
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
Total equities
|
314,482
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
8
|
%
|
|||
|
Short-Term Investments
|
131,259
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
3
|
%
|
|||
|
Business-owned Life Insurance
|
56,381
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
Investment in Unconsolidated Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Investment in qualified affordable housing tax credit partnerships
|
133,143
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
3
|
%
|
|||
|
Investments in LPs/LLCs, equity method
|
143,358
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
4
|
%
|
|||
|
Total investment in unconsolidated subsidiaries
|
276,501
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
7
|
%
|
|||
|
Other Investments
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Investments in LPs/LLCs, cost method
|
53,258
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
Convertible securities, at fair value
|
28,958
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
1
|
%
|
|||
|
FHLB capital stock and other
|
3,841
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
<1%
|
|
|||
|
Total other investments
|
86,057
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
2
|
%
|
|||
|
Total Investments
|
$
|
4,009,707
|
|
|
$
|
108,886
|
|
|
$
|
19,336
|
|
|
|
|
|
|
100
|
%
|
|
(1)
|
A weighted average rating is calculated using available ratings from Standard & Poor’s, Moody’s and Fitch. The table presents the Standard & Poor’s rating that is equivalent to the computed average.
|
|
(2)
|
The rating presented is the Standard & Poor’s rating rather than the average. The Moody’s rating is
Aaa
and the Fitch rating is
AAA
.
|
|
(In thousands)
|
|
||
|
Fixed maturities
|
$
|
107,131
|
|
|
Equities
|
65,945
|
|
|
|
Short-Term
|
23,931
|
|
|
|
Equity Method LPs/LLCs
|
11,994
|
|
|
|
Convertible Securities
|
30,139
|
|
|
|
Total
|
$
|
239,140
|
|
|
|
|
European Debt Exposure by Country and Industry Type
|
||||||||||||||
|
(In millions)
|
|
Total
Exposure |
|
Financial
Institutions |
|
Industrial &
Utilities |
|
Energy &
Communication |
||||||||
|
United Kingdom
|
|
$
|
73.4
|
|
|
$
|
26.0
|
|
|
$
|
36.2
|
|
|
$
|
11.2
|
|
|
Sweden
|
|
4.5
|
|
|
0.5
|
|
|
4.0
|
|
|
—
|
|
||||
|
France
|
|
10.0
|
|
|
7.0
|
|
|
—
|
|
|
3.0
|
|
||||
|
Germany
|
|
14.5
|
|
|
5.6
|
|
|
6.4
|
|
|
2.5
|
|
||||
|
Finland
|
|
1.5
|
|
|
—
|
|
|
1.5
|
|
|
—
|
|
||||
|
Denmark
|
|
3.8
|
|
|
1.8
|
|
|
2.0
|
|
|
—
|
|
||||
|
Netherlands
|
|
23.2
|
|
|
11.9
|
|
|
2.3
|
|
|
9.0
|
|
||||
|
Norway
|
|
8.9
|
|
|
1.3
|
|
|
2.8
|
|
|
4.8
|
|
||||
|
Belgium
|
|
10.2
|
|
|
—
|
|
|
10.2
|
|
|
—
|
|
||||
|
Switzerland
|
|
13.6
|
|
|
6.4
|
|
|
6.8
|
|
|
0.4
|
|
||||
|
Ireland
|
|
1.6
|
|
|
—
|
|
|
1.6
|
|
|
—
|
|
||||
|
Spain
|
|
2.1
|
|
|
—
|
|
|
—
|
|
|
2.1
|
|
||||
|
Luxembourg
|
|
5.6
|
|
|
—
|
|
|
2.3
|
|
|
3.3
|
|
||||
|
Cyprus
|
|
1.3
|
|
|
—
|
|
|
—
|
|
|
1.3
|
|
||||
|
|
|
$
|
174.2
|
|
|
$
|
60.5
|
|
|
$
|
76.1
|
|
|
$
|
37.6
|
|
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
|
Treasury shares at the beginning of the period
|
900
|
|
244
|
|
7,996
|
|
Shares reissued in conjunction with stock split
|
—
|
|
—
|
|
(7,729)
|
|
Shares reacquired, at cost of $222 million and $32 million, respectively
|
4,909
|
|
681
|
|
—
|
|
Shares reissued, primarily those reissued pursuant to the ProAssurance 2011 Employee Stock Ownership Plan, fair value of $2.1 million, $1.1 million and $1 million, respectively
|
(46)
|
|
(25)
|
|
(23)
|
|
Treasury shares at the end of the period
|
5,763
|
|
900
|
|
244
|
|
Quarterly Cash Dividends Declared, per Share
|
||||||
|
|
|
2014
|
|
2013
|
|
2012
|
|
First Quarter
|
|
$0.300
|
|
$0.250
|
|
$0.125
|
|
Second Quarter
|
|
$0.300
|
|
$0.250
|
|
$0.125
|
|
Third Quarter
|
|
$0.300
|
|
$0.250
|
|
$0.125
|
|
Fourth Quarter - Regular
|
|
$0.310
|
|
$0.300
|
|
$0.250
|
|
Fourth Quarter - Special dividend
|
|
$2.650
|
|
—
|
|
$2.500
|
|
|
|
Payments due by period
|
||||||||||||||||||
|
(In thousands)
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than
5 years
|
||||||||||
|
Loss and loss adjustment expenses
|
|
$
|
2,058,266
|
|
|
$
|
559,905
|
|
|
$
|
704,351
|
|
|
$
|
386,630
|
|
|
$
|
407,380
|
|
|
Long-term debt obligations including interest
|
|
367,594
|
|
|
13,250
|
|
|
26,500
|
|
|
26,500
|
|
|
301,344
|
|
|||||
|
Revolving credit agreement fees
|
|
438
|
|
|
350
|
|
|
88
|
|
|
—
|
|
|
—
|
|
|||||
|
Operating lease obligations
|
|
24,309
|
|
|
5,024
|
|
|
8,516
|
|
|
5,537
|
|
|
5,232
|
|
|||||
|
Funding commitments primarily related to non-public investment entities
|
|
169,375
|
|
|
98,757
|
|
|
69,236
|
|
|
640
|
|
|
742
|
|
|||||
|
Total
|
|
$
|
2,619,982
|
|
|
$
|
677,286
|
|
|
$
|
808,691
|
|
|
$
|
419,307
|
|
|
$
|
714,698
|
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands, except per share data)
|
2014
|
|
2013
|
|
Change
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net premiums written
|
$
|
701,849
|
|
|
$
|
525,182
|
|
|
$
|
176,667
|
|
|
Net premiums earned
|
$
|
699,731
|
|
|
$
|
527,919
|
|
|
$
|
171,812
|
|
|
Net investment result
|
129,543
|
|
|
136,804
|
|
|
(7,261
|
)
|
|||
|
Net realized investment gains (losses)
|
14,654
|
|
|
67,904
|
|
|
(53,250
|
)
|
|||
|
Other income
|
8,398
|
|
|
7,551
|
|
|
847
|
|
|||
|
Total revenues
|
852,326
|
|
|
740,178
|
|
|
112,148
|
|
|||
|
|
|
|
|
|
|
||||||
|
Expenses:
|
|
|
|
|
|
||||||
|
Losses and loss adjustment expenses
|
379,232
|
|
|
243,015
|
|
|
136,217
|
|
|||
|
Reinsurance recoveries
|
(16,148
|
)
|
|
(18,254
|
)
|
|
2,106
|
|
|||
|
Net losses and loss adjustment expenses
|
363,084
|
|
|
224,761
|
|
|
138,323
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
211,311
|
|
|
147,817
|
|
|
63,494
|
|
|||
|
Segregated portfolio cells dividend expense
|
1,842
|
|
|
—
|
|
|
1,842
|
|
|||
|
Interest expense
|
14,084
|
|
|
2,755
|
|
|
11,329
|
|
|||
|
Total expenses
|
590,321
|
|
|
375,333
|
|
|
214,988
|
|
|||
|
Gain on acquisition
|
—
|
|
|
32,314
|
|
|
(32,314
|
)
|
|||
|
Income before income taxes
|
262,005
|
|
|
397,159
|
|
|
(135,154
|
)
|
|||
|
Income taxes
|
65,440
|
|
|
99,636
|
|
|
(34,196
|
)
|
|||
|
Net income
|
$
|
196,565
|
|
|
$
|
297,523
|
|
|
$
|
(100,958
|
)
|
|
Operating income
|
$
|
186,367
|
|
|
$
|
221,097
|
|
|
$
|
(34,730
|
)
|
|
Earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
3.32
|
|
|
$
|
4.82
|
|
|
$
|
(1.50
|
)
|
|
Diluted
|
$
|
3.30
|
|
|
$
|
4.80
|
|
|
$
|
(1.50
|
)
|
|
Operating earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
3.14
|
|
|
$
|
3.58
|
|
|
$
|
(0.44
|
)
|
|
Diluted
|
$
|
3.13
|
|
|
$
|
3.56
|
|
|
$
|
(0.43
|
)
|
|
Net loss ratio
|
51.9
|
%
|
|
42.6
|
%
|
|
9.3
|
|
|||
|
Underwriting expense ratio
|
30.2
|
%
|
|
28.0
|
%
|
|
2.2
|
|
|||
|
Combined ratio
|
82.1
|
%
|
|
70.6
|
%
|
|
11.5
|
|
|||
|
Operating ratio
|
64.2
|
%
|
|
46.1
|
%
|
|
18.1
|
|
|||
|
Effective tax rate
|
25.0
|
%
|
|
25.1
|
%
|
|
(0.1
|
)
|
|||
|
Return on equity*
|
8.6
|
%
|
|
11.4
|
%
|
|
(2.8
|
)
|
|||
|
* Gain on acquisition is excluded from the calculation of return on equity for 2013.
|
|
|
|||||||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Net Premiums Earned
|
|
|
|
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
492,733
|
|
|
$
|
527,919
|
|
|
$
|
(35,186
|
)
|
|
(6.7
|
%)
|
|
Workers' Compensation
|
194,540
|
|
|
—
|
|
|
194,540
|
|
|
nm
|
|
|||
|
Lloyd's Syndicate
|
12,458
|
|
|
—
|
|
|
12,458
|
|
|
nm
|
|
|||
|
Consolidated total
|
$
|
699,731
|
|
|
$
|
527,919
|
|
|
$
|
171,812
|
|
|
32.5
|
%
|
|
|
Year Ended December 31
|
||||||||||
|
($ in millions)
|
2014
|
|
2013
|
|
Change
|
||||||
|
Current accident year net loss ratio
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
77.9
|
%
|
|
84.8
|
%
|
|
(6.9
|
)
|
|||
|
Specialty P&C
|
83.0
|
%
|
|
84.8
|
%
|
|
(1.8
|
)
|
|||
|
Workers' Compensation
|
65.7
|
%
|
|
—
|
%
|
|
nm
|
|
|||
|
Lloyd's Syndicate
|
67.7
|
%
|
|
—
|
%
|
|
nm
|
|
|||
|
Calendar year net loss ratio
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
51.9
|
%
|
|
42.6
|
%
|
|
9.3
|
|
|||
|
Specialty P&C
|
46.3
|
%
|
|
42.6
|
%
|
|
3.7
|
|
|||
|
Workers' Compensation
|
65.0
|
%
|
|
—
|
%
|
|
nm
|
|
|||
|
Lloyd's Syndicate
|
67.7
|
%
|
|
—
|
%
|
|
nm
|
|
|||
|
Favorable net loss development, prior accident years
|
|
|
|
|
|
||||||
|
Consolidated
|
$
|
182.1
|
|
|
$
|
222.7
|
|
|
$
|
(40.6
|
)
|
|
Specialty P&C
|
$
|
180.8
|
|
|
$
|
222.7
|
|
|
$
|
(41.9
|
)
|
|
Workers' Compensation
|
$
|
1.3
|
|
|
$
|
—
|
|
|
$
|
1.3
|
|
|
Lloyd's Syndicate
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Year Ended December 31
|
||||||
|
|
2014
|
|
2013
|
|
Change
|
||
|
Underwriting Expense Ratio, as reported
|
|
|
|
|
|
||
|
Consolidated
|
30.2
|
%
|
|
28.0
|
%
|
|
2.2
|
|
Underwriting Expense Ratio, excluding the effect of discrete events and Syndicate 1729
|
|
|
|
|
|
||
|
Consolidated
|
28.4
|
%
|
|
26.3
|
%
|
|
2.1
|
|
Specialty P&C
|
26.5
|
%
|
|
24.2
|
%
|
|
2.3
|
|
Workers' Compensation
|
29.6
|
%
|
|
—
|
%
|
|
nm
|
|
|
Book Value Per Share
|
||
|
Book Value Per Share at December 31, 2013
|
$
|
39.13
|
|
|
Increase (decrease) to book value per share during the year ended December 31, 2014 attributable to:
|
|
||
|
Net income
|
3.32
|
|
|
|
Decrease in accumulated other comprehensive income
|
(0.02
|
)
|
|
|
Dividends declared
|
(3.86
|
)
|
|
|
Other, primarily the repurchase of shares
|
(0.40
|
)
|
|
|
Book Value Per Share at December 31, 2014
|
$
|
38.17
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands, except per share data)
|
2014
|
|
2013
|
||||
|
Net income
|
$
|
196,565
|
|
|
$
|
297,523
|
|
|
Items excluded in the calculation of operating income:
|
|
|
|
||||
|
Net realized investment (gains) losses
|
(14,654
|
)
|
|
(67,904
|
)
|
||
|
Guaranty fund assessments (recoupments)
|
(169
|
)
|
|
40
|
|
||
|
Gain on acquisition
|
—
|
|
|
(32,314
|
)
|
||
|
Effect of confidential settlements, net
|
(866
|
)
|
|
—
|
|
||
|
Pre-tax effect of exclusions
|
(15,689
|
)
|
|
(100,178
|
)
|
||
|
|
|
|
|
||||
|
Tax effect, at 35%, exclusive of non-taxable gain on acquisition
|
5,491
|
|
|
23,752
|
|
||
|
|
|
|
|
||||
|
Operating income
|
$
|
186,367
|
|
|
$
|
221,097
|
|
|
Per diluted common share:
|
|
|
|
||||
|
Net income
|
$
|
3.30
|
|
|
$
|
4.80
|
|
|
Effect of exclusions
|
(0.17
|
)
|
|
(1.24
|
)
|
||
|
Operating income per diluted common share
|
$
|
3.13
|
|
|
$
|
3.56
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Net premiums written
|
$
|
467,046
|
|
|
$
|
525,182
|
|
|
$
|
(58,136
|
)
|
|
(11.1
|
%)
|
|
Net premiums earned
|
$
|
492,733
|
|
|
$
|
527,919
|
|
|
$
|
(35,186
|
)
|
|
(6.7
|
%)
|
|
Net losses and loss adjustment expenses
|
$
|
228,199
|
|
|
$
|
224,761
|
|
|
$
|
3,438
|
|
|
1.5
|
%
|
|
Underwriting, policy acquisition and operating expenses
|
$
|
133,132
|
|
|
$
|
132,076
|
|
|
$
|
1,056
|
|
|
0.8
|
%
|
|
Net loss ratio
|
46.3
|
%
|
|
42.6
|
%
|
|
3.7
|
|
|
|
||||
|
Underwriting expense ratio
|
27.0
|
%
|
|
25.0
|
%
|
|
2.0
|
|
|
|
||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
532,608
|
|
|
$
|
567,547
|
|
|
$
|
(34,939
|
)
|
|
(6.2
|
%)
|
|
Ceded premiums written
|
(65,562
|
)
|
|
(42,365
|
)
|
|
(23,197
|
)
|
|
(54.8
|
%)
|
|||
|
Net premiums written
|
$
|
467,046
|
|
|
$
|
525,182
|
|
|
$
|
(58,136
|
)
|
|
(11.1
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Professional liability
|
|
|
|
|
|
|
|
|||||||
|
Physicians (1):
|
|
|
|
|
|
|
|
|||||||
|
Twelve month term
|
$
|
362,056
|
|
|
$
|
388,583
|
|
|
$
|
(26,527
|
)
|
|
(6.8
|
%)
|
|
Twenty-four month term
|
19,949
|
|
|
25,584
|
|
|
(5,635
|
)
|
|
(22.0
|
%)
|
|||
|
Total Physicians
|
382,005
|
|
|
414,167
|
|
|
(32,162
|
)
|
|
(7.8
|
%)
|
|||
|
Other healthcare providers (2)
|
33,589
|
|
|
33,971
|
|
|
(382
|
)
|
|
(1.1
|
%)
|
|||
|
Healthcare facilities (3)
|
33,521
|
|
|
35,356
|
|
|
(1,835
|
)
|
|
(5.2
|
%)
|
|||
|
Legal professionals (4)
|
27,776
|
|
|
27,060
|
|
|
716
|
|
|
2.6
|
%
|
|||
|
Tail coverages (5)
|
18,745
|
|
|
20,920
|
|
|
(2,175
|
)
|
|
(10.4
|
%)
|
|||
|
Total professional liability
|
495,636
|
|
|
531,474
|
|
|
(35,838
|
)
|
|
(6.7
|
%)
|
|||
|
Medical technology and life sciences products liability (6)
|
35,265
|
|
|
34,190
|
|
|
1,075
|
|
|
3.1
|
%
|
|||
|
Other
|
1,707
|
|
|
1,883
|
|
|
(176
|
)
|
|
(9.3
|
%)
|
|||
|
Total
|
$
|
532,608
|
|
|
$
|
567,547
|
|
|
$
|
(34,939
|
)
|
|
(6.2
|
%)
|
|
(1)
|
Physician policies were our greatest source of premium revenues in both
2014
and
2013
. We offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The
decline
in twenty-four month premium, as compared to
2013
, primarily reflects the normal cycle of renewals (policies subject to renewal in
2014
were previously written in
2012
rather than in
2013
). There was no significant volume change associated with twenty-four month policies during the
year ended
December 31, 2014
.
|
|
(2)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals.
|
|
(3)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other facilities)
decline
d in
2014
, principally due to the non-renewal of certain business.
|
|
(4)
|
Our legal professionals policies are offered throughout the United States, principally through agent and brokerage arrangements.
|
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer "tail" coverage through custom policies. The amount of tail coverage premium written can vary widely from period to period.
|
|
(6)
|
Our medical technology and life sciences products liability (products liability) business is marketed throughout the United States; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products. In addition to the previously listed factors that affect our premium volume, our products liability premium volume is impacted by the sales volume of insureds.
|
|
|
Year Ended December 31
|
||||||
|
(In millions)
|
2014
|
|
2013
|
||||
|
Physicians
|
$
|
16.2
|
|
|
$
|
18.0
|
|
|
Other healthcare providers
|
$
|
2.8
|
|
|
$
|
2.5
|
|
|
Healthcare facilities
|
$
|
4.5
|
|
|
$
|
6.2
|
|
|
Legal professionals *
|
$
|
4.2
|
|
|
$
|
2.0
|
|
|
Medical technology and life sciences products liability *
|
$
|
5.4
|
|
|
na
|
|
|
|
|
|
|
|
||||
|
* Excludes new business attributable to our Medmarc acquisition for the year ended December 31, 2013, as the entire Medmarc book of business was new to us in 2013.
|
|||||||
|
|
Year Ended December 31
|
||||
|
|
2014
|
|
2013
|
||
|
Physicians, standard lines only
|
89
|
%
|
|
89
|
%
|
|
Other healthcare providers
|
81
|
%
|
|
82
|
%
|
|
Healthcare facilities
|
83
|
%
|
|
79
|
%
|
|
Legal professionals *
|
82
|
%
|
|
88
|
%
|
|
Medical technology and life sciences products liability *
|
85
|
%
|
|
na
|
|
|
|
|
|
|
||
|
* Premiums contributed by our Medmarc acquisition are excluded from the calculation of retention for the year ended December 31, 2013, as the entire Medmarc book of business was new to us in 2013.
|
|||||
|
|
Year Ended December 31
|
|
|
|
2014
|
|
|
Physicians
|
1
|
%
|
|
Other healthcare providers
|
4
|
%
|
|
Healthcare facilities
|
(3
|
%)
|
|
Legal professionals
|
6
|
%
|
|
Medical technology and life sciences products liability
|
2
|
%
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Excess of loss reinsurance arrangements
|
$
|
31,031
|
|
|
$
|
30,571
|
|
|
$
|
460
|
|
|
1.5
|
%
|
|
Premium ceded to Syndicate 1729 (1)
|
20,899
|
|
|
—
|
|
|
20,899
|
|
|
nm
|
|
|||
|
Other shared risk arrangements (2)
|
20,642
|
|
|
19,040
|
|
|
1,602
|
|
|
8.4
|
%
|
|||
|
Other ceded premiums written
|
8,705
|
|
|
9,157
|
|
|
(452
|
)
|
|
(4.9
|
%)
|
|||
|
Reduction in premiums owed under reinsurance agreements, prior accident years, net (3)
|
(15,715
|
)
|
|
(16,403
|
)
|
|
688
|
|
|
4.2
|
%
|
|||
|
Total ceded premiums written
|
$
|
65,562
|
|
|
$
|
42,365
|
|
|
$
|
23,197
|
|
|
54.8
|
%
|
|
(1)
|
Effective January 1, 2014, one of our subsidiaries began ceding premium to Syndicate 1729 under a quota share agreement, net of a related ceding commission. As previously discussed, we are a 58% participant in Syndicate 1729 and record our pro rata share of its operating results in our Lloyd's Syndicate segment on a quarter delay. We also record the Specialty P&C segment results for this agreement on a quarter delay as the amounts are not material and this permits the cession to be reported by both the Lloyd's Syndicate segment and the Specialty P&C segment in the same reporting period. Premium ceded to Syndicate 1729 reported for the
year ended
December 31, 2014
in the table above reflects cessions that occurred during the nine-months ended
September 30, 2014
. The related ceding commission income recorded as an offset to deferred policy acquisition costs for the
year ended
December 31, 2014
was
$5.6 million
. The
fourth
quarter cession of
$4.8 million
and the related ceding commission income of
$1.3 million
will be recorded in the first quarter of
2015
. Eliminations of the inter-segment portion (58% of the Specialty P&C cession) of the transactions are also recorded on a quarter delay.
|
|
(2)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health Certitude and CAPAssurance Programs. The increase in ceded premiums written under our shared risk arrangements for the
year ended
December 31, 2014
principally reflected premiums ceded under arrangements begun during 2014, partially offset by a large policy under one of the arrangements that did not renew in 2014.
|
|
(3)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. In both
2014
and
2013
, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the change in estimates occur.
|
|
|
Year Ended December 31
|
|||||||
|
|
2014
|
|
2013
|
|
Change
|
|||
|
Ceded premiums ratio, as reported
|
12.3
|
%
|
|
7.5
|
%
|
|
4.8
|
|
|
Less the effect of reduction in premiums owed under reinsurance agreements, prior accident years (as previously discussed)*
|
(3.0
|
%)
|
|
(2.9
|
%)
|
|
(0.1
|
)
|
|
Ratio, current accident year
|
15.3
|
%
|
|
10.4
|
%
|
|
4.9
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
543,052
|
|
|
$
|
569,433
|
|
|
$
|
(26,381
|
)
|
|
(4.6
|
%)
|
|
Ceded premiums earned
|
(50,319
|
)
|
|
(41,514
|
)
|
|
(8,805
|
)
|
|
(21.2
|
%)
|
|||
|
Net premiums earned
|
$
|
492,733
|
|
|
$
|
527,919
|
|
|
$
|
(35,186
|
)
|
|
(6.7
|
%)
|
|
|
Net Loss Ratios (1)
|
|||||||
|
|
Year Ended December 31
|
|||||||
|
|
2014
|
|
2013
|
|
Change
|
|||
|
Calendar year net loss ratio
|
46.3
|
%
|
|
42.6
|
%
|
|
3.7
|
|
|
Less impact of prior accident years on the net loss ratio
|
(36.7
|
%)
|
|
(42.2
|
%)
|
|
5.5
|
|
|
Current accident year net loss ratio
|
83.0
|
%
|
|
84.8
|
%
|
|
(1.8
|
)
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|||
|
Ceded premium reductions, prior accident years (2)
|
(2.7
|
%)
|
|
(2.7
|
%)
|
|
—
|
|
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium (3)
|
85.7
|
%
|
|
87.5
|
%
|
|
(1.8
|
)
|
|
(1)
|
Net losses as specified divided by net premiums earned.
|
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) in both
2014
and
2013
. The net increase to the ratio in 2013 reflects an offset of 0.3 percentage points that is attributable to loss reserves acquired in business combinations. See the discussion in the Premiums section for our Specialty P&C segment under the heading “Ceded Premiums Written” for additional information.
|
|
(3)
|
The remaining decrease in the current accident year net loss ratio primarily reflects a
decrease
in our loss reserves related to death, disability and retirement (DDR) coverage endorsements provided to our insureds. The reserve for DDR is actuarially estimated and is affected by changes in the number of insureds expected to benefit from the coverage endorsement. This decrease was partially offset by the effect of a higher accrual for internal claims adjustment expenses on a lower volume of premiums earned.
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Underwriting, policy acquisition and operating expenses
|
$
|
133,132
|
|
|
$
|
132,076
|
|
|
$
|
1,056
|
|
|
0.8
|
%
|
|
|
|
||
|
(In millions)
|
Increase (Decrease) 2014 vs 2013
|
||
|
Excluding the effect from purchase accounting listed separately below, DPAC amortization decreased in 2014. The amortization decrease was primarily attributable to a $2.8 million increase in ceding commission income. Ceding commissions are an offset to acquisition costs.
|
$
|
(1.9
|
)
|
|
Amortization of deferred policy acquisition costs was lower due to the application of GAAP purchase accounting rules in 2013, but was at a normal level in 2014.
|
3.8
|
|
|
|
Costs associated with ongoing technology enhancement initiatives
|
1.2
|
|
|
|
Other variances not individually significant
|
(0.3
|
)
|
|
|
Expenses associated with discrete events:
|
|
||
|
Transaction-related costs associated with entities acquired in 2013, principally professional fees and one time compensation costs
|
(2.7
|
)
|
|
|
Discontinued technology initiatives
|
0.9
|
|
|
|
Net change in expenses
|
$
|
1.0
|
|
|
|
Underwriting Expense Ratio
|
|||||||
|
|
Year Ended December 31
|
|||||||
|
|
2014
|
|
2013
|
|
Change
|
|||
|
Underwriting expense ratio, as reported
|
27.0
|
%
|
|
25.0
|
%
|
|
2.0
|
|
|
Less estimated ratio increase (decrease) attributable to expenses associated with discrete events (see table above)
|
0.5
|
%
|
|
0.8
|
%
|
|
(0.3
|
)
|
|
Underwriting expense ratio, less listed effects
|
26.5
|
%
|
|
24.2
|
%
|
|
2.3
|
|
|
|
|
Year Ended
|
||
|
($ in thousands)
|
|
December 31, 2014
|
||
|
Net premiums written
|
|
$
|
202,697
|
|
|
Net premiums earned
|
|
$
|
194,540
|
|
|
Net losses and loss adjustment expenses
|
|
$
|
126,447
|
|
|
Underwriting, policy acquisition and operating expenses
|
|
$
|
60,357
|
|
|
Segregated portfolio cell dividend expense
|
|
$
|
1,842
|
|
|
Net loss ratio
|
|
65.0
|
%
|
|
|
Underwriting expense ratio
|
|
31.0
|
%
|
|
|
|
Year Ended December 31, 2014
|
||||||||||
|
(In thousands)
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results
|
||||||
|
Gross premiums written
|
$
|
166,004
|
|
|
$
|
59,359
|
|
|
$
|
225,363
|
|
|
Ceded premiums written
|
(10,401
|
)
|
|
(12,265
|
)
|
|
(22,666
|
)
|
|||
|
Net premiums written
|
$
|
155,603
|
|
|
$
|
47,094
|
|
|
$
|
202,697
|
|
|
|
Year Ended December 31, 2014
|
||||||||||
|
(In thousands)
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results |
||||||
|
Gross premiums written
|
$
|
166,004
|
|
|
$
|
59,359
|
|
|
$
|
225,363
|
|
|
|
Year Ended December 31, 2014
|
||||||||||
|
($ in thousands)
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results |
||||||
|
Retention rate (1)
|
82
|
%
|
|
86
|
%
|
|
83
|
%
|
|||
|
Change in renewal pricing (2)
|
2
|
%
|
|
—
|
%
|
|
1
|
%
|
|||
|
New business
|
$
|
35,111
|
|
|
$
|
8,614
|
|
|
$
|
43,725
|
|
|
Audit premium
|
$
|
3,057
|
|
|
$
|
347
|
|
|
$
|
3,404
|
|
|
|
Year Ended December 31, 2014
|
||||||||||
|
(In thousands)
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results
|
||||||
|
Premiums ceded to external reinsurers
|
$
|
10,720
|
|
|
$
|
5,927
|
|
|
$
|
16,647
|
|
|
Return premium estimate under external reinsurance
|
(319
|
)
|
|
—
|
|
|
(319
|
)
|
|||
|
Premiums ceded to unaffiliated captive insurers
|
—
|
|
|
6,338
|
|
|
6,338
|
|
|||
|
Total ceded premiums written
|
$
|
10,401
|
|
|
$
|
12,265
|
|
|
$
|
22,666
|
|
|
|
Year Ended December 31, 2014
|
||||
|
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results
|
|
Ceded premiums ratio, as reported
|
6.3%
|
|
20.7%
|
|
10.1%
|
|
Less the effect of:
|
|
|
|
|
|
|
Return premium estimated under external reinsurance
|
(0.2%)
|
|
—%
|
|
(0.1%)
|
|
Premiums ceded to unaffiliated captive insurer (100%)
|
—%
|
|
10.7%
|
|
2.8%
|
|
Ceded premiums ratio, less the effects of above
|
6.5%
|
|
10.0%
|
|
7.4%
|
|
|
Year Ended December 31, 2014
|
||||||||||
|
(In thousands)
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results
|
||||||
|
Gross premiums earned
|
$
|
160,717
|
|
|
$
|
55,616
|
|
|
$
|
216,333
|
|
|
Ceded premiums earned
|
(9,849
|
)
|
|
(11,944
|
)
|
|
(21,793
|
)
|
|||
|
Net premiums earned
|
$
|
150,868
|
|
|
$
|
43,672
|
|
|
$
|
194,540
|
|
|
|
Net Loss Ratios
|
|||||||
|
|
December 31, 2014
|
|||||||
|
|
Traditional Business
|
|
Alternative Market Business
|
|
Segment
Results
|
|||
|
Calendar year net loss ratio
|
65.0
|
%
|
|
65.1
|
%
|
|
65.0
|
%
|
|
Less impact of prior accident years on the net loss ratio
|
(1.0
|
%)
|
|
0.6
|
%
|
|
(0.7
|
%)
|
|
Current accident year net loss ratio
|
66.0
|
%
|
|
64.5
|
%
|
|
65.7
|
%
|
|
Less impact of audit premium on loss ratio
|
(1.3
|
%)
|
|
(0.5
|
%)
|
|
(1.2
|
%)
|
|
Current accident year net loss ratio, excluding the effect of audit premium
|
67.3
|
%
|
|
65.0
|
%
|
|
66.9
|
%
|
|
|
Year Ended
|
||
|
(In thousands)
|
December 31, 2014
|
||
|
Traditional business
|
$
|
46,717
|
|
|
Alternative market business
|
13,640
|
|
|
|
Underwriting, policy acquisition and operating expenses
|
$
|
60,357
|
|
|
|
Expense Increase (Decrease)
|
||
|
|
Year Ended
|
||
|
(In thousands)
|
December 31, 2014
|
||
|
One-time professional fees
|
$
|
661
|
|
|
Transaction-related expenses
|
$
|
2,180
|
|
|
|
Year Ended December 31, 2014
|
|||||||
|
|
Traditional Business
|
|
Alternative Market Business*
|
|
Segment Results
|
|||
|
Underwriting expense ratio, as reported
|
31.0
|
%
|
|
31.2
|
%
|
|
31.0
|
%
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|||
|
Transaction-related expenses
|
1.4
|
%
|
|
—
|
%
|
|
1.1
|
%
|
|
One-time professional fees
|
0.4
|
%
|
|
—
|
%
|
|
0.3
|
%
|
|
Amortization of intangible assets
|
3.4
|
%
|
|
—
|
%
|
|
2.7
|
%
|
|
Impact of return premium estimate
|
(0.1
|
%)
|
|
—
|
%
|
|
(0.1
|
%)
|
|
Impact of audit premium
|
(0.6
|
%)
|
|
(0.3
|
%)
|
|
(0.6
|
%)
|
|
Underwriting expense ratio, less listed effects
|
26.5
|
%
|
|
31.5
|
%
|
|
27.6
|
%
|
|
|
Year Ended
|
||
|
(In thousands)
|
December 31, 2014
|
||
|
Segregated portfolio cell net operating results
|
$
|
2,539
|
|
|
Eastern participation - (profit)/loss retained
|
(697
|
)
|
|
|
Segregated portfolio cell dividend expense
|
$
|
1,842
|
|
|
|
Year Ended
|
||
|
($ in thousands)
|
December 31, 2014
|
||
|
Net premiums written
|
$
|
32,106
|
|
|
Net premiums earned
|
$
|
12,458
|
|
|
Net investment income
|
$
|
410
|
|
|
Net losses and loss adjustment expenses
|
$
|
8,438
|
|
|
Underwriting, policy acquisition and operating expenses
|
$
|
9,535
|
|
|
|
|
||
|
Net loss ratio
|
67.7
|
%
|
|
|
Underwriting expense ratio
|
76.5
|
%
|
|
|
|
Year Ended
|
||
|
($ in thousands)
|
December 31, 2014
|
||
|
Gross premiums written:
|
|
||
|
Casualty
|
$
|
21,703
|
|
|
Property
|
6,110
|
|
|
|
Catastrophe
|
5,918
|
|
|
|
Ceded premiums written
|
(1,625
|
)
|
|
|
Net premiums written
|
$
|
32,106
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
125,147
|
|
|
$
|
129,265
|
|
|
$
|
(4,118
|
)
|
|
(3.2
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
3,986
|
|
|
7,539
|
|
|
(3,553
|
)
|
|
(47.1
|
%)
|
|||
|
Net investment result
|
$
|
129,133
|
|
|
$
|
136,804
|
|
|
$
|
(7,671
|
)
|
|
(5.6
|
%)
|
|
Total net realized investment gains (losses)
|
$
|
14,650
|
|
|
$
|
67,904
|
|
|
$
|
(53,254
|
)
|
|
(78.4
|
%)
|
|
Operating expense
|
$
|
8,768
|
|
|
$
|
15,748
|
|
|
$
|
(6,980
|
)
|
|
(44.3
|
%)
|
|
Interest expense
|
$
|
14,084
|
|
|
$
|
2,755
|
|
|
$
|
11,329
|
|
|
>100%
|
|
|
Income taxes
|
$
|
65,440
|
|
|
$
|
99,636
|
|
|
$
|
(34,196
|
)
|
|
(34.3
|
%)
|
|
Gain on acquisition
|
$
|
—
|
|
|
$
|
32,314
|
|
|
$
|
(32,314
|
)
|
|
(100
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2014
|
|
2013
|
|
Change
|
|||||||||
|
Fixed maturities
|
$
|
111,442
|
|
|
$
|
122,065
|
|
|
$
|
(10,623
|
)
|
|
(8.7
|
%)
|
|
Equities
|
10,817
|
|
|
9,454
|
|
|
1,363
|
|
|
14.4
|
%
|
|||
|
Short-term and Other investments
|
8,833
|
|
|
2,584
|
|
|
6,249
|
|
|
>100%
|
|
|||
|
Business owned life insurance
|
2,006
|
|
|
1,960
|
|
|
46
|
|
|
2.3
|
%
|
|||
|
Investment fees and expenses
|
(7,951
|
)
|
|
(6,798
|
)
|
|
(1,153
|
)
|
|
(17.0
|
%)
|
|||
|
Net investment income
|
$
|
125,147
|
|
|
$
|
129,265
|
|
|
$
|
(4,118
|
)
|
|
(3.2
|
%)
|
|
|
Year Ended December 31
|
||
|
|
2014
|
|
2013
|
|
Average income yield
|
3.6%
|
|
3.7%
|
|
Average tax equivalent income yield
|
4.2%
|
|
4.3%
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2014
|
|
2013
|
|
Change
|
||||||
|
Investment LPs/LLCs
|
$
|
14,714
|
|
|
$
|
17,673
|
|
|
$
|
(2,959
|
)
|
|
Tax credit partnerships
|
(10,728
|
)
|
|
(10,134
|
)
|
|
(594
|
)
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
3,986
|
|
|
$
|
7,539
|
|
|
$
|
(3,553
|
)
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2014
|
|
2013
|
||||
|
Tax credits recognized during the period
|
$
|
17,918
|
|
|
$
|
17,888
|
|
|
Tax benefit of amortization
|
$
|
3,755
|
|
|
$
|
3,547
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2014
|
|
2013
|
||||
|
GAAP net investment result:
|
|
|
|
||||
|
Net investment income
|
$
|
125,147
|
|
|
$
|
129,265
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
3,986
|
|
|
7,539
|
|
||
|
GAAP net investment result, as reported
|
$
|
129,133
|
|
|
$
|
136,804
|
|
|
|
|
|
|
||||
|
Pro forma tax-equivalent investment results
|
$
|
175,344
|
|
|
$
|
184,628
|
|
|
|
|
|
|
||||
|
Reconciliation of pro forma and GAAP tax-equivalent investment results:
|
|
|
|
||||
|
Pro forma tax-equivalent investment results
|
$
|
175,344
|
|
|
$
|
184,628
|
|
|
Less taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
|
State and municipal bonds
|
15,727
|
|
|
17,590
|
|
||
|
BOLI
|
1,080
|
|
|
1,056
|
|
||
|
Dividends received
|
1,754
|
|
|
1,674
|
|
||
|
Tax credit partnerships
|
27,566
|
|
|
27,504
|
|
||
|
Other investments
|
84
|
|
|
—
|
|
||
|
GAAP net investment result, as reported
|
$
|
129,133
|
|
|
$
|
136,804
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2014
|
|
2013
|
||||
|
Other-than-temporary impairment losses, total:
|
|
|
|
||||
|
State and municipal bonds
|
$
|
(50
|
)
|
|
$
|
(71
|
)
|
|
Corporate debt
|
(1,425
|
)
|
|
—
|
|
||
|
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
||||
|
Corporate debt
|
268
|
|
|
—
|
|
||
|
Net impairments recognized in earnings
|
(1,207
|
)
|
|
(71
|
)
|
||
|
Gross realized gains, available-for-sale securities
|
5,623
|
|
|
18,130
|
|
||
|
Gross realized (losses), available-for-sale securities
|
(1,103
|
)
|
|
(7,031
|
)
|
||
|
Net realized gains (losses), trading securities
|
28,018
|
|
|
20,444
|
|
||
|
Net realized gains (losses), other investments
|
326
|
|
|
—
|
|
||
|
Change in unrealized holding gains (losses), trading securities
|
(18,883
|
)
|
|
35,507
|
|
||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of Other investments
|
1,876
|
|
|
—
|
|
||
|
Other
|
—
|
|
|
925
|
|
||
|
Net realized investment gains (losses)
|
$
|
14,650
|
|
|
$
|
67,904
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2014
|
|
2013
|
|
Change
|
||||||
|
Senior notes due 2023
|
$
|
13,433
|
|
|
$
|
1,502
|
|
|
$
|
11,931
|
|
|
Revolving credit agreement (including fees and amortization)
|
507
|
|
|
1,245
|
|
|
(738
|
)
|
|||
|
Other
|
144
|
|
|
8
|
|
|
136
|
|
|||
|
|
$
|
14,084
|
|
|
$
|
2,755
|
|
|
$
|
11,329
|
|
|
|
Year Ended December 31
|
||||
|
|
2014
|
|
2013
|
||
|
Statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
Tax-exempt income
|
(5.0
|
%)
|
|
(3.7
|
%)
|
|
Tax credits
|
(6.8
|
%)
|
|
(4.5
|
%)
|
|
Non-taxable gain on acquisition
|
—%
|
|
|
(2.8
|
%)
|
|
Non-U.S. loss
|
0.7
|
%
|
|
—
|
%
|
|
Other
|
1.1
|
%
|
|
1.1
|
%
|
|
Effective tax rate
|
25.0
|
%
|
|
25.1
|
%
|
|
•
|
a portion of our investment income was tax-exempt
|
|
•
|
we utilized tax credits transferred to us from our tax credit partnership investments
|
|
•
|
we did not recognize a tax benefit related to the operating loss associated with our participation in Lloyd's Syndicate 1729, a U.K. tax entity
|
|
•
|
the gain on acquisition recognized in 2013 was not taxable
|
|
|
Year Ended December 31
|
||||||||||
|
($ in thousands, except per share data)
|
2013
|
|
2012
|
|
Change
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net premiums earned
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
(22,745
|
)
|
|
Net investment income
|
129,265
|
|
|
136,094
|
|
|
(6,829
|
)
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
7,539
|
|
|
(6,873
|
)
|
|
14,412
|
|
|||
|
Net investment result
|
136,804
|
|
|
129,221
|
|
|
7,583
|
|
|||
|
Net realized investment gains (losses)
|
67,904
|
|
|
28,863
|
|
|
39,041
|
|
|||
|
Other income
|
7,551
|
|
|
7,106
|
|
|
445
|
|
|||
|
Total revenues
|
740,178
|
|
|
715,854
|
|
|
24,324
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Losses and loss adjustment expenses
|
243,015
|
|
|
161,726
|
|
|
81,289
|
|
|||
|
Reinsurance recoveries
|
(18,254
|
)
|
|
18,187
|
|
|
(36,441
|
)
|
|||
|
Net losses and loss adjustment expenses
|
224,761
|
|
|
179,913
|
|
|
44,848
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
147,817
|
|
|
135,631
|
|
|
12,186
|
|
|||
|
Interest expense
|
2,755
|
|
|
2,181
|
|
|
574
|
|
|||
|
Loss on extinguishment of debt
|
—
|
|
|
2,163
|
|
|
(2,163
|
)
|
|||
|
Total expenses
|
375,333
|
|
|
319,888
|
|
|
55,445
|
|
|||
|
Gain on acquisition
|
32,314
|
|
|
—
|
|
|
32,314
|
|
|||
|
Income before income taxes
|
397,159
|
|
|
395,966
|
|
|
1,193
|
|
|||
|
Income taxes
|
99,636
|
|
|
120,496
|
|
|
(20,860
|
)
|
|||
|
Net income
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
$
|
22,053
|
|
|
Earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
4.82
|
|
|
$
|
4.49
|
|
|
$
|
0.33
|
|
|
Diluted
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
$
|
0.34
|
|
|
Net loss ratio
|
42.6
|
%
|
|
32.7
|
%
|
|
9.9
|
|
|||
|
Underwriting expense ratio
|
28.0
|
%
|
|
24.6
|
%
|
|
3.4
|
|
|||
|
Combined ratio
|
70.6
|
%
|
|
57.3
|
%
|
|
13.3
|
|
|||
|
Operating ratio
|
46.1
|
%
|
|
32.6
|
%
|
|
13.5
|
|
|||
|
Effective tax rate
|
25.1
|
%
|
|
30.4
|
%
|
|
(5.3
|
)
|
|||
|
Return on equity*
|
11.4
|
%
|
|
12.4
|
%
|
|
(1.0
|
)
|
|||
|
* Gain on acquisition is excluded from the calculation of return on equity.
|
|
|
|||||||||
|
|
Book Value Per Share
|
||
|
Book Value Per Share at December 31, 2012
|
$
|
36.85
|
|
|
Increase (decrease) to book value per share during the year ended December 31, 2013 attributable to:
|
|
||
|
Net income
|
4.82
|
|
|
|
Decline in accumulated other comprehensive income
|
(1.40
|
)
|
|
|
Dividends declared
|
(1.05
|
)
|
|
|
Other
|
(0.09
|
)
|
|
|
Book Value Per Share at December 31, 2013
|
$
|
39.13
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands, except per share data)
|
2013
|
|
2012
|
||||
|
Net income
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
Items excluded in the calculation of operating income:
|
|
|
|
||||
|
(Gain) loss on extinguishment of debt
|
—
|
|
|
2,163
|
|
||
|
Net realized investment (gains) losses
|
(67,904
|
)
|
|
(28,863
|
)
|
||
|
Guaranty fund assessments (recoupments)
|
40
|
|
|
345
|
|
||
|
Gain on acquisition
|
(32,314
|
)
|
|
—
|
|
||
|
Effect of confidential settlements, net
|
—
|
|
|
(1,694
|
)
|
||
|
Pre-tax effect of exclusions
|
(100,178
|
)
|
|
(28,049
|
)
|
||
|
|
|
|
|
||||
|
Tax effect, at 35%, exclusive of non-taxable gain on acquisition
|
23,752
|
|
|
9,817
|
|
||
|
|
|
|
|
||||
|
Operating income
|
$
|
221,097
|
|
|
$
|
257,238
|
|
|
Per diluted common share:
|
|
|
|
||||
|
Net income
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
Effect of exclusions
|
(1.24
|
)
|
|
(0.30
|
)
|
||
|
Operating income per diluted common share
|
$
|
3.56
|
|
|
$
|
4.16
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Net premiums written
|
$
|
525,182
|
|
|
$
|
528,298
|
|
|
$
|
(3,116
|
)
|
|
(0.6
|
%)
|
|
Net premiums earned
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
(22,745
|
)
|
|
(4.1
|
%)
|
|
Net losses and loss adjustment expenses
|
$
|
224,761
|
|
|
$
|
179,913
|
|
|
$
|
44,848
|
|
|
24.9
|
%
|
|
Underwriting, policy acquisition and operating expenses
|
$
|
132,076
|
|
|
$
|
125,292
|
|
|
$
|
6,784
|
|
|
5.4
|
%
|
|
Net loss ratio
|
42.6
|
%
|
|
32.7
|
%
|
|
9.9
|
|
|
|
||||
|
Underwriting expense ratio
|
25.0
|
%
|
|
22.8
|
%
|
|
2.2
|
|
|
|
||||
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
31,116
|
|
|
5.8
|
%
|
|
Ceded premiums written
|
(42,365
|
)
|
|
(8,133
|
)
|
|
(34,232
|
)
|
|
>100%
|
|
|||
|
Net premiums written
|
$
|
525,182
|
|
|
$
|
528,298
|
|
|
$
|
(3,116
|
)
|
|
(0.6
|
%)
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Professional liability
|
|
|
|
|
|
|
|
|||||||
|
Physicians:
|
|
|
|
|
|
|
|
|||||||
|
Twelve month term
|
$
|
388,583
|
|
|
$
|
403,429
|
|
|
$
|
(14,846
|
)
|
|
(3.7
|
%)
|
|
Twenty-four month term
|
25,584
|
|
|
13,081
|
|
|
12,503
|
|
|
95.6
|
%
|
|||
|
Total Physicians
|
414,167
|
|
|
416,510
|
|
|
(2,343
|
)
|
|
(0.6
|
%)
|
|||
|
Other healthcare providers
|
43,125
|
|
|
43,492
|
|
|
(367
|
)
|
|
(0.8
|
%)
|
|||
|
Healthcare facilities
|
26,202
|
|
|
28,259
|
|
|
(2,057
|
)
|
|
(7.3
|
%)
|
|||
|
Legal professionals
|
27,060
|
|
|
17,146
|
|
|
9,914
|
|
|
57.8
|
%
|
|||
|
Tail coverages
|
20,920
|
|
|
29,394
|
|
|
(8,474
|
)
|
|
(28.8
|
%)
|
|||
|
Total professional liability
|
531,474
|
|
|
534,801
|
|
|
(3,327
|
)
|
|
(0.6
|
%)
|
|||
|
Medical technology and life sciences products liability
|
34,190
|
|
|
—
|
|
|
34,190
|
|
|
nm
|
|
|||
|
Other
|
1,883
|
|
|
1,630
|
|
|
253
|
|
|
15.5
|
%
|
|||
|
Total
|
$
|
567,547
|
|
|
$
|
536,431
|
|
|
$
|
31,116
|
|
|
5.8
|
%
|
|
|
Year Ended December 31
|
||
|
($ in thousands)
|
2013
|
||
|
Gross premiums written:
|
|
||
|
Professional liability
|
|
||
|
Physicians, twelve month term
|
$
|
10,474
|
|
|
Other healthcare providers
|
280
|
|
|
|
Legal professionals
|
9,418
|
|
|
|
Total professional liability
|
20,172
|
|
|
|
Medical technology and life sciences products liability
|
34,190
|
|
|
|
Total
|
$
|
54,362
|
|
|
•
|
The acquisition of IND contributed approximately $10.5 million of physician premium to 2013.
|
|
•
|
In addition to premium contributed by IND, we wrote new physician business of approximately $18 million in 2013.
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Primary reinsurance arrangements (1)
|
$
|
16,177
|
|
|
$
|
21,997
|
|
|
$
|
(5,820
|
)
|
|
(26.5
|
%)
|
|
Secondary reinsurance arrangements (2)
|
17,279
|
|
|
9,116
|
|
|
8,163
|
|
|
89.5
|
%
|
|||
|
Reduction in premiums owed under reinsurance agreements, prior accident years, net (3)
|
(16,403
|
)
|
|
(34,328
|
)
|
|
17,925
|
|
|
52.2
|
%
|
|||
|
Premiums ceded associated with acquired entities
|
14,308
|
|
|
—
|
|
|
14,308
|
|
|
nm
|
|
|||
|
Other ceded premiums written
|
11,004
|
|
|
11,348
|
|
|
(344
|
)
|
|
(3.0
|
%)
|
|||
|
Total ceded premiums written
|
$
|
42,365
|
|
|
$
|
8,133
|
|
|
$
|
34,232
|
|
|
>100%
|
|
|
(1)
|
As discussed previously, the premium that we cede under our reinsurance arrangements is determined, in part, by the losses ceded under these arrangements. Ceded premiums decreased due to lower premiums in 2013, and beginning with the second quarter of 2012, we projected (estimated) lower losses for our ceded coverages and reduced our estimate of the associated ceded premium for the current accident year. The year ended December 31, 2013 reflected those lower projections for the full period in 2013 as compared to two quarters in 2012.
|
|
(2)
|
We have secondary arrangements with certain large healthcare groups that include quota share, fronting and other risk sharing arrangements. Growth in these arrangements increased ceded premium in 2013 as compared to 2012. These arrangements are primarily comprised of the following:
|
|
•
|
We share risk of loss for policies written or renewed under the Ascension Health (Ascension) Certitude program with an Ascension affiliate under a quota share arrangement.
|
|
•
|
We have entered into fronting arrangements with certain large healthcare groups. Under the arrangements we provide specified underwriting, claims and risk management services but cede a large portion of the risk of the coverages provided back to the group or affiliates of the group. Volume under such arrangements can vary between periods.
|
|
•
|
During 2013, we entered into quota share arrangements under which we share the risk of loss with captive insurers affiliated with one of our agents.
|
|
(3)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance agreement are known. As a part of the process of estimating our loss reserves we also make estimates regarding the amounts recoverable under our reinsurance agreements. As previously discussed, the amounts ultimately owed under our reinsurance agreements are subject to the losses ceded under the agreements. In both 2013 and 2012, on a net basis, we reduced our estimate of expected losses and associated recoveries for prior year ceded losses, as well as our estimate of ceded premiums owed to reinsurers. The reductions were substantially less in 2013 than in 2012. The net reduction for 2013 includes an offsetting increase of $1.6 million that was attributable to loss reserves acquired in business combinations. In 2012 we also revised the expected amount receivable under certain older reinsurance agreements for which there were limited remaining open items. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the change in estimates occur.
|
|
|
Year Ended December 31
|
||||||
|
|
2013
|
|
2012
|
|
Change
|
||
|
Ceded premiums ratio, as reported
|
7.5
|
%
|
|
1.5
|
%
|
|
6.0
|
|
Less the effect of reduction in premiums owed under reinsurance agreements, prior accident years (as previously discussed)*
|
(2.9
|
%)
|
|
(6.4
|
%)
|
|
3.5
|
|
Ratio, current accident year
|
10.4
|
%
|
|
7.9
|
%
|
|
2.5
|
|
|
Increase (decrease) 2013 versus 2012
|
|
|
Effect on ceded premium ratio, current accident year:
|
|
|
|
Secondary reinsurance arrangements, increased volume
|
1.3
|
|
|
Acquisitions
|
1.6
|
|
|
Other
|
(0.4
|
)
|
|
Net increase in ratio
|
2.5
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
569,433
|
|
|
$
|
558,316
|
|
|
$
|
11,117
|
|
|
2.0
|
%
|
|
Premiums ceded
|
(41,514
|
)
|
|
(7,652
|
)
|
|
(33,862
|
)
|
|
>100%
|
|
|||
|
Net premiums earned
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
$
|
(22,745
|
)
|
|
(4.1
|
%)
|
|
|
Net Loss Ratios (1)
|
||||||
|
|
Year Ended December 31
|
||||||
|
|
2013
|
|
2012
|
|
Change
|
||
|
Calendar year net loss ratio
|
42.6
|
%
|
|
32.7
|
%
|
|
9.9
|
|
Less prior accident year net loss ratio
|
(42.2
|
%)
|
|
(49.4
|
%)
|
|
7.2
|
|
Current accident year net loss ratio
|
84.8
|
%
|
|
82.1
|
%
|
|
2.7
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
||
|
Ceded premium reductions, prior accident years, net (2)
|
(2.7
|
%)
|
|
(5.4
|
%)
|
|
2.7
|
|
Current accident year net loss ratio, less ceded premium effect above (3)
|
87.5
|
%
|
|
87.5
|
%
|
|
—
|
|
(1)
|
Net losses as specified divided by net premiums earned.
|
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net earned premiums (the denominator of the current accident year ratio) in both 2013 and 2012. The net increase to the ratio in 2013 reflects an offset of 0.3 percentage points that is attributable to loss reserves acquired in business combinations. See the discussion under the heading “Ceded Premiums Written” for additional information.
|
|
(3)
|
In addition to the effect of ceded premiums associated with prior accident years, the loss ratio for the current period reflects an increase due to higher unallocated loss adjustment expenses in 2013, the effect of which was offset by decreases to the ratio attributable to a lower amount of tail premium in 2013, a greater benefit from current accident year reinsurance in 2013, and lower average loss ratios for the business acquired from Medmarc and IND. The amount of tail premium affects the average ratio because we generally expect higher losses from tail coverages.
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Underwriting, policy acquisition and operating expenses
|
$
|
132,076
|
|
|
$
|
125,292
|
|
|
$
|
6,784
|
|
|
5.4
|
%
|
|
(In millions)
|
Expense Increase (Decrease)
2013 versus 2012 |
||
|
Expenses of operations from acquired entities *
|
$
|
12.8
|
|
|
Higher compensation costs during 2013, principally attributable to incentive compensation
|
3.1
|
|
|
|
Increase in compensation costs allocated to ULAE or capitalized as deferred policy acquisition costs during 2013
|
(9.1
|
)
|
|
|
Amortization of deferred policy acquisition costs reflects a reduction in 2013 attributable to lower premium volume and a reduction attributable to the adoption of new accounting guidance at the beginning of 2012. The effect of lower premium volume was somewhat offset in 2013 by underwriting compensation costs which were higher in 2013 than in 2012.
|
(2.6
|
)
|
|
|
Other variances not individually significant
|
(0.7
|
)
|
|
|
Expenses associated with discrete events:
|
|
||
|
Medmarc and IND transaction-related costs, principally professional fees and one time compensation costs
|
4.0
|
|
|
|
Compensation costs associated with employee relocation and severance, principally related to the enhancement of our customer service capabilities in 2012
|
(0.7
|
)
|
|
|
Net change in expenses
|
$
|
6.8
|
|
|
*
|
The impact of purchase accounting related to deferred policy acquisition costs reduced the reported expenses by approximately $4.4 million in 2013.
|
|
|
Underwriting Expense Ratio
|
||||||
|
|
Year Ended December 31
|
||||||
|
|
2013
|
|
2012
|
|
Change
|
||
|
Underwriting expense ratio, as reported
|
25.0
|
%
|
|
22.8
|
%
|
|
2.2
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
||
|
Net ceded premium reductions, prior accident years*
|
(0.8
|
%)
|
|
(1.5
|
%)
|
|
0.7
|
|
Expenses associated with other discrete events (see table above)
|
0.8
|
%
|
|
0.2
|
%
|
|
0.6
|
|
Underwriting expense ratio, less listed effects
|
25.0
|
%
|
|
24.1
|
%
|
|
0.9
|
|
|
Increase (decrease), 2013 versus 2012
|
|
|
Estimated ratio increase (decrease) attributable to:
|
|
|
|
Lower net earned premiums, exclusive of acquisitions
|
1.5
|
|
|
Acquisitions, see discussion below
|
0.7
|
|
|
Increased compensation costs
|
0.6
|
|
|
Increase in costs allocated to ULAE or capitalized as deferred policy acquisition costs
|
(1.7
|
)
|
|
Other
|
(0.2
|
)
|
|
Net increase/(decrease) in ratio
|
0.9
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
|
$
|
(6,829
|
)
|
|
(5.0
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
7,539
|
|
|
$
|
(6,873
|
)
|
|
$
|
14,412
|
|
|
>100%
|
|
|
Total net realized investment gains (losses)
|
$
|
67,904
|
|
|
$
|
28,863
|
|
|
$
|
39,041
|
|
|
>100%
|
|
|
Operating expense
|
$
|
15,748
|
|
|
$
|
10,389
|
|
|
$
|
5,359
|
|
|
51.6
|
%
|
|
Interest expense
|
$
|
2,755
|
|
|
$
|
2,181
|
|
|
$
|
574
|
|
|
26.3
|
%
|
|
Income taxes
|
$
|
99,636
|
|
|
$
|
120,496
|
|
|
$
|
(20,860
|
)
|
|
(17.3
|
%)
|
|
Gain on acquisition
|
$
|
32,314
|
|
|
$
|
—
|
|
|
$
|
32,314
|
|
|
nm
|
|
|
|
Year Ended December 31
|
|||||||||||||
|
($ in thousands)
|
2013
|
|
2012
|
|
Change
|
|||||||||
|
Fixed maturities
|
$
|
122,065
|
|
|
$
|
133,088
|
|
|
$
|
(11,023
|
)
|
|
(8.3
|
%)
|
|
Equities
|
9,454
|
|
|
6,947
|
|
|
2,507
|
|
|
36.1
|
%
|
|||
|
Short-term investments and Other invested assets
|
2,584
|
|
|
660
|
|
|
1,924
|
|
|
>100%
|
|
|||
|
Business owned life insurance
|
1,960
|
|
|
2,008
|
|
|
(48
|
)
|
|
(2.4
|
%)
|
|||
|
Investment fees and expenses
|
(6,798
|
)
|
|
(6,609
|
)
|
|
(189
|
)
|
|
(2.9
|
%)
|
|||
|
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
|
$
|
(6,829
|
)
|
|
(5.0
|
%)
|
|
|
Year Ended December 31
|
||
|
|
2013
|
|
2012
|
|
Average income yield
|
3.7%
|
|
3.9%
|
|
Average tax equivalent income yield
|
4.3%
|
|
4.5%
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2013
|
|
2012
|
|
Change
|
||||||
|
Investment LPs
|
$
|
17,673
|
|
|
$
|
278
|
|
|
$
|
17,395
|
|
|
Business LLC interest
|
—
|
|
|
(728
|
)
|
|
728
|
|
|||
|
Tax credit partnerships
|
(10,134
|
)
|
|
(6,423
|
)
|
|
(3,711
|
)
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
7,539
|
|
|
$
|
(6,873
|
)
|
|
$
|
14,412
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2013
|
|
2012
|
||||
|
Tax credits recognized during the period
|
$
|
17,888
|
|
|
$
|
10,005
|
|
|
Deferred tax benefit of amortization
|
$
|
3,547
|
|
|
$
|
2,248
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2013
|
|
2012
|
||||
|
GAAP net investment result:
|
|
|
|
||||
|
Net investment income
|
$
|
129,265
|
|
|
$
|
136,094
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
7,539
|
|
|
(6,873
|
)
|
||
|
GAAP net investment result
|
$
|
136,804
|
|
|
$
|
129,221
|
|
|
|
|
|
|
||||
|
Pro forma tax-equivalent investment results
|
$
|
184,628
|
|
|
$
|
165,632
|
|
|
|
|
|
|
||||
|
Reconciliation of pro forma and GAAP tax-equivalent investment results:
|
|
|
|
||||
|
Pro forma tax-equivalent investment results
|
$
|
184,628
|
|
|
$
|
165,632
|
|
|
Taxable equivalent adjustments, calculated using the 35% federal statutory tax rate:
|
|
|
|
||||
|
State and municipal bonds
|
(17,590
|
)
|
|
(18,482
|
)
|
||
|
BOLI
|
(1,056
|
)
|
|
(1,081
|
)
|
||
|
Dividends received
|
(1,674
|
)
|
|
(1,456
|
)
|
||
|
Tax credit partnerships
|
(27,504
|
)
|
|
(15,392
|
)
|
||
|
GAAP net investment result
|
$
|
136,804
|
|
|
$
|
129,221
|
|
|
|
Year Ended December 31
|
||||||
|
(In thousands)
|
2013
|
|
2012
|
||||
|
Other-than-temporary impairment losses, total:
|
|
|
|
||||
|
State and municipal bonds
|
$
|
(71
|
)
|
|
$
|
—
|
|
|
Residential mortgage-backed securities
|
—
|
|
|
(557
|
)
|
||
|
Corporate debt
|
—
|
|
|
(878
|
)
|
||
|
Other investments
|
—
|
|
|
(131
|
)
|
||
|
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
(201
|
)
|
||
|
Net impairment losses recognized in earnings
|
(71
|
)
|
|
(1,767
|
)
|
||
|
Gross realized gains, available-for-sale securities
|
18,130
|
|
|
18,645
|
|
||
|
Gross realized (losses), available-for-sale securities
|
(7,031
|
)
|
|
(2,076
|
)
|
||
|
Net realized gains (losses), trading securities
|
20,444
|
|
|
1,485
|
|
||
|
Change in unrealized holding gains (losses), trading securities
|
35,507
|
|
|
12,673
|
|
||
|
Decrease (increase) in the fair value of liabilities carried at fair value
|
—
|
|
|
(1,245
|
)
|
||
|
Other
|
925
|
|
|
1,148
|
|
||
|
Net realized investment gains (losses)
|
$
|
67,904
|
|
|
$
|
28,863
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2013
|
|
2012
|
|
Change
|
||||||
|
Senior notes due 2023
|
$
|
1,502
|
|
|
$
|
—
|
|
|
$
|
1,502
|
|
|
Revolving credit agreement (including fees and amortization)
|
1,187
|
|
|
630
|
|
|
557
|
|
|||
|
Letter of credit fees
|
58
|
|
|
—
|
|
|
58
|
|
|||
|
Other debt instruments, principally long-term debt repaid in 2012
|
8
|
|
|
1,551
|
|
|
(1,543
|
)
|
|||
|
|
$
|
2,755
|
|
|
$
|
2,181
|
|
|
$
|
574
|
|
|
|
Year Ended December 31
|
||||
|
|
2013
|
|
2012
|
||
|
Statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
Tax-exempt income
|
(3.7
|
%)
|
|
(3.7
|
%)
|
|
Tax credits
|
(4.5
|
%)
|
|
(2.5
|
%)
|
|
Non-taxable gain on acquisition
|
(2.8
|
%)
|
|
—
|
%
|
|
Other
|
1.1
|
%
|
|
1.6
|
%
|
|
Effective tax rate
|
25.1
|
%
|
|
30.4
|
%
|
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
|
December 31, 2014
|
||||||||||||||||||
|
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
|
Fair Value (in millions):
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
176
|
|
|
$
|
172
|
|
|
$
|
167
|
|
|
$
|
161
|
|
|
$
|
156
|
|
|
U.S. Government-sponsored enterprise obligations
|
41
|
|
|
40
|
|
|
40
|
|
|
38
|
|
|
37
|
|
|||||
|
State and municipal bonds
|
1,114
|
|
|
1,097
|
|
|
1,063
|
|
|
1,024
|
|
|
985
|
|
|||||
|
Corporate debt
|
1,503
|
|
|
1,468
|
|
|
1,417
|
|
|
1,365
|
|
|
1,316
|
|
|||||
|
Asset-backed securities
|
468
|
|
|
467
|
|
|
458
|
|
|
447
|
|
|
432
|
|
|||||
|
All fixed maturity securities
|
$
|
3,302
|
|
|
$
|
3,244
|
|
|
$
|
3,145
|
|
|
$
|
3,035
|
|
|
$
|
2,926
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
3.56
|
|
|
3.50
|
|
|
3.43
|
|
|
3.36
|
|
|
3.30
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
2.53
|
|
|
2.49
|
|
|
2.80
|
|
|
3.08
|
|
|
3.12
|
|
|||||
|
State and municipal bonds
|
3.40
|
|
|
3.49
|
|
|
3.60
|
|
|
3.73
|
|
|
3.85
|
|
|||||
|
Corporate debt
|
3.71
|
|
|
3.73
|
|
|
3.82
|
|
|
3.76
|
|
|
3.70
|
|
|||||
|
Asset-backed securities
|
1.51
|
|
|
1.69
|
|
|
2.36
|
|
|
3.08
|
|
|
3.47
|
|
|||||
|
All fixed maturity securities
|
3.30
|
|
|
3.30
|
|
|
3.50
|
|
|
3.60
|
|
|
3.70
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
December 31, 2013
|
||||||||||||||||||
|
Fair Value (in millions):
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
176
|
|
|
$
|
174
|
|
|
$
|
171
|
|
|
$
|
168
|
|
|
$
|
165
|
|
|
U.S. Government-sponsored enterprise obligations
|
34
|
|
|
34
|
|
|
33
|
|
|
32
|
|
|
30
|
|
|||||
|
State and municipal bonds
|
1,220
|
|
|
1,195
|
|
|
1,155
|
|
|
1,107
|
|
|
1,061
|
|
|||||
|
Corporate debt
|
1,453
|
|
|
1,413
|
|
|
1,361
|
|
|
1,308
|
|
|
1,257
|
|
|||||
|
Asset-backed securities
|
410
|
|
|
406
|
|
|
398
|
|
|
385
|
|
|
371
|
|
|||||
|
All fixed maturity securities
|
$
|
3,293
|
|
|
$
|
3,222
|
|
|
$
|
3,118
|
|
|
$
|
3,000
|
|
|
$
|
2,884
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
3.85
|
|
|
3.81
|
|
|
3.77
|
|
|
3.72
|
|
|
3.68
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
2.82
|
|
|
3.07
|
|
|
3.15
|
|
|
3.12
|
|
|
3.07
|
|
|||||
|
State and municipal bonds
|
3.61
|
|
|
3.84
|
|
|
4.07
|
|
|
4.20
|
|
|
4.25
|
|
|||||
|
Corporate debt
|
4.10
|
|
|
4.13
|
|
|
4.09
|
|
|
4.03
|
|
|
3.96
|
|
|||||
|
Asset-backed securities
|
2.08
|
|
|
2.55
|
|
|
3.12
|
|
|
3.57
|
|
|
3.80
|
|
|||||
|
All fixed maturity securities
|
3.60
|
|
|
3.80
|
|
|
3.90
|
|
|
4.00
|
|
|
4.00
|
|
|||||
|
Index to Consolidated Financial Statements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Financial Statements
. The following consolidated financial statements of ProAssurance Corporation and subsidiaries are included herein in accordance with Item 8 of Part II of this report.
|
|
(b)
|
The exhibits required to be filed by Item 15(b) are listed herein in the Exhibit Index.
|
|
PROASSURANCE CORPORATION
|
|
|
|
|
|
By:
|
/
S
/ W. S
TANCIL
S
TARNES
|
|
|
W. Stancil Starnes
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
||
|
|
/
S
/ W. S
TANCIL
S
TARNES
, J.D.
|
|
Chairman of the Board, Chief Executive Officer
|
|
February 24, 2015
|
|
|
W. Stancil Starnes, J.D.
|
|
(Principal Executive Officer) and President
|
|
|
|
|
|
|
|
||
|
|
/
S
/ E
DWARD
L. R
AND
, J
R
.
|
|
Chief Financial Officer
|
|
February 24, 2015
|
|
|
Edward L. Rand, Jr.
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ K
ELLY
B. B
REWER
|
|
Chief Accounting Officer
|
|
February 24, 2015
|
|
|
Kelly B. Brewer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ S
AMUEL
A. D
I
P
IAZZA,
J
R.
|
|
Director
|
|
February 24, 2015
|
|
|
Samuel A. Di Piazza, Jr.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ R
OBERT
E. F
LOWERS,
M.D
.
|
|
Director
|
|
February 24, 2015
|
|
|
Robert E. Flowers, M.D.
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ M. J
AMES
G
ORRIE
|
|
Director
|
|
February 24, 2015
|
|
|
M. James Gorrie
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ W
ILLIAM
J. L
ISTWAN
, M.D.
|
|
Director
|
|
February 24, 2015
|
|
|
William J. Listwan, M.D.
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ J
OHN
J. M
C
M
AHON
|
|
Director
|
|
February 24, 2015
|
|
|
John J. McMahon
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ A
NN
F. P
UTALLAZ
, P
H
.D.
|
|
Director
|
|
February 24, 2015
|
|
|
Ann F. Putallaz, Ph.D.
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ F
RANK
A. S
PINOSA
, D.P.M.
|
|
Director
|
|
February 24, 2015
|
|
|
Frank A. Spinosa, D.P.M.
|
|
|
|
|
|
|
|
|
|
||
|
|
/
S
/ A
NTHONY
R. T
ERSIGNI
, E
D
.D., FACHE
|
|
Director
|
|
February 24, 2015
|
|
|
Anthony R. Tersigni, Ed.D., FACHE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/
S
/ T
HOMAS
A. S. W
ILSON
, J
R
., M.D.
|
|
Director
|
|
February 24, 2015
|
|
|
Thomas A. S. Wilson, Jr., M.D.
|
|
|
|
|
|
|
December 31,
2014 |
|
December 31,
2013 |
||||
|
Assets
|
|
|
|
||||
|
Investments
|
|
|
|
||||
|
Fixed maturities, available for sale, at fair value; amortized cost, $3,055,477 and $3,026,256, respectively
|
$
|
3,145,027
|
|
|
$
|
3,118,049
|
|
|
Equity securities, trading, at fair value; cost, $283,107 and $203,308, respectively
|
314,482
|
|
|
253,541
|
|
||
|
Short-term investments
|
131,259
|
|
|
248,605
|
|
||
|
Business owned life insurance
|
56,381
|
|
|
54,374
|
|
||
|
Investment in unconsolidated subsidiaries
|
276,501
|
|
|
214,236
|
|
||
|
Other investments, $28,958 at fair value at December 31, 2014, otherwise at cost or amortized cost
|
86,057
|
|
|
52,240
|
|
||
|
Total Investments
|
4,009,707
|
|
|
3,941,045
|
|
||
|
Cash and cash equivalents
|
197,040
|
|
|
129,383
|
|
||
|
Restricted cash
|
—
|
|
|
78,000
|
|
||
|
Premiums receivable
|
202,528
|
|
|
115,403
|
|
||
|
Receivable from reinsurers on paid losses and loss adjustment expenses
|
6,494
|
|
|
3,231
|
|
||
|
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
237,966
|
|
|
247,518
|
|
||
|
Prepaid reinsurance premiums
|
32,115
|
|
|
21,449
|
|
||
|
Deferred policy acquisition costs
|
38,790
|
|
|
28,207
|
|
||
|
Deferred tax asset
|
—
|
|
|
1,757
|
|
||
|
Real estate, net
|
39,799
|
|
|
41,010
|
|
||
|
Intangible assets
|
100,733
|
|
|
52,002
|
|
||
|
Goodwill
|
210,725
|
|
|
161,115
|
|
||
|
Other assets
|
93,263
|
|
|
329,979
|
|
||
|
Total Assets
|
$
|
5,169,160
|
|
|
$
|
5,150,099
|
|
|
|
|
|
|
||||
|
Liabilities and Shareholders’ Equity
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Policy liabilities and accruals
|
|
|
|
||||
|
Reserve for losses and loss adjustment expenses
|
$
|
2,058,266
|
|
|
$
|
2,072,822
|
|
|
Unearned premiums
|
345,828
|
|
|
255,463
|
|
||
|
Reinsurance premiums payable
|
17,451
|
|
|
34,321
|
|
||
|
Total Policy Liabilities
|
2,421,545
|
|
|
2,362,606
|
|
||
|
Deferred tax liability
|
18,818
|
|
|
—
|
|
||
|
Other liabilities
|
320,853
|
|
|
143,079
|
|
||
|
Long-term debt
|
250,000
|
|
|
250,000
|
|
||
|
Total Liabilities
|
3,011,216
|
|
|
2,755,685
|
|
||
|
Shareholders’ Equity
|
|
|
|
||||
|
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 62,297,214 and 62,096,787 shares issued, respectively
|
623
|
|
|
621
|
|
||
|
Additional paid-in capital
|
359,577
|
|
|
349,894
|
|
||
|
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of $31,342 and $32,127, respectively
|
58,204
|
|
|
59,661
|
|
||
|
Retained earnings
|
1,991,704
|
|
|
2,015,603
|
|
||
|
Treasury shares, at cost, 5,763,388 shares and 900,281 shares, respectively
|
(252,164
|
)
|
|
(31,365
|
)
|
||
|
Total Shareholders’ Equity
|
2,157,944
|
|
|
2,394,414
|
|
||
|
Total Liabilities and Shareholders’ Equity
|
$
|
5,169,160
|
|
|
$
|
5,150,099
|
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
|
Balance at January 1, 2012
|
$
|
346
|
|
|
$
|
538,625
|
|
|
$
|
130,037
|
|
|
$
|
1,699,853
|
|
|
$
|
(204,408
|
)
|
|
$
|
2,164,453
|
|
|
Common shares issued for compensation
|
—
|
|
|
3,041
|
|
|
—
|
|
|
—
|
|
|
553
|
|
|
3,594
|
|
||||||
|
Share-based compensation
|
—
|
|
|
8,639
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,639
|
|
||||||
|
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(4,455
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,453
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(192,466
|
)
|
|
—
|
|
|
(192,466
|
)
|
||||||
|
Two-for-one stock split effected in the form of a stock dividend
|
271
|
|
|
(204,070
|
)
|
|
—
|
|
|
—
|
|
|
203,799
|
|
|
—
|
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
15,343
|
|
|
—
|
|
|
—
|
|
|
15,343
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
275,470
|
|
|
—
|
|
|
275,470
|
|
||||||
|
Balance at December 31, 2012
|
619
|
|
|
341,780
|
|
|
145,380
|
|
|
1,782,857
|
|
|
(56
|
)
|
|
2,270,580
|
|
||||||
|
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32,454
|
)
|
|
(32,454
|
)
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
2,940
|
|
|
—
|
|
|
—
|
|
|
1,145
|
|
|
4,085
|
|
||||||
|
Share-based compensation
|
—
|
|
|
9,242
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,242
|
|
||||||
|
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(4,068
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,066
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(64,777
|
)
|
|
—
|
|
|
(64,777
|
)
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(85,719
|
)
|
|
—
|
|
|
—
|
|
|
(85,719
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
297,523
|
|
|
—
|
|
|
297,523
|
|
||||||
|
Balance at December 31, 2013
|
621
|
|
|
349,894
|
|
|
59,661
|
|
|
2,015,603
|
|
|
(31,365
|
)
|
|
2,394,414
|
|
||||||
|
Common shares reacquired
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(222,360
|
)
|
|
(222,360
|
)
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
—
|
|
|
2,639
|
|
|
|
|
|
—
|
|
|
1,561
|
|
|
4,200
|
|
||||||
|
Share-based compensation
|
—
|
|
|
10,056
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,056
|
|
||||||
|
Net effect of restricted and performance shares issued and stock options exercised
|
2
|
|
|
(3,012
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,010
|
)
|
||||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(220,464
|
)
|
|
—
|
|
|
(220,464
|
)
|
||||||
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
(1,457
|
)
|
|
—
|
|
|
—
|
|
|
(1,457
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
196,565
|
|
|
—
|
|
|
196,565
|
|
||||||
|
Balance at December 31, 2014
|
$
|
623
|
|
|
$
|
359,577
|
|
|
$
|
58,204
|
|
|
$
|
1,991,704
|
|
|
$
|
(252,164
|
)
|
|
$
|
2,157,944
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Revenues
|
|
|
|
|
|
||||||
|
Net premiums earned
|
$
|
699,731
|
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
Net investment income
|
125,557
|
|
|
129,265
|
|
|
136,094
|
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
3,986
|
|
|
7,539
|
|
|
(6,873
|
)
|
|||
|
Net realized investment gains (losses):
|
|
|
|
|
|
||||||
|
Other-than-temporary impairment (OTTI) losses
|
(1,475
|
)
|
|
(71
|
)
|
|
(1,566
|
)
|
|||
|
Portion of OTTI losses recognized in (reclassified from) other comprehensive income before taxes
|
268
|
|
|
—
|
|
|
(201
|
)
|
|||
|
Net impairment losses recognized in earnings
|
(1,207
|
)
|
|
(71
|
)
|
|
(1,767
|
)
|
|||
|
Other net realized investment gains (losses)
|
15,861
|
|
|
67,975
|
|
|
30,630
|
|
|||
|
Total net realized investment gains (losses)
|
14,654
|
|
|
67,904
|
|
|
28,863
|
|
|||
|
Other income
|
8,398
|
|
|
7,551
|
|
|
7,106
|
|
|||
|
|
|
|
|
|
|
||||||
|
Total revenues
|
852,326
|
|
|
740,178
|
|
|
715,854
|
|
|||
|
|
|
|
|
|
|
||||||
|
Expenses
|
|
|
|
|
|
||||||
|
Losses and loss adjustment expenses
|
379,232
|
|
|
243,015
|
|
|
161,726
|
|
|||
|
Reinsurance recoveries
|
(16,148
|
)
|
|
(18,254
|
)
|
|
18,187
|
|
|||
|
Net losses and loss adjustment expenses
|
363,084
|
|
|
224,761
|
|
|
179,913
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
211,311
|
|
|
147,817
|
|
|
135,631
|
|
|||
|
Segregated portfolio cells dividend expense
|
1,842
|
|
|
—
|
|
|
—
|
|
|||
|
Interest expense
|
14,084
|
|
|
2,755
|
|
|
2,181
|
|
|||
|
Loss on extinguishment of debt
|
—
|
|
|
—
|
|
|
2,163
|
|
|||
|
|
|
|
|
|
|
||||||
|
Total expenses
|
590,321
|
|
|
375,333
|
|
|
319,888
|
|
|||
|
|
|
|
|
|
|
||||||
|
Gain on acquisition
|
—
|
|
|
32,314
|
|
|
—
|
|
|||
|
|
|
|
|
|
|
||||||
|
Income before income taxes
|
262,005
|
|
|
397,159
|
|
|
395,966
|
|
|||
|
|
|
|
|
|
|
||||||
|
Provision for income taxes
|
|
|
|
|
|
||||||
|
Current expense (benefit)
|
58,645
|
|
|
74,977
|
|
|
82,752
|
|
|||
|
Deferred expense (benefit)
|
6,795
|
|
|
24,659
|
|
|
37,744
|
|
|||
|
Total income tax expense (benefit)
|
65,440
|
|
|
99,636
|
|
|
120,496
|
|
|||
|
|
|
|
|
|
|
||||||
|
Net income
|
196,565
|
|
|
297,523
|
|
|
275,470
|
|
|||
|
|
|
|
|
|
|
||||||
|
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
(1,457
|
)
|
|
(85,719
|
)
|
|
15,343
|
|
|||
|
|
|
|
|
|
|
||||||
|
Comprehensive income
|
$
|
195,108
|
|
|
$
|
211,804
|
|
|
$
|
290,813
|
|
|
|
|
|
|
|
|
||||||
|
Earnings per share:
|
|
|
|
|
|
||||||
|
Basic
|
$
|
3.32
|
|
|
$
|
4.82
|
|
|
$
|
4.49
|
|
|
Diluted
|
$
|
3.30
|
|
|
$
|
4.80
|
|
|
$
|
4.46
|
|
|
|
|
|
|
|
|
||||||
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
|
Basic
|
59,285
|
|
|
61,761
|
|
|
61,342
|
|
|||
|
Diluted
|
59,525
|
|
|
62,020
|
|
|
61,833
|
|
|||
|
|
|
|
|
|
|
||||||
|
Cash dividends declared per common share
|
$
|
3.86
|
|
|
$
|
1.05
|
|
|
$
|
3.13
|
|
|
|
Year Ended December 31
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Operating Activities
|
|
|
|
|
|
||||||
|
Net income
|
$
|
196,565
|
|
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
Adjustments to reconcile income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Amortization, net of accretion
|
43,367
|
|
|
41,429
|
|
|
32,832
|
|
|||
|
Depreciation
|
6,956
|
|
|
4,538
|
|
|
4,741
|
|
|||
|
Loss (gain) on extinguishment of debt
|
—
|
|
|
—
|
|
|
2,163
|
|
|||
|
Gain on acquisition
|
—
|
|
|
(32,314
|
)
|
|
—
|
|
|||
|
(Increase) decrease in cash surrender value of business owned life insurance
|
(2,007
|
)
|
|
(1,960
|
)
|
|
(2,008
|
)
|
|||
|
Net realized investment gains
|
(14,654
|
)
|
|
(67,904
|
)
|
|
(28,863
|
)
|
|||
|
Share-based compensation
|
10,056
|
|
|
9,242
|
|
|
8,639
|
|
|||
|
Deferred income taxes
|
6,795
|
|
|
24,659
|
|
|
37,744
|
|
|||
|
Policy acquisition costs, net amortization (net deferral)
|
10
|
|
|
(5,820
|
)
|
|
3,448
|
|
|||
|
Equity in earnings of unconsolidated subsidiaries, excluding distributions received and tax credit partnership amortization
|
(10,700
|
)
|
|
(17,376
|
)
|
|
450
|
|
|||
|
Other
|
(8,784
|
)
|
|
(3,014
|
)
|
|
(2,957
|
)
|
|||
|
Other changes in assets and liabilities, excluding effect of business combinations:
|
|
|
|
|
|
||||||
|
Premiums receivable
|
(15,136
|
)
|
|
(6,105
|
)
|
|
16,494
|
|
|||
|
Receivable from reinsurers on paid losses and loss adjustment expenses
|
3,263
|
|
|
2,601
|
|
|
(342
|
)
|
|||
|
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
27,114
|
|
|
15,625
|
|
|
58,870
|
|
|||
|
Prepaid reinsurance premiums
|
(5,672
|
)
|
|
(849
|
)
|
|
(482
|
)
|
|||
|
Other assets
|
36,924
|
|
|
9,582
|
|
|
(11,231
|
)
|
|||
|
Reserve for losses and loss adjustment expenses
|
(167,747
|
)
|
|
(179,677
|
)
|
|
(218,100
|
)
|
|||
|
Unearned premiums
|
10,097
|
|
|
(1,740
|
)
|
|
(21,919
|
)
|
|||
|
Reinsurance premiums payable
|
(26,377
|
)
|
|
(13,269
|
)
|
|
(36,583
|
)
|
|||
|
Other liabilities
|
5,932
|
|
|
(36,569
|
)
|
|
(27,116
|
)
|
|||
|
Net cash provided (used) by operating activities
|
$
|
96,002
|
|
|
$
|
38,602
|
|
|
$
|
91,250
|
|
|
Continued on following page.
|
|
|
|
|
|
||||||
|
|
Year Ended December 31
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Continued from previous page
|
|
|
|
|
|
||||||
|
Investing Activities
|
|
|
|
|
|
||||||
|
Purchases of:
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
$
|
(645,114
|
)
|
|
$
|
(519,161
|
)
|
|
$
|
(646,198
|
)
|
|
Equity securities, trading
|
(119,865
|
)
|
|
(87,604
|
)
|
|
(120,555
|
)
|
|||
|
Other investments
|
(25,109
|
)
|
|
(34,699
|
)
|
|
(9,977
|
)
|
|||
|
Funding of tax credit limited partnerships
|
(8,611
|
)
|
|
(63,489
|
)
|
|
(35,745
|
)
|
|||
|
Investment in unconsolidated subsidiaries
|
(52,295
|
)
|
|
(19,228
|
)
|
|
(11,009
|
)
|
|||
|
Proceeds from sales or maturities of:
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
703,828
|
|
|
970,708
|
|
|
926,221
|
|
|||
|
Equity securities, trading
|
134,005
|
|
|
123,645
|
|
|
54,670
|
|
|||
|
Other investments
|
19,942
|
|
|
2,352
|
|
|
1,180
|
|
|||
|
Distributions from unconsolidated subsidiaries
|
5,428
|
|
|
14,632
|
|
|
1,387
|
|
|||
|
Net sales or maturities (purchases) of short-term investments
|
140,411
|
|
|
(176,092
|
)
|
|
48,565
|
|
|||
|
Cash received in (paid in) acquisition
|
35,013
|
|
|
22,780
|
|
|
(28,439
|
)
|
|||
|
Deposit made for future acquisition
|
—
|
|
|
(205,244
|
)
|
|
(153,700
|
)
|
|||
|
Unsettled security transactions, net change
|
(2,953
|
)
|
|
205
|
|
|
4,852
|
|
|||
|
Funds at Lloyd's in support of Syndicate 1729, returned (deposited)
|
8,690
|
|
|
(8,699
|
)
|
|
—
|
|
|||
|
(Increase) decrease in restricted cash
|
78,000
|
|
|
(78,000
|
)
|
|
—
|
|
|||
|
Other
|
(4,390
|
)
|
|
(9,909
|
)
|
|
(4,409
|
)
|
|||
|
Net cash provided (used) by investing activities
|
266,980
|
|
|
(67,803
|
)
|
|
26,843
|
|
|||
|
Financing Activities
|
|
|
|
|
|
||||||
|
Proceeds from long-term debt
|
—
|
|
|
250,000
|
|
|
125,000
|
|
|||
|
Repayment of long-term debt
|
—
|
|
|
(127,183
|
)
|
|
(57,660
|
)
|
|||
|
Repurchase of common stock
|
(222,360
|
)
|
|
(29,089
|
)
|
|
—
|
|
|||
|
Excess tax benefit from share-based payment arrangements
|
2,702
|
|
|
2,128
|
|
|
7,022
|
|
|||
|
Dividends to shareholders
|
(71,252
|
)
|
|
(46,375
|
)
|
|
(200,118
|
)
|
|||
|
Other
|
(4,415
|
)
|
|
(9,448
|
)
|
|
(4,186
|
)
|
|||
|
Net cash provided (used) by financing activities
|
(295,325
|
)
|
|
40,033
|
|
|
(129,942
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
67,657
|
|
|
10,832
|
|
|
(11,849
|
)
|
|||
|
Cash and cash equivalents at beginning of period
|
129,383
|
|
|
118,551
|
|
|
130,400
|
|
|||
|
Cash and cash equivalents at end of period
|
$
|
197,040
|
|
|
$
|
129,383
|
|
|
$
|
118,551
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental Disclosure of Cash Flow Information
|
|
|
|
|
|
||||||
|
Cash paid during the year for income taxes, net of refunds
|
$
|
26,061
|
|
|
$
|
117,107
|
|
|
$
|
110,278
|
|
|
Cash paid during the year for interest
|
$
|
13,408
|
|
|
$
|
913
|
|
|
$
|
2,342
|
|
|
|
|
|
|
|
|
||||||
|
Significant non-cash transactions
|
|
|
|
|
|
||||||
|
Deposit transferred as consideration for acquisition
|
$
|
205,244
|
|
|
$
|
153,700
|
|
|
$
|
—
|
|
|
Dividends declared and not yet paid
|
$
|
167,744
|
|
|
$
|
18,532
|
|
|
$
|
—
|
|
|
Other investment interest converted to equity securities
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
15,742
|
|
|
(in thousands)
|
|
Premium
Receivables |
|
Agency
Receivables |
||||
|
Allowance for credit losses:
|
|
|
|
|
||||
|
Balance at December 31, 2012
|
|
$
|
1,000
|
|
|
$
|
286
|
|
|
Estimated credit losses
|
|
236
|
|
|
—
|
|
||
|
Account write offs, net of recoveries
|
|
(246
|
)
|
|
(236
|
)
|
||
|
Balance at December 31, 2013
|
|
990
|
|
|
50
|
|
||
|
Estimated credit losses
|
|
299
|
|
|
—
|
|
||
|
Account write offs, net of recoveries
|
|
(299
|
)
|
|
—
|
|
||
|
Allowance acquired from acquisition
|
|
225
|
|
|
—
|
|
||
|
Balance at December 31, 2014
|
|
$
|
1,215
|
|
|
$
|
50
|
|
|
•
|
the length of time for which the fair value of the investment has been less than its recorded basis;
|
|
•
|
the financial condition and near-term prospects of the issuer underlying the investment, taking into consideration the economic prospects of the issuer’s industry and geographical region, to the extent that information is publicly available; and
|
|
•
|
the historical and implied volatility of the fair value of the security.
|
|
•
|
For non-structured fixed maturities (U.S. Treasury securities, obligations of U.S. Government and government agencies and authorities, obligations of states, municipalities and political subdivisions, and corporate debt) the estimate of expected cash flows is determined by projecting a recovery value and a recovery time frame and assessing whether further principal and interest will be received. ProAssurance considers various factors in projecting recovery values and recovery time frames, including the following:
|
|
•
|
third party research and credit rating reports;
|
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
|
•
|
For structured securities (primarily asset-backed securities), ProAssurance estimates the present value of the security’s cash flows using the effective yield of the security at the date of acquisition (or the most recent implied rate used to accrete the security if the implied rate has changed as a result of a previous impairment or changes in expected cash flows). ProAssurance considers the most recently available six month averages of the levels of delinquencies, defaults, severities, and prepayments for the collateral (loans) underlying the securitization or, if historical data is not available, sector based assumptions, to estimate expected future cash flows of these securities.
|
|
|
Gross Carrying Value
|
|
Accumulated Amortization
|
|
Amortization Expense
|
||||||||||||||||||||||
|
|
December 31
|
|
December 31
|
|
Year Ended December 31
|
||||||||||||||||||||||
|
(In millions)
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2012
|
||||||||||||||
|
Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Non-amortizable
|
$
|
25.8
|
|
|
$
|
16.8
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Amortizable
|
96.2
|
|
|
51.7
|
|
|
$
|
21.2
|
|
|
$
|
16.5
|
|
|
$
|
10.3
|
|
|
$
|
5.3
|
|
|
$
|
4.5
|
|
||
|
Total Intangible Assets
|
$
|
122.0
|
|
|
$
|
68.5
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(In millions)
|
|
2014
|
|
2013
|
||||
|
Unpaid dividends
|
|
$
|
167.7
|
|
|
$
|
18.5
|
|
|
Segregated portfolio cell (SPC) dividends payable
|
|
15.8
|
|
|
—
|
|
||
|
All other
|
|
137.4
|
|
|
124.6
|
|
||
|
Total other liabilities
|
|
$
|
320.9
|
|
|
$
|
143.1
|
|
|
(In thousands)
|
|
Eastern
|
|
Medmarc
|
||||
|
Fixed maturities, available for sale
|
|
$
|
107,131
|
|
|
$
|
269,529
|
|
|
Equity securities, trading
|
|
65,945
|
|
|
30,976
|
|
||
|
Cash and short-term investments
|
|
58,944
|
|
|
24,008
|
|
||
|
Other investments
|
|
42,133
|
|
|
5,340
|
|
||
|
Premiums receivable, net
|
|
71,989
|
|
|
2,986
|
|
||
|
Receivable from reinsurers on paid and unpaid losses and LAE
|
|
18,942
|
|
|
73,107
|
|
||
|
Intangible assets
|
|
59,000
|
|
|
3,630
|
|
||
|
Deferred policy acquisition costs (see discussion below)
|
|
10,593
|
|
|
—
|
|
||
|
Other assets
|
|
19,225
|
|
|
14,614
|
|
||
|
Reserve for losses and loss adjustment expenses
|
|
(153,191
|
)
|
|
(201,072
|
)
|
||
|
Unearned premiums
|
|
(80,268
|
)
|
|
(16,937
|
)
|
||
|
Ceded balances payable
|
|
(9,507
|
)
|
|
—
|
|
||
|
Segregated portfolio cells dividends payable
|
|
(14,430
|
)
|
|
—
|
|
||
|
Deferred tax liabilities, net
|
|
(12,835
|
)
|
|
(4,934
|
)
|
||
|
Other liabilities
|
|
(28,038
|
)
|
|
(15,233
|
)
|
||
|
Fair value of net assets acquired
|
|
$
|
155,633
|
|
|
$
|
186,014
|
|
|
Goodwill
|
|
49,610
|
|
|
—
|
|
||
|
Gain on acquisition
|
|
—
|
|
|
(32,314
|
)
|
||
|
Total purchase consideration
|
|
$
|
205,243
|
|
|
$
|
153,700
|
|
|
|
Eastern
|
|
Medmarc
|
|||||||
|
(In millions)
|
Estimated Fair Value on Acquisition Date
|
|
Estimated
Useful Life
|
|
Estimated Fair Value on Acquisition Date
|
|
Estimated
Useful Life
|
|||
|
Agency relationships
|
$27.0
|
|
15
|
|
$—
|
|
—
|
|
|
|
|
Policyholder relationships
|
8.0
|
|
15
|
|
—
|
|
—
|
|
|
|
|
Trade names
|
8.0
|
|
15
|
|
—
|
|
—
|
|
|
|
|
Non-compete agreements
|
7.0
|
|
3
|
|
1.1
|
|
2
|
|
(1)
|
|
|
Total intangibles subject to amortization
|
$50.0
|
|
13
|
(2)
|
|
$1.1
|
|
2
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance license agreements
|
$9.0
|
|
Indefinite
|
|
$2.5
|
|
Indefinite
|
|||
|
•
|
For the year ended
December 31, 2013
, ProAssurance
2013
Actual Consolidated Results, which did not include Eastern, have been adjusted to include Eastern's 2013 operating results. ProAssurance Actual Consolidated Results for the year ended
December 31, 2014
included Eastern's operating results (Revenue of
$202.2 million
and Net income of
$9.1 million
).
|
|
•
|
For the year ended December 31, 2012, ProAssurance 2012 Actual Consolidated Results, which did not include Medmarc, have been adjusted to include Medmarc's 2012 operating results. ProAssurance Actual Consolidated Results for the years ended December 31, 2014 and 2013 included Medmarc's operating results (Revenue of
$41.4 million
and
$46.5 million
, respectively, and Net Income of
$8.1 million
and
$15.7 million
, respectively).
|
|
•
|
Certain costs included in ProAssurance Actual Consolidated Results for the years ended
December 31, 2014
and 2013 have been reported in the Pro Forma Consolidated Results as if the costs had been incurred for the years ended
December 31, 2013
and 2012, respectively. Such costs include direct transaction costs and certain compensation costs directly related to the integration of Eastern and Medmarc operations.
|
|
•
|
Prior to the acquisition date, Medmarc reported on a statutory basis and expensed policy acquisition costs associated with successful contracts as incurred. After the acquisition date, in accordance with GAAP, Medmarc policy acquisition costs associated with successful contracts were capitalized and amortized to expense as the related premium revenues were earned, but no amortization was recognized for Medmarc policies written prior to the acquisition date. The Pro Forma Consolidated Results for both 2013 and 2012 have been adjusted to reflect policy acquisition costs as if Medmarc had followed GAAP guidance for these costs in pre-acquisition periods.
|
|
•
|
Net income for the years ended
December 31, 2013
and 2012, respectively, was reduced to reflect amortization of intangible assets and debt security premiums and discounts recorded as a part of the Eastern and Medmarc purchase price allocations.
|
|
•
|
The non-taxable gain on the Medmarc acquisition of
$32.3 million
that was included in ProAssurance Actual Consolidated Results for the year ended December 31, 2013 has been reported in the Pro Forma Consolidated Results as being recognized during the year ended December 31, 2012.
|
|
|
Year Ended December 31, 2014
|
|
Year Ended December 31, 2013
|
|
Year Ended December 31, 2012
|
||||||
|
(In thousands)
|
ProAssurance
Pro Forma Consolidated Results |
|
ProAssurance
Actual Consolidated Results |
|
ProAssurance
Pro Forma Consolidated Results |
|
ProAssurance
Actual Consolidated Results |
|
ProAssurance
Pro Forma Consolidated Results |
|
ProAssurance
Actual Consolidated Results |
|
Revenue
|
$852,326
|
|
$852,326
|
|
$926,873
|
|
$740,178
|
|
$757,240
|
|
$715,854
|
|
Net income
|
$197,533
|
|
$196,565
|
|
$263,446
|
*
|
$297,523
|
|
$317,097
|
|
$275,470
|
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
|
Level 3:
|
the reporting entity’s own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
|
December 31, 2014
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
166,512
|
|
|
$
|
—
|
|
|
$
|
166,512
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
39,563
|
|
|
—
|
|
|
39,563
|
|
||||
|
State and municipal bonds
|
—
|
|
|
1,057,590
|
|
|
5,025
|
|
|
1,062,615
|
|
||||
|
Corporate debt, multiple observable inputs
|
—
|
|
|
1,404,020
|
|
|
—
|
|
|
1,404,020
|
|
||||
|
Corporate debt, limited observable inputs:
|
|
|
|
|
|
|
|
||||||||
|
Other corporate debt, NRSRO ratings available
|
—
|
|
|
—
|
|
|
10,474
|
|
|
10,474
|
|
||||
|
Other corporate debt, NRSRO ratings not available
|
—
|
|
|
—
|
|
|
2,607
|
|
|
2,607
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
276,056
|
|
|
—
|
|
|
276,056
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
15,493
|
|
|
—
|
|
|
15,493
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
51,063
|
|
|
—
|
|
|
51,063
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
111,855
|
|
|
4,769
|
|
|
116,624
|
|
||||
|
Equity securities
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
79,341
|
|
|
—
|
|
|
—
|
|
|
79,341
|
|
||||
|
Utilities/Energy
|
25,629
|
|
|
—
|
|
|
—
|
|
|
25,629
|
|
||||
|
Consumer oriented
|
65,670
|
|
|
—
|
|
|
—
|
|
|
65,670
|
|
||||
|
Industrial
|
55,460
|
|
|
—
|
|
|
—
|
|
|
55,460
|
|
||||
|
Bond funds
|
55,196
|
|
|
—
|
|
|
—
|
|
|
55,196
|
|
||||
|
All other
|
33,186
|
|
|
—
|
|
|
—
|
|
|
33,186
|
|
||||
|
Short-term investments
|
131,199
|
|
|
60
|
|
|
—
|
|
|
131,259
|
|
||||
|
Financial instruments carried at fair value, classified as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Investment in unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
133,250
|
|
|
133,250
|
|
||||
|
Other investments
|
$
|
6,050
|
|
|
$
|
22,908
|
|
|
$
|
—
|
|
|
$
|
28,958
|
|
|
Total assets
|
$
|
451,731
|
|
|
$
|
3,145,120
|
|
|
$
|
156,125
|
|
|
$
|
3,752,976
|
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
170,714
|
|
|
$
|
—
|
|
|
$
|
170,714
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
32,768
|
|
|
—
|
|
|
32,768
|
|
||||
|
State and municipal bonds
|
—
|
|
|
1,147,328
|
|
|
7,338
|
|
|
1,154,666
|
|
||||
|
Corporate debt, multiple observable inputs
|
—
|
|
|
1,346,977
|
|
|
—
|
|
|
1,346,977
|
|
||||
|
Corporate debt, limited observable inputs:
|
|
|
|
|
|
|
|
||||||||
|
Other corporate debt, NRSRO ratings available
|
—
|
|
|
—
|
|
|
11,449
|
|
|
11,449
|
|
||||
|
Other corporate debt, NRSRO ratings not available
|
—
|
|
|
—
|
|
|
2,727
|
|
|
2,727
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
235,614
|
|
|
—
|
|
|
235,614
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
27,475
|
|
|
—
|
|
|
27,475
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
61,390
|
|
|
—
|
|
|
61,390
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
67,455
|
|
|
6,814
|
|
|
74,269
|
|
||||
|
Equity securities
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
81,536
|
|
|
—
|
|
|
—
|
|
|
81,536
|
|
||||
|
Utilities/Energy
|
32,350
|
|
|
—
|
|
|
—
|
|
|
32,350
|
|
||||
|
Consumer oriented
|
66,461
|
|
|
—
|
|
|
—
|
|
|
66,461
|
|
||||
|
Industrial
|
57,262
|
|
|
—
|
|
|
—
|
|
|
57,262
|
|
||||
|
All other
|
15,932
|
|
|
—
|
|
|
—
|
|
|
15,932
|
|
||||
|
Short-term investments
|
248,605
|
|
|
|
|
|
|
|
|
248,605
|
|
||||
|
Financial instruments carried at fair value, classified as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Investment in unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
72,062
|
|
|
72,062
|
|
||||
|
Total assets
|
$
|
502,146
|
|
|
$
|
3,089,721
|
|
|
$
|
100,390
|
|
|
$
|
3,692,257
|
|
|
•
|
Level 3 securities are priced by the Chief Investment Officer.
|
|
•
|
Level 3 valuations are computed quarterly. Prices are evaluated quarterly against prior period prices and the expected change in price.
|
|
•
|
Exclusive of Investments in unconsolidated subsidiaries, which are valued at NAV, the securities noted in the disclosure are primarily NRSRO rated debt instruments for which comparable market inputs are commonly available for evaluating the securities in question. Valuation of these debt instruments is not overly sensitive to changes in the unobservable inputs used.
|
|
|
Unfunded
Commitments |
Fair Value
|
||||||
|
(In thousands)
|
December 31,
2014 |
December 31,
2014 |
|
December 31,
2013 |
||||
|
Investments in LPs/LLCs:
|
|
|
|
|
||||
|
Private debt funds (1)
|
$27,578
|
$
|
37,296
|
|
|
$
|
13,233
|
|
|
Long equity fund (2)
|
None
|
6,747
|
|
|
6,574
|
|
||
|
Long/Short equity funds (3)
|
None
|
25,301
|
|
|
28,385
|
|
||
|
Non-public equity funds (4)
|
$66,545
|
51,811
|
|
|
23,870
|
|
||
|
Multi-strategy fund of funds (5)
|
None
|
8,271
|
|
|
—
|
|
||
|
Structured credit fund (6)
|
None
|
3,824
|
|
|
—
|
|
||
|
|
|
$
|
133,250
|
|
|
$
|
72,062
|
|
|
(1)
|
Comprised of interests in two unrelated LP funds that are structured to provide interest distributions primarily through diversified portfolios of private debt instruments. One LP allows redemption by special consent; the other does not permit redemption. Income and capital are to be periodically distributed at the discretion of the LPs over an anticipated time frame that spans from
3
to
8
years.
|
|
(2)
|
This fund is an LP that holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of
15 days
and are paid within
10 days
of the end of the calendar month of the redemption request.
|
|
(3)
|
Comprised of interests in multiple unrelated LP funds. The funds hold primarily long and short North American equities, and target absolute returns using strategies designed to take advantage of event-driven market opportunities. The funds generally permit quarterly or semi-annual redemptions of the investors' existing capital balance with notice requirements of
30
to
90
days. For some funds, redemptions above specified thresholds (lowest threshold is
90%
) may be only partially payable until after a fund audit is completed and are then payable within
30 days
.
|
|
(4)
|
Comprised of interests in three unrelated LP funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, mezzanine debt, distressed debt and other private equity-oriented LPs. One LP allows redemption by special consent; the others do not permit redemption. Income and capital are to be periodically distributed at the discretion of the LP over time frames that are anticipated to span up to
9
years.
|
|
(5)
|
This fund is an LLC structured to build and manage low volatility, multi-manager portfolios that have little or no correlation to the broader fixed income and equity security markets. Redemptions are not permitted but the LLC Board is permitted discretion to periodically extend offers to repurchase units of the LLC.
|
|
(6)
|
This fund is an LP seeking to obtain superior risk-adjusted absolute returns by acquiring and actively managing a diversified portfolio of debt securities, including bonds, loans and other asset-backed instruments. Redemptions are allowed at any quarter-end with a prior notice requirement of
90 days
.
|
|
Quantitative Information about Level 3 Fair Value Measurements
|
||||||||||
|
|
|
Fair Value at
|
|
|
|
|
|
|
||
|
(In millions)
|
|
December 31, 2014
|
|
December 31, 2013
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
State and municipal bonds
|
|
$5.0
|
|
$7.3
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
Corporate debt with limited observable inputs
|
|
$13.1
|
|
$14.2
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
Other asset-backed securities
|
|
$4.8
|
|
$6.8
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
December 31, 2014
|
||||||||||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||||||
|
(In thousands)
|
U.S. Government-sponsored Enterprise Obligations
|
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Investment in Unconsolidated Subsidiaries
|
|
Total
|
||||||||||||
|
Balance December 31, 2013
|
$
|
—
|
|
|
$
|
7,338
|
|
|
$
|
14,176
|
|
|
$
|
6,814
|
|
|
$
|
72,062
|
|
|
$
|
100,390
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net investment income
|
—
|
|
|
(14
|
)
|
|
65
|
|
|
—
|
|
|
—
|
|
|
51
|
|
||||||
|
Equity in earnings of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,538
|
|
|
10,538
|
|
||||||
|
Net realized investment gains (losses)
|
—
|
|
|
(95
|
)
|
|
3
|
|
|
—
|
|
|
—
|
|
|
(92
|
)
|
||||||
|
Included in other comprehensive income
|
1
|
|
|
(29
|
)
|
|
688
|
|
|
59
|
|
|
—
|
|
|
719
|
|
||||||
|
Purchases
|
1,000
|
|
|
1,861
|
|
|
2,000
|
|
|
3,340
|
|
|
56,340
|
|
|
64,541
|
|
||||||
|
Sales
|
—
|
|
|
(1,731
|
)
|
|
(1,826
|
)
|
|
(61
|
)
|
|
(5,690
|
)
|
|
(9,308
|
)
|
||||||
|
Transfers in
|
—
|
|
|
2,119
|
|
|
—
|
|
|
305
|
|
|
—
|
|
|
2,424
|
|
||||||
|
Transfers out
|
(1,001
|
)
|
|
(4,424
|
)
|
|
(2,025
|
)
|
|
(5,688
|
)
|
|
—
|
|
|
(13,138
|
)
|
||||||
|
Balance December 31, 2014
|
$
|
—
|
|
|
$
|
5,025
|
|
|
$
|
13,081
|
|
|
$
|
4,769
|
|
|
$
|
133,250
|
|
|
$
|
156,125
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
10,538
|
|
|
$
|
10,538
|
|
|
|
December 31, 2013
|
||||||||||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||||||||||
|
(In thousands)
|
U.S. Government-sponsored Enterprise Obligations
|
|
State and Municipal Bonds
|
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Investment in Unconsolidated Subsidiaries
|
|
Total
|
||||||||||||
|
Balance December 31, 2012
|
$
|
—
|
|
|
$
|
7,175
|
|
|
$
|
15,191
|
|
|
$
|
4,035
|
|
|
$
|
33,739
|
|
|
$
|
60,140
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net investment income
|
—
|
|
|
—
|
|
|
(103
|
)
|
|
(17
|
)
|
|
—
|
|
|
(120
|
)
|
||||||
|
Equity in earnings of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,877
|
|
|
6,877
|
|
||||||
|
Net realized investment gains (losses)
|
—
|
|
|
(44
|
)
|
|
(69
|
)
|
|
—
|
|
|
—
|
|
|
(113
|
)
|
||||||
|
Included in other comprehensive income
|
—
|
|
|
1
|
|
|
(725
|
)
|
|
(61
|
)
|
|
—
|
|
|
(785
|
)
|
||||||
|
Purchases
|
—
|
|
|
—
|
|
|
9,470
|
|
|
1,356
|
|
|
24,567
|
|
|
35,393
|
|
||||||
|
Sales
|
—
|
|
|
(2,106
|
)
|
|
(1,629
|
)
|
|
(18
|
)
|
|
(14,632
|
)
|
|
(18,385
|
)
|
||||||
|
Transfers in
|
—
|
|
|
2,312
|
|
|
2,114
|
|
|
3,800
|
|
|
21,511
|
|
|
29,737
|
|
||||||
|
Transfers out
|
—
|
|
|
—
|
|
|
(10,073
|
)
|
|
(2,281
|
)
|
|
—
|
|
|
(12,354
|
)
|
||||||
|
Balance December 31, 2013
|
$
|
—
|
|
|
$
|
7,338
|
|
|
$
|
14,176
|
|
|
$
|
6,814
|
|
|
$
|
72,062
|
|
|
$
|
100,390
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,877
|
|
|
$
|
6,877
|
|
|
|
December 31, 2014
|
|
December 31, 2013
|
||||||||||||
|
(In thousands)
|
Carrying
Value |
|
Fair
Value |
|
Carrying
Value |
|
Fair
Value |
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
||||||||
|
BOLI
|
$
|
56,381
|
|
|
$
|
56,381
|
|
|
$
|
54,374
|
|
|
$
|
54,374
|
|
|
Other investments
|
57,099
|
|
|
57,994
|
|
|
52,240
|
|
|
51,833
|
|
||||
|
Other assets
|
22,440
|
|
|
22,399
|
|
|
17,940
|
|
|
17,940
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Senior notes due 2023
|
$
|
250,000
|
|
|
$
|
276,503
|
|
|
$
|
250,000
|
|
|
$
|
262,500
|
|
|
Other liabilities
|
14,656
|
|
|
14,645
|
|
|
13,303
|
|
|
13,303
|
|
||||
|
|
December 31, 2014
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
163,714
|
|
|
$
|
3,785
|
|
|
$
|
987
|
|
|
$
|
166,512
|
|
|
U.S. Government-sponsored enterprise obligations
|
38,022
|
|
|
1,641
|
|
|
100
|
|
|
39,563
|
|
||||
|
State and municipal bonds
|
1,015,555
|
|
|
47,395
|
|
|
335
|
|
|
1,062,615
|
|
||||
|
Corporate debt
|
1,389,970
|
|
|
44,234
|
|
|
17,103
|
|
|
1,417,101
|
|
||||
|
Residential mortgage-backed securities
|
266,306
|
|
|
10,198
|
|
|
448
|
|
|
276,056
|
|
||||
|
Agency commercial mortgage-backed securities
|
15,344
|
|
|
208
|
|
|
59
|
|
|
15,493
|
|
||||
|
Other commercial mortgage-backed securities
|
50,025
|
|
|
1,137
|
|
|
99
|
|
|
51,063
|
|
||||
|
Other asset-backed securities
|
116,541
|
|
|
288
|
|
|
205
|
|
|
116,624
|
|
||||
|
|
$
|
3,055,477
|
|
|
$
|
108,886
|
|
|
$
|
19,336
|
|
|
$
|
3,145,027
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2013
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
166,115
|
|
|
$
|
6,118
|
|
|
$
|
1,519
|
|
|
$
|
170,714
|
|
|
U.S. Government-sponsored enterprise obligations
|
30,942
|
|
|
2,251
|
|
|
425
|
|
|
32,768
|
|
||||
|
State and municipal bonds
|
1,116,060
|
|
|
46,533
|
|
|
7,927
|
|
|
1,154,666
|
|
||||
|
Corporate debt
|
1,321,838
|
|
|
53,059
|
|
|
13,744
|
|
|
1,361,153
|
|
||||
|
Residential mortgage-backed securities
|
230,861
|
|
|
7,608
|
|
|
2,855
|
|
|
235,614
|
|
||||
|
Agency commercial mortgage-backed securities
|
27,268
|
|
|
343
|
|
|
136
|
|
|
27,475
|
|
||||
|
Other commercial mortgage-backed securities
|
59,066
|
|
|
2,491
|
|
|
167
|
|
|
61,390
|
|
||||
|
Other asset-backed securities
|
74,106
|
|
|
487
|
|
|
324
|
|
|
74,269
|
|
||||
|
|
$
|
3,026,256
|
|
|
$
|
118,890
|
|
|
$
|
27,097
|
|
|
$
|
3,118,049
|
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
163,714
|
|
|
$
|
9,584
|
|
|
$
|
113,489
|
|
|
$
|
39,264
|
|
|
$
|
4,175
|
|
|
$
|
166,512
|
|
|
U.S. Government-sponsored enterprise obligations
|
38,022
|
|
|
3,641
|
|
|
25,286
|
|
|
10,287
|
|
|
349
|
|
|
39,563
|
|
||||||
|
State and municipal bonds
|
1,015,555
|
|
|
44,334
|
|
|
380,741
|
|
|
453,275
|
|
|
184,265
|
|
|
1,062,615
|
|
||||||
|
Corporate debt
|
1,389,970
|
|
|
115,301
|
|
|
711,806
|
|
|
566,585
|
|
|
23,409
|
|
|
1,417,101
|
|
||||||
|
Residential mortgage-backed securities
|
266,306
|
|
|
|
|
|
|
|
|
|
|
276,056
|
|
||||||||||
|
Agency commercial mortgage-backed securities
|
15,344
|
|
|
|
|
|
|
|
|
|
|
15,493
|
|
||||||||||
|
Other commercial mortgage-backed securities
|
50,025
|
|
|
|
|
|
|
|
|
|
|
51,063
|
|
||||||||||
|
Other asset-backed securities
|
116,541
|
|
|
|
|
|
|
|
|
|
|
116,624
|
|
||||||||||
|
|
$
|
3,055,477
|
|
|
|
|
|
|
|
|
|
|
$
|
3,145,027
|
|
||||||||
|
(In thousands)
|
December 31,
2014 |
|
December 31,
2013 |
||||
|
Investments in LPs/LLCs, at cost
|
$
|
53,258
|
|
|
$
|
47,258
|
|
|
Convertible securities, at fair value, see Note 1
|
28,958
|
|
|
—
|
|
||
|
Other, principally FHLB capital stock, at cost
|
3,841
|
|
|
4,982
|
|
||
|
|
$
|
86,057
|
|
|
$
|
52,240
|
|
|
|
December 31, 2014
|
|
Carrying Value
|
|||||||||||
|
(In thousands)
|
Unfunded
Commitments* |
|
Percentage
Ownership |
|
December 31,
2014 |
|
December 31,
2013 |
|||||||
|
Investment in LPs/LLCs:
|
|
|
|
|
|
|
|
|
||||||
|
Tax credit partnerships
|
$
|
15,537
|
|
|
See below
|
|
$
|
133,143
|
|
|
$
|
142,174
|
|
|
|
Private debt funds
|
27,578
|
|
|
<
|
20%
|
|
37,296
|
|
|
13,233
|
|
|||
|
Long equity fund
|
None
|
|
|
<
|
20%
|
|
6,747
|
|
|
6,574
|
|
|||
|
Long/short equity funds
|
None
|
|
|
<
|
25%
|
|
25,301
|
|
|
28,385
|
|
|||
|
Non-public equity funds
|
80,070
|
|
|
<
|
20%
|
|
58,128
|
|
|
23,870
|
|
|||
|
Multi-strategy fund of funds
|
—
|
|
|
<
|
20%
|
|
8,271
|
|
|
—
|
|
|||
|
Structured credit fund
|
—
|
|
|
<
|
20%
|
|
3,824
|
|
|
—
|
|
|||
|
Real estate fund
|
6,526
|
|
|
<
|
20%
|
|
3,791
|
|
|
—
|
|
|||
|
|
|
|
|
|
|
$
|
276,501
|
|
|
$
|
214,236
|
|
||
|
|
|
|
|
|
|
|
|
|
||||||
|
* Unfunded commitments are included in the carrying value of tax credit partnerships only.
|
||||||||||||||
|
|
December 31, 2014
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
61,209
|
|
|
$
|
987
|
|
|
$
|
46,869
|
|
|
$
|
617
|
|
|
$
|
14,340
|
|
|
$
|
370
|
|
|
U.S. Government-sponsored enterprise obligations
|
6,268
|
|
|
100
|
|
|
2,775
|
|
|
44
|
|
|
3,493
|
|
|
56
|
|
||||||
|
State and municipal bonds
|
39,831
|
|
|
335
|
|
|
18,910
|
|
|
84
|
|
|
20,921
|
|
|
251
|
|
||||||
|
Corporate debt
|
423,107
|
|
|
17,103
|
|
|
326,804
|
|
|
13,236
|
|
|
96,303
|
|
|
3,867
|
|
||||||
|
Residential mortgage-backed securities
|
45,006
|
|
|
448
|
|
|
14,406
|
|
|
31
|
|
|
30,600
|
|
|
417
|
|
||||||
|
Agency commercial mortgage-backed securities
|
4,783
|
|
|
59
|
|
|
70
|
|
|
—
|
|
|
4,713
|
|
|
59
|
|
||||||
|
Other commercial mortgage-backed securities
|
13,860
|
|
|
99
|
|
|
7,005
|
|
|
28
|
|
|
6,855
|
|
|
71
|
|
||||||
|
Other asset-backed securities
|
62,577
|
|
|
205
|
|
|
59,176
|
|
|
109
|
|
|
3,401
|
|
|
96
|
|
||||||
|
|
$
|
656,641
|
|
|
$
|
19,336
|
|
|
$
|
476,015
|
|
|
$
|
14,149
|
|
|
$
|
180,626
|
|
|
$
|
5,187
|
|
|
Other investments
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Investments in LPs/LLCs carried at cost
|
$
|
23,683
|
|
|
$
|
3,948
|
|
|
$
|
22,265
|
|
|
$
|
3,711
|
|
|
$
|
1,418
|
|
|
$
|
237
|
|
|
|
December 31, 2013
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
47,668
|
|
|
$
|
1,519
|
|
|
$
|
44,304
|
|
|
$
|
1,182
|
|
|
$
|
3,364
|
|
|
$
|
337
|
|
|
U.S. Goverment-sponsored enterprise obligations
|
$
|
6,640
|
|
|
$
|
425
|
|
|
$
|
5,752
|
|
|
$
|
321
|
|
|
$
|
888
|
|
|
$
|
104
|
|
|
State and municipal bonds
|
203,970
|
|
|
7,927
|
|
|
184,401
|
|
|
6,640
|
|
|
19,569
|
|
|
1,287
|
|
||||||
|
Corporate debt
|
349,277
|
|
|
13,744
|
|
|
324,510
|
|
|
12,061
|
|
|
24,767
|
|
|
1,683
|
|
||||||
|
Residential mortgage-backed securities
|
93,608
|
|
|
2,855
|
|
|
84,045
|
|
|
2,393
|
|
|
9,563
|
|
|
462
|
|
||||||
|
Agency commercial mortgage-backed securities
|
11,658
|
|
|
136
|
|
|
11,082
|
|
|
116
|
|
|
576
|
|
|
20
|
|
||||||
|
Other commercial mortgage-backed securities
|
11,153
|
|
|
167
|
|
|
10,215
|
|
|
159
|
|
|
938
|
|
|
8
|
|
||||||
|
Other asset-backed securities
|
25,539
|
|
|
324
|
|
|
21,804
|
|
|
77
|
|
|
3,735
|
|
|
247
|
|
||||||
|
|
$
|
749,513
|
|
|
$
|
27,097
|
|
|
$
|
686,113
|
|
|
$
|
22,949
|
|
|
$
|
63,400
|
|
|
$
|
4,148
|
|
|
Other investments
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Investments in LPs/LLCs carried at cost
|
$
|
14,752
|
|
|
$
|
1,059
|
|
|
$
|
13,166
|
|
|
$
|
1,018
|
|
|
$
|
1,586
|
|
|
$
|
41
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Fixed maturities
|
$
|
111,895
|
|
|
$
|
122,065
|
|
|
$
|
133,088
|
|
|
Equities
|
10,817
|
|
|
9,454
|
|
|
6,947
|
|
|||
|
Short-term and Other investments
|
8,833
|
|
|
2,584
|
|
|
660
|
|
|||
|
Business owned life insurance
|
2,006
|
|
|
1,960
|
|
|
2,008
|
|
|||
|
Investment fees and expenses
|
(7,994
|
)
|
|
(6,798
|
)
|
|
(6,609
|
)
|
|||
|
Net investment income
|
$
|
125,557
|
|
|
$
|
129,265
|
|
|
$
|
136,094
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Total other-than-temporary impairment losses:
|
|
|
|
|
|
||||||
|
State and municipal bonds
|
$
|
(50
|
)
|
|
$
|
(71
|
)
|
|
$
|
—
|
|
|
Residential mortgage-backed securities
|
—
|
|
|
—
|
|
|
(557
|
)
|
|||
|
Corporate debt
|
(1,425
|
)
|
|
—
|
|
|
(878
|
)
|
|||
|
Other investments
|
—
|
|
|
—
|
|
|
(131
|
)
|
|||
|
Portion recognized in (reclassified from) Other Comprehensive Income:
|
|
|
|
|
|
||||||
|
Corporate debt
|
268
|
|
|
—
|
|
|
(201
|
)
|
|||
|
Net impairments recognized in earnings
|
(1,207
|
)
|
|
(71
|
)
|
|
(1,767
|
)
|
|||
|
Gross realized gains, available-for-sale securities
|
5,627
|
|
|
18,130
|
|
|
18,645
|
|
|||
|
Gross realized (losses), available-for-sale securities
|
(1,103
|
)
|
|
(7,031
|
)
|
|
(2,076
|
)
|
|||
|
Net realized gains (losses), trading securities
|
28,018
|
|
|
20,444
|
|
|
1,485
|
|
|||
|
Net realized gains (losses), Other investments
|
326
|
|
|
—
|
|
|
—
|
|
|||
|
Change in unrealized holding gains (losses), trading securities
|
(18,883
|
)
|
|
35,507
|
|
|
12,673
|
|
|||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value
|
1,876
|
|
|
—
|
|
|
—
|
|
|||
|
Decrease (increase) in the fair value of liabilities carried at fair value
|
—
|
|
|
—
|
|
|
(1,245
|
)
|
|||
|
Other
|
—
|
|
|
925
|
|
|
1,148
|
|
|||
|
Net realized investment gains (losses)
|
$
|
14,654
|
|
|
$
|
67,904
|
|
|
$
|
28,863
|
|
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Balance January 1
|
$
|
83
|
|
|
$
|
3,301
|
|
|
$
|
5,870
|
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
|
|
||||||
|
No OTTI has been previously recognized
|
149
|
|
|
—
|
|
|
—
|
|
|||
|
OTTI has been previously recognized
|
—
|
|
|
—
|
|
|
268
|
|
|||
|
Reductions due to:
|
|
|
|
|
|
||||||
|
Securities sold during the period (realized)
|
—
|
|
|
(3,218
|
)
|
|
(2,837
|
)
|
|||
|
Balance December 31
|
$
|
232
|
|
|
$
|
83
|
|
|
$
|
3,301
|
|
|
|
Year Ended December 31
|
|||||||||
|
(In millions)
|
2014
|
|
2013
|
2012
|
||||||
|
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
244.9
|
|
|
$
|
593.3
|
|
$
|
500.2
|
|
|
Purchases
|
$
|
645.1
|
|
|
$
|
519.2
|
|
$
|
646.2
|
|
|
(In thousands)
|
|
2014 Premiums
|
|
2013 Premiums
|
|
2012 Premiums
|
||||||||||||||||||
|
|
|
Written
|
|
Earned
|
|
Written
|
|
Earned
|
|
Written
|
|
Earned
|
||||||||||||
|
Direct
|
|
$
|
761,043
|
|
|
$
|
755,623
|
|
|
$
|
566,745
|
|
|
$
|
568,629
|
|
|
$
|
536,318
|
|
|
$
|
558,200
|
|
|
Assumed
|
|
18,566
|
|
|
12,987
|
|
|
802
|
|
|
804
|
|
|
113
|
|
|
116
|
|
||||||
|
Ceded
|
|
(77,760
|
)
|
|
(68,879
|
)
|
|
(42,365
|
)
|
|
(41,514
|
)
|
|
(8,133
|
)
|
|
(7,652
|
)
|
||||||
|
Net premiums
|
|
$
|
701,849
|
|
|
$
|
699,731
|
|
|
$
|
525,182
|
|
|
$
|
527,919
|
|
|
$
|
528,298
|
|
|
$
|
550,664
|
|
|
(In thousands)
|
|
2014
|
|
2013
|
||||
|
Deferred tax assets
|
|
|
|
|
||||
|
Unpaid loss discount
|
|
$
|
44,002
|
|
|
$
|
51,879
|
|
|
Unearned premium adjustment
|
|
23,972
|
|
|
21,861
|
|
||
|
Compensation related
|
|
18,623
|
|
|
18,172
|
|
||
|
Intangibles
|
|
1,957
|
|
|
2,074
|
|
||
|
Total deferred tax assets
|
|
88,554
|
|
|
93,986
|
|
||
|
Deferred tax liabilities
|
|
|
|
|
||||
|
Deferred acquisition costs
|
|
9,180
|
|
|
10,150
|
|
||
|
Unrealized gains on investments, net
|
|
31,342
|
|
|
32,127
|
|
||
|
Fixed assets
|
|
3,689
|
|
|
4,166
|
|
||
|
Basis differentials–investments
|
|
31,657
|
|
|
31,247
|
|
||
|
Intangibles
|
|
27,294
|
|
|
13,238
|
|
||
|
Other
|
|
4,210
|
|
|
1,301
|
|
||
|
Total deferred tax liabilities
|
|
107,372
|
|
|
92,229
|
|
||
|
Net deferred tax assets (liabilities)
|
|
$
|
(18,818
|
)
|
|
$
|
1,757
|
|
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Balance at January 1
|
|
$
|
4,823
|
|
|
$
|
4,823
|
|
|
$
|
18,585
|
|
|
Increase for tax position acquired as result of a business combination
|
|
414
|
|
|
—
|
|
|
—
|
|
|||
|
Increases for tax positions taken during the current year
|
|
163
|
|
|
—
|
|
|
—
|
|
|||
|
(Decreases) for tax positions taken during the current year
|
|
(4,823
|
)
|
|
—
|
|
|
(10,206
|
)
|
|||
|
(Decreases) for tax positions taken during prior years
|
|
—
|
|
|
—
|
|
|
(3,556
|
)
|
|||
|
Balance at December 31
|
|
$
|
577
|
|
|
$
|
4,823
|
|
|
$
|
4,823
|
|
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Computed “expected” tax expense
|
|
$
|
91,702
|
|
|
$
|
139,005
|
|
|
$
|
138,588
|
|
|
Tax-exempt income
|
|
(13,250
|
)
|
|
(14,509
|
)
|
|
(14,374
|
)
|
|||
|
Tax credits, qualified affordable housing
|
|
(17,918
|
)
|
|
(17,888
|
)
|
|
(10,005
|
)
|
|||
|
Non-taxable gain on acquisition
|
|
—
|
|
|
(11,310
|
)
|
|
—
|
|
|||
|
Non-U.S. Loss
|
|
1,741
|
|
|
—
|
|
|
—
|
|
|||
|
Other
|
|
3,165
|
|
|
4,338
|
|
|
6,287
|
|
|||
|
Total
|
|
$
|
65,440
|
|
|
$
|
99,636
|
|
|
$
|
120,496
|
|
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Balance, beginning of year
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
$
|
2,247,772
|
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
247,518
|
|
|
191,645
|
|
|
247,658
|
|
|||
|
Net balance, beginning of year
|
1,825,304
|
|
|
1,863,349
|
|
|
2,000,114
|
|
|||
|
Net reserves acquired from acquisitions
|
139,549
|
|
|
126,007
|
|
|
22,464
|
|
|||
|
Net losses:
|
|
|
|
|
|
||||||
|
Current year
|
545,168
|
|
|
447,510
|
|
|
451,951
|
|
|||
|
Favorable development of reserves established in prior years, net
|
(182,084
|
)
|
|
(222,749
|
)
|
|
(272,038
|
)
|
|||
|
Total
|
363,084
|
|
|
224,761
|
|
|
179,913
|
|
|||
|
Paid related to:
|
|
|
|
|
|
||||||
|
Current year
|
(93,737
|
)
|
|
(43,616
|
)
|
|
(38,439
|
)
|
|||
|
Prior years
|
(413,900
|
)
|
|
(345,197
|
)
|
|
(300,703
|
)
|
|||
|
Total paid
|
(507,637
|
)
|
|
(388,813
|
)
|
|
(339,142
|
)
|
|||
|
Net balance, end of year
|
1,820,300
|
|
|
1,825,304
|
|
|
1,863,349
|
|
|||
|
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
237,966
|
|
|
247,518
|
|
|
191,645
|
|
|||
|
Balance, end of year
|
$
|
2,058,266
|
|
|
$
|
2,072,822
|
|
|
$
|
2,054,994
|
|
|
Operating Leases
|
|||
|
(In thousands)
|
|||
|
2015
|
$
|
5,024
|
|
|
2016
|
4,915
|
|
|
|
2017
|
3,601
|
|
|
|
2018
|
2,965
|
|
|
|
2019
|
2,572
|
|
|
|
Thereafter
|
5,232
|
|
|
|
Total minimum lease payments
|
$
|
24,309
|
|
|
(In thousands)
|
December 31,
2014 |
|
December 31,
2013 |
||||
|
Senior notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
Revolving credit agreement, outstanding borrowings not permitted to exceed $200 million aggregately, expires in 2016
|
—
|
|
|
—
|
|
||
|
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
(1)
|
ProAssurance is not permitted to have a leverage ratio of Consolidated Funded Indebtedness (principally, obligations for borrowed money, obligations evidenced by instruments such as notes or acceptances, standby and commercial Letters of Credit, and contingent obligations) to Consolidated Total Capitalization (principally, total non-trade liabilities on a consolidated basis plus consolidated shareholders’ equity, exclusive of accumulated other comprehensive income) greater than
0.35
to
1.0
, determined at the end of each fiscal quarter.
|
|
(2)
|
ProAssurance is required to maintain a minimum net worth of not less than the sum of
75%
of Consolidated Net Worth (consolidated shareholders’ equity, exclusive of accumulated other comprehensive income) at December 31, 2010, plus
|
|
(In thousands of shares)
|
2014
|
|
2013
|
|
2012
|
|||
|
Issued and outstanding shares - January 1
|
61,197
|
|
|
61,624
|
|
|
61,107
|
|
|
Repurchase of shares
|
(4,909
|
)
|
|
(681
|
)
|
|
—
|
|
|
Shares issued due to exercise of options and vesting of share-based compensation awards
|
154
|
|
|
169
|
|
|
436
|
|
|
Other shares issued for compensation and shares reissued to stock purchase plan*
|
92
|
|
|
85
|
|
|
81
|
|
|
Issued and outstanding shares - December 31
|
56,534
|
|
|
61,197
|
|
|
61,624
|
|
|
*
|
Shares issued were valued at fair value (the market price of a ProAssurance common share on the date of issue).
|
|
|
|
Cash Dividends Declared, per Share
|
||||||||||
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
First Quarter
|
|
$
|
0.300
|
|
|
$
|
0.250
|
|
|
$
|
0.125
|
|
|
Second Quarter
|
|
$
|
0.300
|
|
|
$
|
0.250
|
|
|
$
|
0.125
|
|
|
Third Quarter
|
|
$
|
0.300
|
|
|
$
|
0.250
|
|
|
$
|
0.125
|
|
|
Fourth Quarter*
|
|
$
|
2.960
|
|
|
$
|
0.300
|
|
|
$
|
2.750
|
|
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Reclassifications from accumulated other comprehensive income to net income, available-for-sale securities:
|
|
|
|
|
|
||||||
|
Realized investment gains (losses)
|
$
|
3,317
|
|
|
$
|
11,375
|
|
|
$
|
17,350
|
|
|
Non-credit impairment losses reclassified to earnings, due to sale of securities or reclassification as a credit loss
|
—
|
|
|
(347
|
)
|
|
(2,417
|
)
|
|||
|
Total amounts reclassified, before tax effect
|
3,317
|
|
|
11,028
|
|
|
14,933
|
|
|||
|
Tax effect (at 35%)
|
(1,161
|
)
|
|
(3,860
|
)
|
|
(5,227
|
)
|
|||
|
Net reclassification adjustments
|
$
|
2,156
|
|
|
$
|
7,168
|
|
|
$
|
9,706
|
|
|
|
|
|
|
|
|
||||||
|
Deferred tax expense (benefit) included in OCI
|
$
|
(785
|
)
|
|
$
|
(46,157
|
)
|
|
$
|
8,262
|
|
|
|
|
Share-Based
Compensation Expense |
|
Unrecognized Compensation Cost
|
||||||||||||||
|
|
|
Year Ended December 31
|
|
December 31, 2014
|
||||||||||||||
|
|
|
2014
|
|
2013
|
|
2012
|
|
Amount
|
|
Remaining
Recognition Period |
||||||||
|
|
|
(In millions)
|
|
(In millions)
|
|
(Weighted average years)
|
||||||||||||
|
Restricted Share Units
|
|
1.7
|
|
|
1.6
|
|
|
1.6
|
|
|
2.0
|
|
|
1.8
|
||||
|
Performance Share Units
|
|
7.6
|
|
|
7.1
|
|
|
6.7
|
|
|
6.3
|
|
|
1.7
|
||||
|
Purchase Match Units
|
|
0.8
|
|
|
0.5
|
|
|
0.3
|
|
|
1.6
|
|
|
2.2
|
||||
|
Total share-based compensation expense
|
|
$
|
10.1
|
|
|
$
|
9.2
|
|
|
$
|
8.6
|
|
|
$
|
9.9
|
|
|
|
|
Tax benefit recognized
|
|
$
|
3.5
|
|
|
$
|
3.2
|
|
|
$
|
3.0
|
|
|
|
|
|
||
|
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
|
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|
Options
|
|
Weighted
Average Exercise Price |
|||||||||
|
Outstanding, beginning of year
|
|
18,082
|
|
|
$
|
23.00
|
|
|
20,302
|
|
|
$
|
23.15
|
|
|
1,014,661
|
|
|
$
|
22.76
|
|
|
Granted
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Exercised
|
|
(13,626
|
)
|
|
22.47
|
|
|
(2,220
|
)
|
|
24.28
|
|
|
(994,148
|
)
|
|
22.75
|
|
|||
|
Forfeited or expired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(211
|
)
|
|
25.67
|
|
|||
|
Outstanding at end of year
|
|
4,456
|
|
|
24.64
|
|
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|||
|
Exercisable at end of year
|
|
4,456
|
|
|
24.64
|
|
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|||
|
Outstanding at end of year,
vested or expected to vest |
|
4,456
|
|
|
24.64
|
|
|
18,082
|
|
|
23.00
|
|
|
20,302
|
|
|
23.15
|
|
|||
|
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
138,770
|
|
|
$
|
38.92
|
|
|
157,212
|
|
|
$
|
31.94
|
|
|
167,236
|
|
|
$
|
25.52
|
|
|
Granted
|
|
49,750
|
|
|
46.34
|
|
|
39,400
|
|
|
46.97
|
|
|
51,864
|
|
|
42.22
|
|
|||
|
Forfeited
|
|
(2,044
|
)
|
|
44.88
|
|
|
(603
|
)
|
|
35.91
|
|
|
(2,823
|
)
|
|
35.23
|
|
|||
|
Vested and released
|
|
(49,674
|
)
|
|
29.22
|
|
|
(57,239
|
)
|
|
25.25
|
|
|
(59,065
|
)
|
|
22.61
|
|
|||
|
Ending non-vested balance
|
|
136,802
|
|
|
45.02
|
|
|
138,770
|
|
|
38.92
|
|
|
157,212
|
|
|
31.94
|
|
|||
|
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
|
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|
Base Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
486,680
|
|
|
$
|
39.86
|
|
|
552,417
|
|
|
$
|
33.21
|
|
|
522,599
|
|
|
$
|
26.36
|
|
|
Granted
|
|
160,900
|
|
|
46.34
|
|
|
145,580
|
|
|
46.97
|
|
|
212,205
|
|
|
42.22
|
|
|||
|
Forfeited
|
|
(14,221
|
)
|
|
45.30
|
|
|
(17,043
|
)
|
|
38.90
|
|
|
(20,492
|
)
|
|
31.44
|
|
|||
|
Vested and released
|
|
(166,499
|
)
|
|
31.33
|
|
|
(194,274
|
)
|
|
26.39
|
|
|
(161,895
|
)
|
|
23.13
|
|
|||
|
Ending non-vested balance
|
|
466,860
|
|
|
44.97
|
|
|
486,680
|
|
|
39.86
|
|
|
552,417
|
|
|
33.21
|
|
|||
|
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
|
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|
Units
|
|
Weighted
Average Grant Date Fair Value |
|||||||||
|
Beginning non-vested balance
|
|
63,125
|
|
|
$
|
41.34
|
|
|
40,985
|
|
|
$
|
39.85
|
|
|
18,900
|
|
|
$
|
36.20
|
|
|
Granted
|
|
29,069
|
|
|
44.55
|
|
|
25,151
|
|
|
43.57
|
|
|
23,799
|
|
|
42.59
|
|
|||
|
Forfeited
|
|
(2,968
|
)
|
|
43.14
|
|
|
(2,456
|
)
|
|
40.71
|
|
|
(1,610
|
)
|
|
37.72
|
|
|||
|
Vested and released
|
|
(17,125
|
)
|
|
36.61
|
|
|
(555
|
)
|
|
36.33
|
|
|
(104
|
)
|
|
36.20
|
|
|||
|
Ending non-vested balance
|
|
72,101
|
|
|
43.69
|
|
|
63,125
|
|
|
41.34
|
|
|
40,985
|
|
|
39.85
|
|
|||
|
|
Year Ended December 31, 2014
|
||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
|
Net premiums earned
|
$
|
492,733
|
|
|
$
|
194,540
|
|
|
$
|
12,458
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
699,731
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
410
|
|
|
125,147
|
|
|
—
|
|
|
125,557
|
|
||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
3,986
|
|
|
—
|
|
|
3,986
|
|
||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
4
|
|
|
14,650
|
|
|
—
|
|
|
14,654
|
|
||||||
|
Other income
|
5,823
|
|
|
645
|
|
|
126
|
|
|
2,285
|
|
|
(481
|
)
|
|
8,398
|
|
||||||
|
Net losses and loss adjustment expenses
|
(228,199
|
)
|
|
(126,447
|
)
|
|
(8,438
|
)
|
|
—
|
|
|
—
|
|
|
(363,084
|
)
|
||||||
|
Underwriting, policy acquisition and operating expenses
|
(133,132
|
)
|
|
(60,357
|
)
|
|
(9,535
|
)
|
|
(8,768
|
)
|
|
481
|
|
|
(211,311
|
)
|
||||||
|
Segregated portfolio cells dividend expense
|
—
|
|
|
(1,842
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,842
|
)
|
||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,084
|
)
|
|
—
|
|
|
(14,084
|
)
|
||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
(65,440
|
)
|
|
—
|
|
|
(65,440
|
)
|
||||||
|
Segment operating results
|
$
|
137,225
|
|
|
$
|
6,539
|
|
|
$
|
(4,975
|
)
|
|
$
|
57,776
|
|
|
$
|
—
|
|
|
$
|
196,565
|
|
|
Significant non-cash items
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
$
|
8,945
|
|
|
$
|
5,828
|
|
|
$
|
477
|
|
|
$
|
35,073
|
|
|
$
|
—
|
|
|
$
|
50,323
|
|
|
|
Year Ended December 31, 2013
|
||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
|
Net premiums earned
|
$
|
527,919
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
527,919
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
—
|
|
|
129,265
|
|
|
—
|
|
|
129,265
|
|
||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
7,539
|
|
|
—
|
|
|
7,539
|
|
||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
—
|
|
|
67,904
|
|
|
—
|
|
|
67,904
|
|
||||||
|
Other income
|
5,648
|
|
|
—
|
|
|
—
|
|
|
1,910
|
|
|
(7
|
)
|
|
7,551
|
|
||||||
|
Gain on acquisition
|
—
|
|
|
—
|
|
|
—
|
|
|
32,314
|
|
|
—
|
|
|
32,314
|
|
||||||
|
Net losses and loss adjustment expenses
|
(224,761
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(224,761
|
)
|
||||||
|
Underwriting, policy acquisition and operating expenses
|
(132,076
|
)
|
|
—
|
|
|
—
|
|
|
(15,748
|
)
|
|
7
|
|
|
(147,817
|
)
|
||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,755
|
)
|
|
—
|
|
|
(2,755
|
)
|
||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
—
|
|
|
(99,636
|
)
|
|
—
|
|
|
(99,636
|
)
|
||||||
|
Segment operating results
|
$
|
176,730
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
120,793
|
|
|
$
|
—
|
|
|
$
|
297,523
|
|
|
Significant non-cash items
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
$
|
7,199
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
38,768
|
|
|
$
|
—
|
|
|
$
|
45,967
|
|
|
|
Year Ended December 31, 2012
|
||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
|
Net premiums earned
|
$
|
550,664
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
550,664
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
—
|
|
|
136,094
|
|
|
—
|
|
|
136,094
|
|
||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,873
|
)
|
|
—
|
|
|
(6,873
|
)
|
||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
|
|
28,863
|
|
|
—
|
|
|
28,863
|
|
|||||||
|
Other income
|
5,331
|
|
|
—
|
|
|
—
|
|
|
1,825
|
|
|
(50
|
)
|
|
7,106
|
|
||||||
|
Gain on acquisition
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Net losses and loss adjustment expenses
|
(179,913
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(179,913
|
)
|
||||||
|
Underwriting, policy acquisition and operating expenses
|
(125,292
|
)
|
|
—
|
|
|
—
|
|
|
(10,389
|
)
|
|
50
|
|
|
(135,631
|
)
|
||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,181
|
)
|
|
—
|
|
|
(2,181
|
)
|
||||||
|
Loss on extinguishment of debt
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,163
|
)
|
|
—
|
|
|
(2,163
|
)
|
||||||
|
Income tax benefit (expense)
|
—
|
|
|
|
|
|
|
(120,496
|
)
|
|
|
|
(120,496
|
)
|
|||||||||
|
Segment operating results
|
$
|
250,790
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
24,680
|
|
|
$
|
—
|
|
|
$
|
275,470
|
|
|
Significant non-cash items
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
$
|
7,355
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
30,218
|
|
|
$
|
—
|
|
|
$
|
37,573
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Specialty P&C Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Healthcare professional liability
|
|
$
|
477,031
|
|
|
$
|
507,222
|
|
|
$
|
539,729
|
|
|
Legal professional liability
|
|
28,278
|
|
|
27,162
|
|
|
17,042
|
|
|||
|
Medical technology and life sciences products liability
|
|
35,913
|
|
|
33,242
|
|
|
—
|
|
|||
|
Other
|
|
1,830
|
|
|
1,807
|
|
|
1,545
|
|
|||
|
Ceded premiums earned*
|
|
(50,319
|
)
|
|
(41,514
|
)
|
|
(7,652
|
)
|
|||
|
Segment net premiums earned
|
|
$
|
492,733
|
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
|
|
|
|
|
|
|
||||||
|
Workers' Compensation Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Traditional business
|
|
$
|
160,717
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Alternative market business
|
|
55,616
|
|
|
—
|
|
|
—
|
|
|||
|
Ceded premiums earned
|
|
(21,793
|
)
|
|
—
|
|
|
—
|
|
|||
|
Segment net premiums earned
|
|
$
|
194,540
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||
|
Lloyd's Syndicate Segment
|
|
|
|
|
|
|
||||||
|
Gross premiums earned:
|
|
|
|
|
|
|
||||||
|
Property and casualty*
|
|
$
|
13,429
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Ceded premiums earned
|
|
(971
|
)
|
|
—
|
|
|
—
|
|
|||
|
Segment net premiums earned
|
|
$
|
12,458
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||
|
Consolidated net premiums earned
|
|
$
|
699,731
|
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
(In millions)
|
||||||||
|
Statutory Net Earnings
|
|
Statutory Capital and Surplus
|
||||||
|
2014
|
|
2013
|
|
2012
|
|
2014
|
|
2013
|
|
$246
|
|
$256
|
|
$312
|
|
$1,681
|
|
$1,642
|
|
|
|
2014
|
||||||||||||||
|
(In thousands, except per share data)
|
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
|
Net premiums earned
|
|
$
|
171,730
|
|
|
$
|
176,303
|
|
|
$
|
177,028
|
|
|
$
|
174,670
|
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
||||||||
|
Current year
|
|
137,647
|
|
|
141,126
|
|
|
142,124
|
|
|
124,271
|
|
||||
|
Prior year
|
|
(48,139
|
)
|
|
(42,213
|
)
|
|
(42,902
|
)
|
|
(48,830
|
)
|
||||
|
Net income
|
|
46,731
|
|
|
49,942
|
|
|
34,778
|
|
|
65,114
|
|
||||
|
Basic earnings per share*
|
|
0.76
|
|
|
0.84
|
|
|
0.59
|
|
|
1.13
|
|
||||
|
Diluted earnings per share*
|
|
0.76
|
|
|
0.84
|
|
|
0.59
|
|
|
1.12
|
|
||||
|
|
|
2013
|
||||||||||||||
|
(In thousands, except per share data)
|
|
1st
|
|
2nd
|
|
3rd
|
|
4th
|
||||||||
|
Net premiums earned
|
|
$
|
134,578
|
|
|
$
|
130,352
|
|
|
$
|
133,598
|
|
|
$
|
129,392
|
|
|
Net losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
||||||||
|
Current year
|
|
110,726
|
|
|
109,109
|
|
|
110,987
|
|
|
116,689
|
|
||||
|
Prior year
|
|
(53,100
|
)
|
|
(38,500
|
)
|
|
(49,350
|
)
|
|
(81,799
|
)
|
||||
|
Net income
|
|
112,850
|
|
|
50,451
|
|
|
63,357
|
|
|
70,864
|
|
||||
|
Basic earnings per share*
|
|
1.83
|
|
|
0.82
|
|
|
1.02
|
|
|
1.15
|
|
||||
|
Diluted earnings per share*
|
|
1.82
|
|
|
0.81
|
|
|
1.02
|
|
|
1.14
|
|
||||
|
*
|
Quarterly and year-to-date computations of per share amounts are made independently; therefore, the sum of per share amounts for the quarters may not equal per share amounts for the respective year-to-date periods.
|
|
Type of Investment
|
|
Recorded
Cost Basis |
|
Fair
Value |
|
Amount Which is
Presented in the Balance Sheet |
||||||
|
(In thousands)
|
|
|
|
|
|
|
||||||
|
Fixed Maturities
|
|
|
|
|
|
|
||||||
|
Bonds:
|
|
|
|
|
|
|
||||||
|
U.S. Government or government agencies and authorities
|
|
$
|
201,736
|
|
|
$
|
206,075
|
|
|
$
|
206,075
|
|
|
States, municipalities and political subdivisions
|
|
1,015,555
|
|
|
1,062,615
|
|
|
1,062,615
|
|
|||
|
Foreign Governments
|
|
2,709
|
|
|
2,871
|
|
|
2,871
|
|
|||
|
Public utilities
|
|
80,086
|
|
|
83,668
|
|
|
83,668
|
|
|||
|
All other corporate bonds
|
|
1,307,025
|
|
|
1,330,412
|
|
|
1,330,412
|
|
|||
|
Certificates of deposit
|
|
150
|
|
|
150
|
|
|
150
|
|
|||
|
Mortgage-backed securities
|
|
448,216
|
|
|
459,236
|
|
|
459,236
|
|
|||
|
Total Fixed Maturities
|
|
3,055,477
|
|
|
3,145,027
|
|
|
3,145,027
|
|
|||
|
Equity Securities, trading
|
|
|
|
|
|
|
||||||
|
Common Stocks:
|
|
|
|
|
|
|
||||||
|
Public utilities
|
|
6,559
|
|
|
7,981
|
|
|
7,981
|
|
|||
|
Banks, trusts and insurance companies
|
|
75,171
|
|
|
79,341
|
|
|
79,341
|
|
|||
|
Industrial, miscellaneous and all other
|
|
201,377
|
|
|
227,160
|
|
|
227,160
|
|
|||
|
Total Equity Securities, trading
|
|
283,107
|
|
|
314,482
|
|
|
314,482
|
|
|||
|
Other long-term investments
|
|
418,939
|
|
|
421,655
|
|
|
418,939
|
|
|||
|
Short-term investments
|
|
131,259
|
|
|
131,259
|
|
|
131,259
|
|
|||
|
Total Investments
|
|
$
|
3,888,782
|
|
|
$
|
4,012,423
|
|
|
$
|
4,009,707
|
|
|
|
|
December 31
|
||||||
|
(In thousands)
|
|
2014
|
|
2013
|
||||
|
Assets
|
|
|
|
|
||||
|
Investment in subsidiaries, at equity
|
|
$
|
2,145,358
|
|
|
$
|
1,996,721
|
|
|
Fixed maturities available for sale, at fair value
|
|
203,451
|
|
|
86,603
|
|
||
|
Equity securities, trading, at fair value
|
|
—
|
|
|
12,043
|
|
||
|
Short-term investments
|
|
42,790
|
|
|
191,991
|
|
||
|
Cash and cash equivalents
|
|
87,200
|
|
|
37,459
|
|
||
|
Restricted cash
|
|
—
|
|
|
78,000
|
|
||
|
Due from subsidiaries
|
|
87,719
|
|
|
12,014
|
|
||
|
Other assets
|
|
25,736
|
|
|
255,313
|
|
||
|
Total Assets
|
|
$
|
2,592,254
|
|
|
$
|
2,670,144
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
||||
|
Liabilities:
|
|
|
|
|
||||
|
Other liabilities
|
|
$
|
184,310
|
|
|
$
|
25,730
|
|
|
Long-term debt
|
|
250,000
|
|
|
250,000
|
|
||
|
Total Liabilities
|
|
434,310
|
|
|
275,730
|
|
||
|
Shareholders’ Equity:
|
|
|
|
|
||||
|
Common stock
|
|
623
|
|
|
621
|
|
||
|
Other shareholders’ equity, including unrealized gains (losses) on securities of subsidiaries
|
|
2,157,321
|
|
|
2,393,793
|
|
||
|
Total Shareholders’ Equity
|
|
2,157,944
|
|
|
2,394,414
|
|
||
|
Total Liabilities and Shareholders’ Equity
|
|
$
|
2,592,254
|
|
|
$
|
2,670,144
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Net investment income
|
|
$
|
3,295
|
|
|
$
|
5,789
|
|
|
$
|
5,281
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
—
|
|
|
—
|
|
|
(728
|
)
|
|||
|
Net realized investment gains (losses)
|
|
990
|
|
|
5,334
|
|
|
3,230
|
|
|||
|
Other income (loss)
|
|
660
|
|
|
170
|
|
|
54
|
|
|||
|
|
|
4,945
|
|
|
11,293
|
|
|
7,837
|
|
|||
|
Expenses:
|
|
|
|
|
|
|
||||||
|
Interest expense
|
|
14,084
|
|
|
2,747
|
|
|
1,534
|
|
|||
|
Other expenses
|
|
7,083
|
|
|
13,213
|
|
|
8,870
|
|
|||
|
|
|
21,167
|
|
|
15,960
|
|
|
10,404
|
|
|||
|
Income (loss) before income tax expense (benefit) and equity in net income of consolidated subsidiaries
|
|
(16,222
|
)
|
|
(4,667
|
)
|
|
(2,567
|
)
|
|||
|
Income tax expense (benefit)
|
|
(6,728
|
)
|
|
(1,007
|
)
|
|
773
|
|
|||
|
Income (loss) before equity in net income of consolidated subsidiaries
|
|
(9,494
|
)
|
|
(3,660
|
)
|
|
(3,340
|
)
|
|||
|
Equity in net income of consolidated subsidiaries
|
|
206,059
|
|
|
301,183
|
|
|
278,810
|
|
|||
|
Net income
|
|
$
|
196,565
|
|
|
$
|
297,523
|
|
|
$
|
275,470
|
|
|
Other comprehensive income
|
|
$
|
(1,457
|
)
|
|
$
|
(85,719
|
)
|
|
$
|
15,343
|
|
|
Comprehensive income
|
|
$
|
195,108
|
|
|
$
|
211,804
|
|
|
$
|
290,813
|
|
|
|
|
Year Ended December 31
|
||||||||||
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Net cash provided (used) by operating activities
|
|
$
|
20,086
|
|
|
$
|
(24,654
|
)
|
|
$
|
3,601
|
|
|
Investing activities
|
|
|
|
|
|
|
||||||
|
Purchases of equity securities trading
|
|
(310
|
)
|
|
(1,265
|
)
|
|
(364
|
)
|
|||
|
Proceeds from sale or maturities of:
|
|
|
|
|
|
|
||||||
|
Fixed maturities, available for sale
|
|
104,844
|
|
|
224,993
|
|
|
150,192
|
|
|||
|
Equity securities trading
|
|
12,813
|
|
|
1,113
|
|
|
616
|
|
|||
|
Net decrease (increase) in short-term investments
|
|
149,202
|
|
|
(187,625
|
)
|
|
58,657
|
|
|||
|
Dividends from subsidiaries
|
|
67,188
|
|
|
239,484
|
|
|
59,369
|
|
|||
|
Contribution of capital to subsidiaries
|
|
(7,000
|
)
|
|
—
|
|
|
(184,330
|
)
|
|||
|
Deposit made for future acquisition
|
|
—
|
|
|
(205,244
|
)
|
|
—
|
|
|||
|
(Increase) decrease in restricted cash
|
|
78,000
|
|
|
(78,000
|
)
|
|
—
|
|
|||
|
Funds advanced for Syndicate 1729 FAL deposit
|
|
(76,553
|
)
|
|
(8,699
|
)
|
|
—
|
|
|||
|
Funds advanced under Syndicate 1729 credit agreement
|
|
(9,107
|
)
|
|
(1,665
|
)
|
|
—
|
|
|||
|
Other
|
|
415
|
|
|
(20
|
)
|
|
(1
|
)
|
|||
|
Net cash provided (used) by investing activities
|
|
319,492
|
|
|
(16,928
|
)
|
|
84,139
|
|
|||
|
Financing activities
|
|
|
|
|
|
|
||||||
|
Proceeds from long-term debt
|
|
—
|
|
|
250,000
|
|
|
125,000
|
|
|||
|
Principal repayment of debt
|
|
—
|
|
|
(125,000
|
)
|
|
(32,992
|
)
|
|||
|
Repurchase of common stock
|
|
(222,360
|
)
|
|
(29,089
|
)
|
|
—
|
|
|||
|
Subsidiary payments for common shares and share-based compensation awarded to subsidiary employees
|
|
8,301
|
|
|
6,258
|
|
|
7,066
|
|
|||
|
Excess of tax benefit from share-based payment arrangements
|
|
1,631
|
|
|
2,128
|
|
|
7,022
|
|
|||
|
Dividends to shareholders
|
|
(70,490
|
)
|
|
(46,375
|
)
|
|
(200,118
|
)
|
|||
|
Other
|
|
(6,919
|
)
|
|
(8,278
|
)
|
|
(12,259
|
)
|
|||
|
Net cash provided (used) by financing activities
|
|
(289,837
|
)
|
|
49,644
|
|
|
(106,281
|
)
|
|||
|
Increase (decrease) in cash and cash equivalents
|
|
49,741
|
|
|
8,062
|
|
|
(18,541
|
)
|
|||
|
Cash and cash equivalents, beginning of period
|
|
37,459
|
|
|
29,397
|
|
|
47,938
|
|
|||
|
Cash and cash equivalents, end of period
|
|
$
|
87,200
|
|
|
$
|
37,459
|
|
|
$
|
29,397
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
|
||||||
|
Cash paid during the year for income taxes, net of refunds
|
|
$
|
26,061
|
|
|
$
|
117,107
|
|
|
$
|
110,278
|
|
|
Cash paid during the year for interest
|
|
$
|
13,408
|
|
|
$
|
913
|
|
|
$
|
2,342
|
|
|
Significant non-cash transactions:
|
|
|
|
|
|
|
||||||
|
Dividends declared and not yet paid
|
|
$
|
167,744
|
|
|
$
|
18,532
|
|
|
$
|
—
|
|
|
Securities transferred at fair value as dividends from subsidiaries
|
|
$
|
227,412
|
|
|
$
|
69,011
|
|
|
$
|
241,081
|
|
|
(In thousands)
|
|
2014
|
|
2013
|
||||
|
Senior notes due 2023, unsecured, interest at 5.3% annually
|
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
Revolving credit agreement, outstanding borrowings not permitted to exceed $200 million aggregately, expires in 2016
|
|
—
|
|
|
—
|
|
||
|
|
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
(In thousands)
|
2014
|
|
2013
|
|
2012
|
||||||
|
Net premiums earned
|
|
|
|
|
|
||||||
|
Specialty P&C
|
$
|
492,733
|
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
Workers' Compensation
|
194,540
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
12,458
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
699,731
|
|
|
527,919
|
|
|
550,664
|
|
|||
|
Net investment income (1)
|
|
|
|
|
|
||||||
|
Lloyd's Syndicate
|
410
|
|
|
—
|
|
|
—
|
|
|||
|
Corporate
|
125,147
|
|
|
129,265
|
|
|
136,094
|
|
|||
|
Consolidated
|
125,557
|
|
|
129,265
|
|
|
136,094
|
|
|||
|
Losses and loss adjustment expenses incurred related to current year, net of reinsurance
|
|
|
|
|
|
||||||
|
Specialty P&C
|
408,987
|
|
|
447,510
|
|
|
451,951
|
|
|||
|
Workers' Compensation
|
127,743
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
8,438
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
545,168
|
|
|
447,510
|
|
|
451,951
|
|
|||
|
Losses and loss adjustment expenses incurred related to prior year, net of reinsurance
|
|
|
|
|
|
||||||
|
Specialty P&C
|
(180,788
|
)
|
|
(222,749
|
)
|
|
(272,038
|
)
|
|||
|
Workers' Compensation
|
(1,296
|
)
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
(182,084
|
)
|
|
(222,749
|
)
|
|
(272,038
|
)
|
|||
|
Paid losses and loss adjustment expenses, net of reinsurance
|
|
|
|
|
|
||||||
|
Specialty P&C
|
389,458
|
|
|
388,813
|
|
|
339,142
|
|
|||
|
Workers' Compensation
|
117,775
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
404
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
507,637
|
|
|
388,813
|
|
|
339,142
|
|
|||
|
Amortization of deferred policy acquisition costs
|
|
|
|
|
|
||||||
|
Specialty P&C
|
55,105
|
|
|
53,207
|
|
|
54,887
|
|
|||
|
Workers' Compensation
|
10,307
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
3,165
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
68,577
|
|
|
53,207
|
|
|
54,887
|
|
|||
|
Other underwriting, policy acquisition and operating expenses
|
|
|
|
|
|
||||||
|
Specialty P&C
|
78,027
|
|
|
78,869
|
|
|
70,405
|
|
|||
|
Workers' Compensation
|
50,050
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
6,370
|
|
|
—
|
|
|
—
|
|
|||
|
Corporate
|
8,768
|
|
|
15,748
|
|
|
10,389
|
|
|||
|
Consolidated (2)
|
142,734
|
|
|
94,610
|
|
|
80,744
|
|
|||
|
Net premiums written
|
|
|
|
|
|
||||||
|
Specialty P&C
|
467,046
|
|
|
525,182
|
|
|
528,298
|
|
|||
|
Workers' Compensation
|
202,697
|
|
|
—
|
|
|
—
|
|
|||
|
Lloyd's Syndicate
|
32,106
|
|
|
—
|
|
|
—
|
|
|||
|
Consolidated
|
701,849
|
|
|
525,182
|
|
|
528,298
|
|
|||
|
Deferred policy acquisition costs (1)
|
38,790
|
|
|
28,207
|
|
|
23,179
|
|
|||
|
Reserve for losses and loss adjustment expenses (1)
|
2,058,266
|
|
|
2,072,822
|
|
|
2,054,994
|
|
|||
|
Unearned premiums (1)
|
345,828
|
|
|
255,463
|
|
|
233,861
|
|
|||
|
(In thousands)
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Property and Liability *
|
|
|
|
|
|
|
||||||
|
Premiums earned
|
|
$
|
755,623
|
|
|
$
|
568,629
|
|
|
$
|
558,200
|
|
|
Premiums ceded
|
|
(68,879
|
)
|
|
(41,514
|
)
|
|
(7,652
|
)
|
|||
|
Premiums assumed
|
|
12,987
|
|
|
804
|
|
|
116
|
|
|||
|
Net premiums earned
|
|
$
|
699,731
|
|
|
$
|
527,919
|
|
|
$
|
550,664
|
|
|
Percentage of amount assumed to net
|
|
1.86
|
%
|
|
0.15
|
%
|
|
0.02
|
%
|
|||
|
*
|
All of ProAssurance’s premiums are related to property and liability coverages.
|
|
Exhibit Number
|
|
Description
|
|
|
|
|
|
2
|
|
Schedules to the following documents are omitted; the contents of the schedules are generally described in the documents; and ProAssurance will upon request furnish to the Commission supplementally a copy of any omitted schedule
|
|
|
|
|
|
2.1
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, CA Bridge Corporation and American Physicians Service Group, Inc. dated August 31, 2010, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring August 31, 2010 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
2.2
|
|
Stock Purchase Agreement dated as of June 26, 2012, by and among ProAssurance Corporation, PRA Professional Liability Group, Inc. and Medmarc Mutual Insurance Company, filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
2.3
|
|
Agreement and Plan of Merger by and among ProAssurance Corporation, PA Merger Company and Eastern Insurance Holdings, Inc., dated September 23, 2013, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring September 24, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
3.1(a)
|
|
Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Registration Statement on Form S-4 (File No. 333-49378) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
3.1(b)
|
|
Certificate of Amendment to Certificate of Incorporation of ProAssurance, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2001 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
3.2
|
|
Third Restatement of the Bylaws of ProAssurance, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring December 1, 2010 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
4.1
|
|
Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
4.2
|
|
First Supplemental Indenture, dated November 21, 2013, between ProAssurance and Wilmington Trust Company relating to the $250,000 5.30% Senior Notes due 2023, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
|
|
ProAssurance will file with the Commission upon request pursuant to the requirements of Item 601 (b)(4) of Regulation S-K documents defining rights of holders of ProAssurance’s long-term indebtedness that has not been registered. See also the documents related to long term indebtedness filed as material contracts under Exhibits 10.14(a), (b), (c), (d) and (e) to this Form 10-K.
|
|
|
|
|
|
10.1(a)
|
|
Medical Assurance, Inc. Incentive Compensation Stock Plan (formerly known as the Mutual Assurance, Inc. 1995 Stock Award Plan), filed as an Exhibit to MAIC Holding’s Registration Statement on Form S-4 (File No. 33-91508) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.1(b)
|
|
Amendment and Assumption Agreement by and between ProAssurance and Medical Assurance, Inc., filed as an Exhibit to ProAssurance’s Registration Statement on Form S-4 (File No. 333-49378) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.1(c)
|
|
Amendment and Assumption Agreement by and between Mutual Assurance, Inc. and MAIC Holdings, Inc. dated April 8, 1996, filed as an Exhibit to MAIC Holding’s Proxy Statement for the 1996 Annual Meeting (File No. 0-19439) is incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.2(a)
|
|
ProAssurance Corporation 2004 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 16, 2004 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.2(b)
|
|
First amendment to 2004 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.3(a)
|
|
Form of Release and Severance Compensation Agreement dated as of January 1, 2008 between ProAssurance and each of the following named executive officers (11):*
|
|
|
|
Howard H. Friedman Jeffrey P. Lisenby
Frank B. O’Neil Edward L. Rand
|
|
|
|
Filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.4(a)
|
|
Employment Agreement between ProAssurance and W. Stancil Starnes dated as of May 1, 2007, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for the event occurring May 12, 2007 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.4(b)
|
|
Amendment to Employment Agreement with W. Stancil Starnes (May 1, 2007), effective as of January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.5
|
|
Consulting Agreement between ProAssurance and William J. Listwan, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2009 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.6
|
|
Form of Release and Severance Compensation Agreement dated as of September 1, 2011 between ProAssurance and Ross E. Taubman, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.7
|
|
Form of Indemnification Agreement between ProAssurance and each of the following named executive officers and directors of ProAssurance*:
|
|
|
|
Lucian F. Bloodworth Samuel A. Di Piazza, Jr.
Robert E. Flowers Howard H. Friedman
M. James Gorrie Jeffrey P. Lisenby
William J. Listwan John J. McMahon
Drayton Nabers Frank B. O’Neil
Ann F. Putallaz Edward L. Rand, Jr.
Frank A. Spinosa W. Stancil Starnes
Ross E. Taubman Anthony R. Tersigni
Thomas A. S. Wilson, Jr.
|
|
|
|
Filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.8
|
|
ProAssurance Group Employee Benefit Plan which includes the Executive Supplemental Life Insurance Program (Article VIII), filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2004 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.9
|
|
Amendment and Restatement of the Executive Non-Qualified Excess Plan and Trust effective January 1, 2008, filed as an Exhibit to ProAssurance’s Annual Report on Form 10-K for the year ended December 31, 2007 (File No. 001-16533) and incorporated herein by this reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.10(a)
|
|
Director Deferred Compensation Plan as amended and restated December 7, 2011, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.10(b)
|
|
Amendment No. 1 to the Amended and Restated Director Deferred Compensation Plan dated May 22, 2013, filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.12(a)
|
|
ProAssurance Corporation 2008 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Registration Statement on Form S-8 (File No. 333-156645) and incorporated by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.12(b)
|
|
First Amendment to the 2008 Equity Incentive Plan, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.13
|
|
ProAssurance Corporation 2008 Annual Incentive Compensation Plan, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) on April 11, 2008 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.14(a)
|
|
Revolving Credit Agreement, dated April 15, 2011, between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.14(b)
|
|
Amendment No. 1 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.14(c)
|
|
Amendment No. 2 to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 8, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.14(d)
|
|
Form of the Augmenting Lender Supplement to Revolving Credit Agreement between ProAssurance and U.S. Bank National Association, Wells Fargo Bank, National Association, Branch Banking and Trust Company, First Tennessee Bank, N.A., and JP Morgan Chase Bank N.A., filed as an Exhibit to ProAssurance's Quarterly Report on Form 10-Q for the quarter ending June 30, 2014 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.14(e)
|
|
Pledge and Security Agreement between ProAssurance and U.S. Bank National Association, filed as an Exhibit to ProAssurance’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.15
|
|
ProAssurance Corporation Amended and Restated 2014 Equity Incentive Plan, filed as an Exhibit to ProAssurance’s Current Report on Form 8-K for event occurring May 14, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.16
|
|
ProAssurance Corporation 2014 Annual Incentive Plan, filed as an Exhibit to ProAssurance’s Definitive Proxy Statement (File No. 001-16533) filed on April 22, 2013 and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.17
|
|
Retention and Severance Compensation Agreement effective January 1, 2013, between ProAssurance and Mary Todd Peterson, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
10.18
|
|
Facility Agreement between ProAssurance and the Premiums Trust Fund of Syndicate 1729, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.19
|
|
Underwriting Agreement between ProAssurance and Goldman, Sachs & Co. and Wells Fargo Securities, LLC, filed as an Exhibit to ProAssurance's Current Report on Form 8-K for event occurring November 21, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.
|
|
|
|
|
|
10.20
|
|
Retention and Severance Compensation Agreement effective January 1, 2014, between ProAssurance and Michael L. Boguski, filed as an Exhibit to ProAssurance's Annual Report on Form 10-K for the year ended December 31, 2013 (File No. 001-16533) and incorporated herein by reference pursuant to SEC Rule 12b-32.*
|
|
|
|
|
|
21.1
|
|
Subsidiaries of ProAssurance Corporation
|
|
|
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
31.2
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(a)
|
|
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350)
|
|
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer of ProAssurance as required under SEC Rule 13a-14(b) and 18 U.S.C. 1350
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
* Denotes a management contract or compensatory plan, contract or arrangement required to be filed as an Exhibit to
this report
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|